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1 Introduction 
1.1 The worldwide social problem of infertility 
According to the world health organization (WHO), a couple can be considered 
infertile if it is not able to conceive after having unprotected intercourse continuously 
for more than one year (Tvrda et al., 2015). Infertility has remained a global concern 
since the first demographic survey provided by the WHO in 2002. On the average, 8-
12% of sexually matured couples suffer from childlessness all over the world. In several 
regions, including Africa, South and Central Asia, Central and Eastern Europe, the 
infertility rates reach as high as 30%. Correspondingly, a global growth of in vitro 
fertilization (IVF) services and assisted reproductive techniques (ARTs) are being 
recorded (Inhorn and Patrizio, 2015). Therefore a better understanding of the processes 
that lead to female and male infertility became of crucial importance. Although in more 
than half of these cases, the reason for the childlessness is due to the male partner, 
research on male infertility remains a neglected field. One of the most important 
university centers, where laboratory research is currently conducted to elucidate the 
molecular and metabolic causes that can lead to infertility in men, is the Hessian 
Reproduction Center in Giessen, Germany.  
1.1.1 Cause of male infertility 
Male infertility can result from genetic defect such as chromosome disorder or 
epigenetic factors e.g. incorrect gene transcription induced by DNA methylation and 
histone modification. Abnormal expression of genes on Y chromosome may cause 
oligozoospermia or azoospermia (Reijo et al., 1996). Moreover, male patients with 
Klinefelter syndrome (47, XXY) suffer from hypogonadism and Down syndrome (47, 
XX/XY, +21) patients often show poor testicular development (Hafeez et al., 2007). An 
example for epigenetic alterations has been found in the NANOG promoter, a germ cell 
tumor marker. This promoter has been observed to be hypomethylated in spermatogonia 
and hypermethylated in spermatozoa, and its methylation state corresponds to the 
differentiation of testicular tumor cells (Nettersheim et al., 2011). Additionally, many 
environmental factors have been suspected to cause male infertility such as chemical 
and physical agents from daily life activities, including heavy metals, pesticides such as 
cypermethrin (Jin et al., 2011), organochlorides, radiation and plastics like bisphenol A 
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and plasticizers (Marques-Pinto and Carvalho, 2013). Certain chemicals with hormonal 
properties commonly referred to as endocrine disrupting agents (EDAs) bind membrane 
receptors preventing the endogenous steroid hormone synthesis, secretion and 
metabolism. Sertoli cells known as the testicular nurse cells and key players during 
spermatogenesis, have been found to be severely disrupted by EDAs accumulation. 
Furthermore, exposure to EDAs leads to inhibition of follicle-stimulating hormone 
(FSH) synthesis, which causes a decline in Sertoli cell number. The Sertoli cell 
malfunction in turn leads to disruption of the spermatogenesis and probably induces 
Testicular Dysgenesis Syndrome (TDS) (Tvrda et al., 2015).  
1.2 Sertoli cells 
1.2.1 Morphology and function of Sertoli cells 
Sertoli cells are located in the basement membrane of seminiferous tubules in 
the testis (Figure 1) and play a crucial role in spermatogenesis, male phenotypic 
development, and the hypothalamic-pituitary-gonadal axis (Sharpe et al., 2003; Skinner 
and Griswold, 2004). These cells are closely connected to each other via tight junctions, 
forming the blood-testis barrier (BTB) also termed Sertoli cell barrier (SCB). SCB 
controls the chemical composition of the luminal fluid and prevents cytotoxic agents 
from penetrating the seminiferous tubules. Sertoli cells directly interact with male 
germ cells and support their development by structural protection and nutrition. 
Therefore, Sertoli cells are considered as support- or nurse cells (Griswold et al., 1987; 
Guo et al., 2015; Nenicu, 2010; Nenicu et al., 2007).  
Sertoli cells also play a key role in secretion of regulatory factors, e.g. growth 
factors, hormones and cytokines, and the FSH response (Guo et al., 2015; McGuinness 
et al., 1994). Besides the support to spermatogenesis, the presence of Sertoli cells is also 
required to maintain the normal level of germ cell and Leydig cell population as well as 
functional peritubular myoid cells in the adult male testis (Rebourcet et al., 2014). The 
total number of Sertoli cells will determine the efficiency of sperm production and 
testicular size. There is a positive correlation between the number of Sertoli cells and 
testis weight, the percentage and volume of blood vessels, the seminiferous epithelium 
volume and the daily number of produced germ cells (Leal et al., 2004). For these 
reasons any disturbance of these cells could potentially cause infertility or an androgen-
related endocrine disorder. 
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Figure 1 Schematic illustration of testis structure (Figure 1A) and the hypothalamic-pituitary-testicular 
axis (Figure 1B). Figure 1A is taken from website of the “School of Biological Sciences at University of 
Texas at Austin” http://www.zo.utexas.edu/faculty/sjasper/images/f36.12.jpg and Figure 1B is taken 
from the website https://imueos.wordpress.com/2010/05/24/spermatogenesis-x/. 
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1.2.2 Models to study Sertoli cells in vitro  
For in vitro studies, primary Sertoli cells are often used. These cells are usually 
isolated from the immature testis, and can be obtained with a relatively high purity 
(Nenicu et al., 2007). However, compared to aged cells, these cells have significant 
differences in the cell structure, transferrin expression level, and sensitivity to 
androgens (Anway et al., 2003). Although a method of the isolation of Sertoli cells from 
adult testis was recently established, these cells are often contaminated with germ cells 
or peritubular cells. Moreover, these primary Sertoli cells start to lose the 
responsiveness to hormones such as FSH within 6-10 days in culture (McGuinness et 
al., 1994). Therefore, in several studies the TM4 cell line was used, which provides a 
good model system to study Sertoli cell functions (Skinner and Griswold, 2004).  
The TM4 cell line was established from immature mouse Sertoli cell cultures, 
which was successfully used as a feeder layer for isolated original germ cells. Compared 
with primary Sertoli cells, the TM4 cells are less sensitive to FSH stimulation. 
Additionally, TM4 cells can inhibit testosterone production in Leydig cells, which is 
rare in vivo. Nevertheless, TM4 cells still possess the major characteristics of primary 
immature Sertoli cells, thereby providing a good tool to study Sertoli cell line signal 
transduction processes (Skinner and Griswold, 2004). 
1.2.3 Sertoli cell function regulation 
Sertoli cell function is regulated by an interaction of endocrine and paracrine 
signals in vivo. In males, the pituitary gland gonadotropins, follicle stimulation hormone 
(FSH) and luteinizing hormone (LH), regulate reproductive functions, such as 
spermatogenesis and steroid hormone (estrogen and androgen) production (Figure 1B). 
FSH binds to the FSH receptor (FSHR) on the Sertoli cell surface and initiates 
spermatogenesis. LH binds to the luteinizing hormone receptor (LHR) on Leydig cells, 
where testosterone are produced and released. Testosterone diffuses into the 
seminiferous tubules, which in turn stimulates Sertoli cells to produce androgen-binding 
protein (ABP) by which the testosterone is concentrated and enriched to promote the 
spermatogenesis (McGuinness et al., 1994).  
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bin/highlight_pathway?scale=1.0&map=map04024&keyword=FSH%20%20AMP%20PKA 
Figure 2 FSH stimulated cAMP-PKA signaling pathway (Figure 2A) and localization of PKA Cα in 
different cell types of a seminiferous tubule in the testis of a 120d-old wild-type mouse (Figure 2B1) and 
in TM4 Sertoli cells (Figure 2B2-2B3). Figure 2A contains the integrated information from the literatures 
(Hunzicker-Dunn and Maizels, 2006; Kim et al., 2005; Lazennec et al., 2000; Misra et al., 2002; Wahli et 
al., 1995; Walker and Cheng, 2005) and KEGG Pathway Database
①
. In Figure 2B1, vimentin (red) was 
used as Sertoli cell marker (Guo et al., 2015; Nenicu et al., 2007; Skinner and Griswold, 2004). PKA Cα 
subunit distribution exhibits strong differences between different spermatogenic stages of germ cell 
development. It is highest abundant in the cytoplasm of round spermatids (rSpt) and elongated spermatids 
(eSpt), whereas the cytoplasm of spermatocytes (Spc) contains much less PKA Cα. Spermatogonia (Spg) 
are only very weakly labelled by PKA Cα. Sertoli cells (SC) exhibit an intermediate PKA Cα staining 
level between spermatocytes* and round spermatids*. PKA Cα is abundant in the cytoplasm and is 
present also on a few organelle-like structures in TM4 Sertoli cells, suggesting that FSH-signalling 
should work properly in this cell type (Figure 2B2-2B3). 
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Gonadotropin hormones modulate the Sertoli and Leydig cells via the cAMP 
signal-transduction pathway: FSH and LH bind to surface receptors on Sertoli or Leydig 
cells respectively and thereby stimulate the adenylyl cyclase (AC), causing an increase 
in intracelluar levels of cAMP. An increase in intracellular cAMP results in the 
activation of the cAMP-dependent protein kinase A (PKA) (Figure 2A), leading to 
typical cell-specific responses in both cell types (McLean et al., 2002). 
The complex cyclical interplay of FSH and testosterone testosterone maintain 
Sertoli cells function by providing the energy required for male germ cell maturation 
and testicular structure development. FSH and testosterone play a role in the regulation 
of the synthesis of lactate, transferrin, androgen binding protein, transforming growth 
factor (TGF) -α and -β, insulin-like growth factor-1 (IGF-1), fibroblast growth factor 
(FGF), epidermal growth factor (EGF), mullerian-inhibiting substance (MIS), and 
inhibin in Sertoli cells (Skinner and Griswold, 2004). 
1.2.3.1 FSH signaling 
FSH acts on Sertoli cells by binding the FSH receptor (FSHR). FSHR is a cell-
surface receptor containing 7 transmembrane domains. Its structure is very similar to the 
LH receptor (LHR) and the thyroid-stimulating hormone receptor (TSHR). FSH-
binding promotes the FSHR associated partner, the inactive heterotrimeric G proteins 
with α-, β-, and γ-subunits, to release the Gα-GTP, which will bind to the adenylate 
cyclase (AC). The adenylate cyclase is then activated to convert ATP into cAMP, which 
is an ubiquitous second messenger for intracellular signal transduction. cAMP works by 
activating protein kinase A (PKA) to dissociate its C subunit (Cα, Cβ or Cγ), which will 
phosphorylate nearby substrates (Lazennec et al., 2000).  
One PKA target is the transcription factor CREB (cAMP response element 
binding protein). It is rapidly activated by phosphorylation of Ser
133
 in response to FSH. 
Several genes involved in spermatocyte survival are controlled by CREB, such as 
lactate dehydrogenase (LDH-A), stem cell factor, aromatase, and IGF-1. Mutation in 
CREB can cause more than 75% of spermatid loss due to apoptosis (Scobey et al., 2001; 
Walker and Cheng, 2005). 
CREB plays also a role in ROS toxicity and mitochondrial biogenesis. These 
processes are under the control of the key effector- Peroxisome proliferator activated 
receptor gamma coactivator -1α (PPARγ coactivator -1α, PGC-1α). PGC-1α interacts 
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with CREB as well as the nuclear receptor PPARγ, driving the expression of ROS 
detoxifying enzymes, such as GPx1 and superoxide dismutase 2 (SOD2), to regulate 
oxidative stress (Figure 2A) (Lee et al., 2009). Interestingly, PPARγ is also a key 
regulator of peroxisome metabolism and proliferation (Colasante et al., 2015).  
In addition to the transcriptional control induced by FSH/PKA signaling, A-
kinase anchoring protein (AKAP) might tether the PKA to organelle surfaces on which 
the PKA can directly influence metabolic processes, such as by the phosphorylation of 
StAR after binding to AKAP1 on the mitochondrial surface (Dyson et al., 2008; Merrill 
and Strack, 2014). 
1.2.3.2 Testosterone signaling  
The androgen testosterone is essential to maintain normal spermatogenesis. A 
lower intratesticular testosterone concentration would dramatically reduce the rate of 
spermatogenesis, for example testosterone reduction from 20 to 10ng/ml in adult rats 
induced an approximately 50% reduction of maintained spermatids per testis (Zirkin et 
al., 1989). However, compared with our knowledge on the FSH signaling pathway, little 
is known about testosterone-regulation on gene expression in Sertoli cells. Walker and 
Cheng (2005) showed that when testosterone is taken up by Sertoli cells through the 
plasma membrane, the Pem transcription factor is initiated via the binding of the 
androgen receptor (AR) to the androgen response elements (ARE) in the promoter 
region to support spermatogenesis (Figure 2A) (Walker and Cheng, 2005).  
1.3 AKAPs: Scaffolds for local signaling  
AKAP is an acronym for “A-Kinase Anchoring Protein” due to their ability to 
bind PKA (Carr et al., 1992). Originally AKAPs were named by their apparent 
molecular mass in SDS-PAGE. However, this nomenclature could be confusing when 
naming splice variants of the same Akap gene (e.g. D-AKAP1 and S-AKAP84) or 
homologs from different species (e.g. human AKAP149 and mouse/rat AKAP121) 
(Wong and Scott, 2004). Therefore, the human genome organization nomenclature 
committee (HGNC) renamed existing AKAPs from AKAP1 to AKAP14
①
 with no 
regard to their order of discovery or reference to their traditional name. For example, the 
first AKAP discovered by Carr and his colleagues in 1992 is human AKAP79 (Carr et 
                                                 
①
 http://www.genenames.org/genefamilies/AKAP 
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al., 1992), together with its homologs bovine AKAP75 and mouse/rat AKAP150 are 
now known as AKAP5. Some AKAPs which were not included in this classification 
still maintained their original name, such as Gravin, Ezrin, Rab32 and WAVE-1 (Smith 
et al., 2006; Welch et al., 2010). Most AKAPs are usually high-molecular-weight 
proteins (e.g. AKAP450 and AKAP-Lbc, each > 300kDa) but some AKAPs exist as 
small molecular weight proteins (e.g. GSKIP is only 15.6kDa) (Skroblin et al., 2010). 
1.3.1 AKAP binding features and signaling cross-talk 
AKAPs bind PKA through the unifying motif of a 14-18 amino acid α-helix 
(Day et al., 2011). PKA is normally an inactive heterotetrameric holoenzyme, consisting 
of two catalytic and two regulatory subunit dimers (C2R2). Because the majority of 
AKAPs prefer anchoring PKA RII subunits dimers, this binding domain was also 
termed RII-binding domain (RIIBD). Additionally, AKAPs also contain unique protein-
lipid or protein-protein targeting domains for anchoring its complex to specific 
subcellular locations (McConnachie et al., 2006). 
Members of the AKAP protein family act as unique assemble scaffolds, 
tethering PKA and other enzyme components together and directing them to a particular 
subcellular location close to the downstream substrates. This spatial separation between 
effector and substrate is critical for precise regulation and facilitation of signal 
transduction (McConnachie et al., 2006). As shown in Figure 3, all the cAMP-depended 
signal transduction pathways work with a series of similar components, such as GPCR, 
adenylyl cyclase, protein phosphatase, PDE, Epac and PKA. The isoform of binding 
partners recruited by AKAPs depend on the specific cell type. The adenylyl cyclase 
generates cAMP; while, PDE degrades it into 5’-AMP, not only determines the level of 
cAMP in cells, but also terminates the signal transduction at specific cellular sites. 
(Skroblin et al., 2010).  
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AKAPs do not only coordinate cAMP signaling, but also regulate other events 
by forming multi-functional complexes with protein phosphatases, ion channels, PKD 
and other kinases, small GTP-binding proteins, ERK1/2, GSK3β (see subsection 
1.4.1.1), IQGAP1 (see subsection 1.4.1.3), StAR or mRNA (see subsection 1.4.2.3). 
Therefore, AKAPs play an essential role in integrating the signaling cross talk 
(McConnachie et al., 2006; Skroblin et al., 2010).  
1.3.2 Structure of AKAP-PKA interaction 
AKAP family members contain diverse amino acid sequences without any 
conserved region, even the unifying RIIBDs only share less than 30% amino acid 
identity (Figure 4). However, despite their sequences diversity, the RIIBDs of AKAP 
proteins display a conserved unique structural feature throughout the family, which is an 
amphipathic α-helix motif, interacting with D/D domain of the PKA R subunits (Figure 
5).                                                                                                                                  
                             
Figure 3 AKAPs assemble the key enzymes and factors, forming a complex to facilitate integration of 
cAMP and relative signaling pathways. This picture is taken from the book “International review of cell 
and molecular biology” (Skroblin et al., 2010). All the partners have defined functions: G-protein-
coupled receptor (GPCR) initiates the signal from external stimulation; adenylyl cyclase (AC) transfers 
the external signal into second messenger cAMP; phosphodiesterase (PDE) is responsible for cAMP 
degradation, regulates cAMP concentration together with AC; exchange proteins directly activated by 
cAMP (Epac) acts as cAMP-effected GTP exchange factors; cyclic nucleotide gated ion channel (cNGC 
or CNG) is also a cAMP effector; protein kinase A and other kinases activated by cAMP phosphorylate 
multiple associated substrates, which are helpful for the integration and synergy of further signaling 
pathways; and protein phosphatase (PP) is mediating the desphosphorylation of those substrates, 
avoiding dysregulation of signal transduction. 
 Page | 16 
 
 
 
 
AKAP RIIBDs consist of hydrophobic and hydrophilic residue pairs, forming a 
consensus pattern [AVLISE]-X-X-[AVLIF]-[AVLI]-X-X-[AVLI]-[AVLIF]-X-X-
[AVLISE] (X = any amino acid) (Hundsrucker et al., 2010; Skroblin et al., 2010). The 
isoelectric point (pI) of known RIIBDs is in the range of 3.43-6.23. The conserved 
sequence motif and the pI range could be used together to screen for unknown AKAPs 
with low false positive hits ratio in a database.  
The PKA holoenzymes are divided into two categories: type-I with RI subunits 
(RIα or RIβ) and type-II with RII subunits (RIIα or RIIβ). Type-I PKA is found 
primarily in the cytoplasm, whereas the type-II is associated with particulate subcellular 
fractions (Dell’Acqua and Scott, 1997). According to the bias of binding PKA R 
subunits, AKAPs can be subdivided into 3 classes: RI-, RII-, or dual-specific AKAPs. 
For example, AKAP1, AKAP4, AKAP10 and AKAP11 are dual-specific and anchor 
both RI and RII subunits (Day et al., 2011; Nipper et al., 2006). In general, the specific 
interaction between RIIBD and RII has higher affinity and a lower release-rate than the 
interaction between RIIBD and RI subunits. Thus, two peptides were developed as 
isoform-selective R-binding peptides: RI-anchoring disruptor (RIAD) (Carlson et al., 
2006) and AKAP-IS which is RII-preferring (Gold et al., 2006). The artificial disruptor 
peptides maintain higher affinity and specificity than natural AKAPs. These peptides 
bind PKA R dimer by mimicking the RIIBD amphipathic helix structure, so that they 
Figure 4 Alignment of the PKA RII-binding regions of the indicated AKAPs and artificial disruptor 
peptides (Gold et al., 2006; Hundsrucker et al., 2010; Skroblin et al., 2010) 
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can competitively disrupt PKA-AKAP interaction and inhibit PKA-dependent signaling 
by mislocalization of PKA (Carlson et al., 2006).       
 
 
 
1.3.3 Diversity and evolution within the AKAP family  
Most AKAPs are “canonical AKAPs” and present widely in all organ and cell 
type, interacting with the D/D domain of PKA R subunit dimers via an amphipathic 
helix and anchoring PKA and other partners to target organelles, like the plasma 
membrane, the cytoskeleton, mitochondria, the Golgi apparatus, the nucleus, or 
vesicular structures (Wong and Scott, 2004).   
Some AKAP-PKA binding mechanism work differently. These exceptions are 
called “non-canonical AKAPs”, such as pericentrin (Diviani et al., 2000) and inactive 
RSK1 (Gao et al., 2010). Their PKA binding sequence could even be a 100-amino acid, 
Figure 5 Crystal structure (PDB ID: 2HWN) displaying the contact point between the AKAP RIIBD 
and PKA RII D/D domain (dimerization and docking domain). This picture was generated by Swiss 
PDBViewer version 4.1.0. Residues Ile
3
, Lie
5
 and Leu
21
 in D/D domain are necessary for AKAPs/PKA 
binding. PKA RII dimer I is formed by helix I (cyan)-turn-helix II (green), and dimer II by helix I’ 
(pink)-turn-helix II’ (red). Dimer I interacts dimer II in an antiparallel manner resulting an X-form, 4-
helix bundle, which is called D/D domain. The connection is stabilized by the interaction between the 
hydrophobic core of D/D domain and amphipathic helix from AKAPs  (Kinderman et al., 2006). 
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non-helical, Leucine-rich region that interacts with RII. This binding is also insensitive 
to AKAP-PKA disruptor peptides. Therefore, the non-canonical AKAPs are often 
undetected during AKAP screenings and as such often classified as false positive hits, 
or defined as “putative AKAPs”.      
Homologues of many mammalian AKAPs were found in lower vertebrates too. 
Such as the GSKIP homologue in the one of most basal chordate subphylum, Florida 
lancelet (Branchiostoma floridae), named DUF727, which shares more sequence 
similarity with human GSKIP than invertebrate GSKIP. There is a big gap between the 
vertebrate AKAPs and invertebrate orthologs. For example, all the vertebrate AKAP 
GSKIPs bind PKA RII subunit, in contrast to invertebrate or fungal GSKIP homologues 
that do not bind RII, suggesting that the RIIBD was formed as vertebrate evolved 
(Hundsrucker et al., 2010).  
1.4 A closer look to four AKAPs used in this study  
As mentioned above in subsection 1.2.3 (Figure 2A), the hypothalamic-pituitary-
testicular axis is critical for the male reproductive system development by secreting the 
hormone FSH and LH to maintain normal spermatogenesis. Moreover, the cAMP-PKA-
dependent signaling cascades initiated by FSH and LH stimulation are assumed to be 
regulated by certain AKAPs. AKAP11, AKAP1, AKAP4 and AKAP10 have been 
identified in the testis and are assumed to contain potential organelle targeting motif. 
Therefore, understanding the connection between these 4 AKAPs and the FSH/LH-
stimulated phosphorylation pathways are necessary to further our knowledge of male 
fertility. 
1.4.1 AKAP11 (=AKAP220) 
AKAP220, now named AKAP11, was first described as an ubiquitously 
expressed 220kDa PKA anchoring protein, encoded by the Akap11 gene, which was 
previously shown to sequester PKA to peroxisomes (Lester et al., 1996). AKAP220 
might influence peroxisomal metabolism in the testis by binding PKA to the 
peroxisomes. Therefore, it is of interest to define why male patients with peroxisomal 
dysfunction exhibit male infertility and why peroxisomes are very abundant in Sertoli 
and Leydig cells (Dastig et al., 2011; Nenicu et al., 2007).  
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1.4.1.1 Sequence structure and partner binding sites of AKAP11 
The human AKAP220 [Q9UKA4.1] is the most well studied AKAP220, also a 
dual-specificity AKAP that can bind both PKA RI and RII subunits (Reinton et al., 
2000). Other binding partners that have been identified by immunoprecipitation include 
protein phosphatase 1 (PP1) and glycogen synthase kinase-3β (GSK-3β) (Logue et al., 
2011a; Tanji et al., 2002). The PKA holoenzyme recruitment could enhance protein 
phosphatase 1 inhibition, so that the intermolecular interactions influence the other 
binding partners’ activity within one signaling scaffold (Schillace et al., 2001). For 
example GSK-3β, another enzyme that associates with AKAP220, is phosphorylated by 
PKA at Ser
9
, thereby decreasing its activity. In contrast, protein phosphoatase1 
dephosphorylates Ser
9
 of GSK-3β to enhance its function (Tanji et al., 2002). GSK-3β is 
a Ser/Thr kinase that regulates glycogen synthase activity (Plyte et al., 1992), and also 
induces apoptosis in cerebellar granule neurons (Li et al., 2000).  
 
 
 
                                                                          
1.4.1.2 Subcellular localization 
In rats, the first AKAP220 [Q62924.1] was shown by immunofluorescence to be 
targeted to peroxisomes, which contains a putative peroxisomal targeting signal (PTS1) 
at its C-terminus (the last 3 amino acids “CRL”) (Lester et al., 1996). However, this 
peroxisomal targeting remains to be dubious since other researchers have claimed it 
might be the result of a “partial overlap of a couple of puncta, possibly caused by 
chance, was seen in only a few cells either stained for PMP70 or stained for proteins 
with another peroxisomal targeting sequence –SKL” (Day et al., 2011). PMP70 is a 70-
Figure 6 Schematic diagram of hAKAP220 (1901-amino acid) and its partner-binding positions 
examined by experiments. The color boxes indicate the binding sites or regions as described with 
corresponding color text (Logue et al., 2011b; Okutsu et al., 2008; Schillace and Scott, 1999; Schillace 
et al., 2001; Tanji et al., 2002). 
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kDa peroxisomal membrane protein. Another AKAP220 isoform [NP_036905.2] in rats 
without PTS1 signal was found as the most abundant AKAP in kidney. Double 
immunofluorescence staining clearly colocalized AKAP220 with Aquaporin 2 (AQP2) 
in the subapical cytoplasmic region of inner medullary collecting ducts (Okutsu et al., 
2008; Uawithya et al., 2008). 
The mRNA of hAKAP220 was found to be highly transcribed in human testis, 
especially in isolated pachytene spermatocytes and round spermatids. 
Immunofluorescence labeling showed that endogeneous hAKAP220 displayed different 
subcellular localizations during the human sperm development: cytoplasmic in 
premeiotic pachytene spermatocytes and centrosomal of postmeiotic male germ cells, 
elongating spermatocytes and mature sperm. Moreover, the hAKAP220 complex 
together with PKA RI, RII and protein phosphatase 1 was suggested to associate with 
cytoskeletal structures of the sperm tail (Reinton et al., 2000). hAKAK220 [Q9UKA4.1] 
also contains no peroxisomal targeting signal. 
In mice, AKAP11 is located in the cytoplasm, and it recruits the type I PKA 
holoenzyme. Under the stimulation of increasing cAMP level, PKA C subunits are 
released and promote AKAP11 to target free RIα to multivesicular bodies (MVBs). No 
colocalization was observed with lysosomes, mitochondria, or peroxisomes, and this 
mAKAP220 also doesn’t contain PTS1 signal  (Day et al., 2011). 
1.4.1.3 Metabolic functions of AKAP220 
AKAP220 has been proposed to be involved in the regulation of the urine 
concentration. When the animal is dehydrated, the pituitary gland produces arginine 
vasopressin (AVP), a peptide hormone that acts on the basolateral plasma membrane of 
collecting ducts of the kidney. The AVP targets the vasopressin type 2 receptor (V2R), 
thereby initiating a cAMP-dependent and AKAP220-mediated PKA signal cascade in 
the collecting ducts. Then the PKA C subunit is activated to phosphorylate a water 
channel Aquaporin 2 (AQP2) at Ser
256
, inducing AQP2 to translocate from cytosol to 
the apical membrane. With the increasing number of AQP2 inserted in the apical 
membrane, water permeability of the collecting ducts will be enhanced to enable water 
reabsorption (Okutsu et al., 2008). 
Other research has proposed AKAP220 to be involved in migration of human 
fibrosarcoma cells. AKAP220 assembles the cytoskeletal scaffolding protein IQGAP1, 
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which plays a role in cytoskeletal polarization and cell motility. AKAP220 supports the 
spatial and temporal synchronization to regulate dynamic instability of microtubule. 
Therefore, AKAP220 could be essential in microtubule dynamic for cancer cells 
migration and invasion as shown in Figure 7 (Logue et al., 2011b).  
                                                                                                                                                   
 
 
 
Research has shown a link between AKAP220 and the development of oral 
cancer. The retinoblastoma (RB) protein is a tumor suppressor protein, which prevents 
cell growth and its dysfunction can cause several different types of cancers (Murphree 
and Benedict, 1984). Rb pathway is known to alter the cell cycle and progression of 
early oral premalignant lesions (OPLs). AKAP220 takes part in the Rb pathway by 
regulating protein phosphatase 1 activation and RB protein dephosphorylation and the 
transcription switch of genes involved in cell proliferation. AKAP220 overexpressed 
significantly in oral tumors, suggesting a role in oral carcinogenesis (Garnis et al., 
2005).  
1.4.2 AKAP1 
A-kinase anchoring protein 1 is also known as AKAP1, PRKA1, AKAP84, 
TDRD17, AKAP121 [Mus musculus], AKAP149 [Homo sapiens], D-AKAP1, 
Figure 7 Schematic diagram of AKAP220 complex leading function in cell migration. This picture is 
taken from (Logue et al., 2011b). IQGAP1 supports Ca
2+
/CaM-dependent association of factors that 
modulate microtubule dynamics. Under the integration of Ca
2+
 and cAMP signals, AKAP220 signaling 
platform was compartmentalized to the substrates at leading edges of migrating cells. Activated GSK-3β, 
which is anchored on AKAP220 complex, phosphorylates the plus-end microtubule tracking protein 
CLASP2 at Ser
533
 and Ser
537
, and inhibits CLASP2 binding to IQGAP1. When the cellular Ca
2+
 level 
increases, CaM and Rac could release IQGAP1, so that IQGAP1 is then free to bind AKAP220. With an 
increasing cAMP concentration, PKA is activated and can phosphorylate and inhibit GSK-3β, resulting 
the releasing of activated CLASP2 to anchor IQGAP1. 
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PPP1R43 or SAKAP84
①
. AKAP1 binds to RI and RII of PKA and anchors them to the 
cytoplasmic face of the mitochondrial outer membrane
②
.  
1.4.2.1 Alternative splicing and subcellular locations  
Akap1 transcripts are widely expressed in testis, heart, liver, kidney, skeletal 
muscle and brain. Diverse Akap1 transcripts are derived from the same gene by 
alternative pre-mRNA splicing. A common N-terminal exon (1-572 amino acids in 
human) codes both the mitochondrial targeting sequence (1-30 aa) and the PKA binding 
helix (347-360 aa). The C-terminal exons are more conserved, coding K homology 
(KH) domain and a Tudor domain. The differing sequence features determine the 
various subcellular localizations of AKAP1. For instance, S-AKAP84, a short AKAP1 
variant, is mainly expressed in male germ cells (Huang et al., 1999) and targeted 
selectively to the mitochondrial sheath in the sperm middle piece (Lin et al., 1995). The 
first 30 amino acids in the N-terminus of AKAP1 N0 form a hydrophobic helix 
followed by positive charges, which are necessary and sufficient to target AKAP1 to the 
mitochondrial outer membrane (MOM) (Huang et al., 1999; Ma and Taylor, 2008). 
Additionally, the AKAP1 N1 variant identified in the mouse liver was reported to target 
AKAP1 to the endoplasmic reticulum and its N-terminus contained additional 33 amino 
acids than the AKAP1 N0 variant and may be generated by either alternative splicing 
and/or differential initiation of translation (Merrill and Strack, 2014). The negatively 
charged Asp
31
 within the first 33 amino acid residues converts the mitochondrial-
targeting signal into both smooth and rough ER-targeting signal consisting of the first 
63 residues, without destroying the mitochondrial-targeting signal. Therefore, the 
availability of the Asp
31
 in AKAP1 N1 variant is responsible to determine its ER or 
mitochondrial specific targeting (Ma and Taylor, 2008).   
 
 
 
                                                 
①
 http://www.ncbi.nlm.nih.gov/gene/8165 
②
 http://www.phosphosite.org/proteinAction.do?id=7076&showAllSites=true 
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1.4.2.2 Sequence features and domains of AKAP1 
 
 
                                                                         
Within the PKA binding domain, the RII tethering domains found in the 
AKAP121 of rat (303-322 aa) and mouse (306-325 aa) are 80% identical (Bridges et al., 
2006; Feliciello et al., 1998). Spermatid-SAKAP84 binds RIIα and RIIβ (Lin et al., 
1995), and residues 306-325 constitute the RII-binding site (Chen et al., 1997).  
The K homology (KH) domain can interact independently or cooperatively with 
different regions of the AU-rich RNAs, and various single strand DNA/RNA-binding 
proteins contain such KH domain. NMR (nuclear magnetic resonance) measurement 
revealed its β-α-α-β-β-α secondary structure① (Figure 9). 
 
 
                                                 
①
 http://pfam.xfam.org/family/KH_1 
Figure 8 Schematic diagram of mouse AKAP1 (AKAP121) [O08715] (857 amino acids). The color 
boxes indicate the binding sites or regions as described with corresponding color text. 
Figure 9 Structure of a 
KH domain (PDB ID: 
2ANR). This picture was 
generated using the Swiss 
PDBViewer version 4.1.0. 
In the downstream of 
AKAP1 protein sequence, 
a KH domain is 
responsible to bind AU-
rich 3’-UTR of aimed 
mRNA (yellow). The KH 
domain displays a unique 
secondary structure 
consisting of 3 α-helixes 
(pink) and 3 β-sheets 
(green): β-α-α-β-β-α.  
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 AKAP121 binds the 3’ untranslated region (3’-UTR) of certain mRNAs over 
the KH domain and plays a role in localization, stabilization, and translational 
regulation of these mRNAs (Cardone et al., 2002). The KH domain, residues 565-613 in 
mouse and 562-610 amino acids in rat AKAP121, is highly conserved (Feliciello et al., 
1998). The phosphorylation of Ser
630
 in the AKAP149 KH domain is required for its 
RNA binding (
627
RYVS
630
 is a conserved PKA phosphorylation site), and 
dephosphorylation of this residue prevents RNA association (Rogne et al., 2009). 
 The Tudor domain of AKAP1 consists of five anti-parallel β-sheets with a 
barrel-like fold
①
, recognizes symmetrically dimethylated Arginines, and also possesses 
a weak RNase activity (Grozdanov and Stocco, 2012). 
The first 30 residues in all AKAP1 isoforms constitute a mitochondrial targeting 
motif. High similarity between the mitochondrial anchor domain of NADH-
cytochorome b5 reductase and N-terminus of S-AKAP84 has been reported (Beasley et 
al., 1993). In 2004, a peptide was derived from the mitochondrial anchor domain of 
AKAP121, [Ac-
1
XKKPLALPGMLALLGWWWFFSRKKX
25
-NH2 (X=β-Ala) 
(AKAPwt). It displays a helical wheel conformation, which might be essential for both 
tubulin binding and mitochondrial targeting. This peptide exhibits a strong competing 
inhibitory function, preventing AKAP121 anchoring PKA to the mitochondrial outer 
membrane (MOM), and in consequence reduces cAMP effects and its further influence 
on cell survival (De Capua et al., 2004). 
Furthermore, all AKAP1 isoforms (AKAP121, AKAP149, S-AKAP84) contain 
a conserved region to interact with cellular microtubules. The tubulin binding motif (10-
25 aa) and mitochondrial targeting motif (1-30 aa) overlap each other. The tubulin 
monomers might promote AKAP1 scaffold to anchor mitochondria (Cardone et al., 
2002).  
1.4.2.3 Binding partners of AKAP1 and responding mechanism and functions 
Sequence features determine secondary structures of proteins, and the three-
dimensional folding of proteins supplies molecular interactions domains for protein-
protein, protein-DNA or -RNA, protein-lipid, protein-ion interaction. Due to these 
                                                 
①
 http://pfam.xfam.org/family/TUDOR 
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domain and interaction, the subcelluar location and function of a specific protein can be 
determined and modified. 
1.4.2.3.1 AKAP1 binds double-hairpin loop of „mitochondrial“ 
mRNAs 
The KH domain of AKAP1 binds the stable stem-loop structure of pyrimidine-
rich RNAs (Livigni et al., 2006). The mRNAs of the steroidogenic acute regulatory 
protein (Star), superoxide dismutase 2 (Sod2, MnSOD), ATP synthase (F0-f) and 
lipoprotein lipase (LPL) contain double-hairpin structures in their 3’UTR (Dyson et al., 
2008; Rogne et al., 2009). When the KH domain is phosphorylated by PKA, the 
AKAP1-mRNA binding stabilizes these mRNAs, leading to more translated proteins 
and thereby increasing the abundance of the corresponding proteins in mitochondria 
after their import into the organelle (Ginsberg et al., 2003; Grozdanov and Stocco, 
2012).    
 
 
Figure 10 An illustration of cAMP-PKA pathway mediated transcriptional and translational regulation 
of StAR. Tropic hormone initiates cAMP-PKA depended signaling pathway to induce Star 
transcription. AKAP1 (AKAP121) recruits Star mRNA to the outer mitochondrial membrane, 
accelerating the translation and activation of StAR protein. AKAP1 also associates type II PKA to the 
mitochondria, which activates StAR at the mitochondrial membrane through the phosphorylation of 
Ser
195
. Some other different kinases also take part in the StAR phosphorylation. And the precursor 
37kDa StAR was cleaved into 30kDa mature form, translocating cholesterol from mitochondrial outer 
membrane to inner membrane. But this whole processing mechanism is still unclear. This picture is 
taken from the review on StAR regulation (Manna et al., 2009). 
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1.4.2.3.2 Binding through a direct protein-protein interaction  
AKAP1 anchors both PKA RI and RII subunits to the outer mitochondrial 
membrane (Herberg et al., 2000). AKAP1/RIα interaction was suggested to influence 
the release of neurotransmitter (Perkins et al., 2001). 
Human AKAP1 (AKAP149) was reported to bind protein phosphatase 1 via 
153
KGVLF
157
 or 
627
RYVSF
631
 motif (Bridges et al., 2006). Protein phosphatase 1 is a 
Ser/Thr phosphatases, consists of one catalytic subunit and one regulatory subunit. Most 
protein phosphatase 1 regulators contain an RVXF motif which interacts with the 
hydrophobic region of protein phosphatase 1 (Rogne et al., 2009).  
AKAP1 also associated with type 4 phosphodiesterases (PDE4), which 
influenced T cell activation, and suppressed inflammation by hydrolyzing cAMP 
(Asirvatham et al., 2004). 
AKAP1 has been shown to interact with a complex of protein tyrosine 
phosphatase D1 (PTPD1) (Møller et al., 1994) and the non-receptor tyrosine kinase Src 
(Dagda et al., 2011). Src was targeted to mitochondria and activated via PTPD1, 
increasing mitochondrial respiration (Livigni et al., 2006). Subsequently, the 
mitochondrial Src phosphorylates cytochrome c oxidase (COX) and stimulates COX 
activity, which positively regulates components of the respiratory chain (Carlucci et al., 
2008). 
A key-signaling event in the control of the mitochondrial morphology is the 
reversible phosphorylation of the fission protein dynamin-related protein 1 (Drp1). PKA 
phosphorylates Ser
637
 in human Drp1 (Ser
656
 in rat Drp1 isoform 1 (Dagda et al., 2011), 
results in Drp1 inhibition (Cribbs and Strack, 2007), and therefore increases the 
mitochondrial stability and cell survival. AKAP1 also recruits the calcium-responsive 
phosphatase calcineurin (CaN, PP2B). CaN dephosphorylates Ser
637
, thus activating 
Drp1 and promoting mitochondrial fission and fragmentation (Carlucci et al., 2008; 
Merrill and Strack, 2014). 
c-myc binding protein (MYCBP, also called AMY-1) was found to bind to the 
PKA RII binding region of AKAP149 and S-AKAK84. AMY-1 and S-AKAP84 
mRNAs were found to be strongly expressed in the testis after the appearance of 
spermatocytes (Furusawa et al., 2001). 
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AKAP149 binds to the RNase H region of HIV-1 reverse transcriptase (HIV-1 
RT), through the association between residues 375-645 of APAK149 and residues 464-
541 of HIV-1 RT p66 (Lemay et al., 2008; Warren et al., 2009).  
AKAP1 also binds AKAP1 itself to form an AKAP1-dimer via their C-terminal 
KH and Tudor domains. Moreover, this self-association requires RNA binding to the 
KH domain, but the molecular mechanism and physiological role of AKAP1 self-
association are not clear (Merrill and Strack, 2014; Rogne et al., 2006). 
 
 
 
                                                                                                                                               
                              
1.4.2.4 Akap1 transcript and posttranslational regulation 
The translational coactivator PPARγ (Peroxisome proliferator-activated receptor 
γ) was shown to be involved in the Akap1 mRNA regulation. Knock-in mice expressing 
mutated PPARγ (P465L), a mutation associated with severe dyslipidemia in humans, 
display reduced AKAP1 expression, whereas obese humans treated with the PPARγ 
agonist rosiglitazone show increased AKAP1 mRNA levels indicating a possible 
involvement of AKAP1 in lipid metabolism  (Rodriguez-Cuenca et al., 2012).      
Figure 11 A model illustrating of AKAP1 scaffold complex on the mitochondrial outer membrane, 
assembling diverse mRNA and protein partners to facilitate and integrate signaling pathways as 
described above (Merrill and Strack, 2014) 
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Caspase (Figure 11, Casp) cut the site DSVD of AKAP1 (579-582 aa in 
AKAP149). This cleavage results in an N-terminal fragment that contains the 
mitochondrial targeting sequence and the PKA binding site and a C-terminal fragment 
with the KH and Tudor domains. Whether this caspase cleavage of AKAP1 is 
functionally involved in the apoptotic program is unknown (Yoo et al., 2008). 
Ischemic insults were shown to promote ubiquitination and degradation of 
AKAP1. This occurs through the activation of the transcription factor HIF-1α (Hypoxia 
induced factor 1α), which induces Siah2 (E3 ubiquitin-protein ligase 7 in-absentia 
homolog 2) for ubiquitination of AKAP1. Ubiquitination accelerates the degradation of 
AKAP1 and promotes apoptosis (Kim et al., 2011). Hypoxia induces transcription and 
accumulation of Siah2, a RING domain E3-ubiquitin ligase. Siah2 targets PHD1 and 
PHD3 enzymes for proteasomal degradation, enabling accumulation of HIF-1α and 
downstream activation of hypoxia-induced genes. Hypoxia promotes Siah2-mediated 
ubiquitination and proteasomal degradation of AKAP121. This regulatory system, 
allows a fast adaptation of ischemic tissue to low oxygen and metabolite levels, and 
might be more rapid than transcriptional regulation (Carlucci et al., 2008). 
1.4.3 AKAP4  
A-kinase anchoring protein 4
①
 (AKAP4, PRKA4, AKAP-4, AKAP110, 
AKAP82, mAKAP82), acts as a prominent structural protein of the sperm fibrous 
sheath (FS), initiating sperm capacitation and influencing sperm motility
②
 (Hu et al., 
2009). 
 
 
                                                 
①
 http://www.ncbi.nlm.nih.gov/gene/11643 
②
 http://www.phosphosite.org/proteinAction.do?id=9139&showAllSites=ture 
Figure 12 Normal sperm structure (this picture is taken from 
https://www.studyblue.com/notes/note/n/male-reproductive-system-/deck/4722824) 
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Mouse AKAP4 (mAKAP82) and its homologue human AKAP4 (hAKAP82), 
are the most abundant proteins of the sperm fibrous sheath as shown in Figure 12 
(Brown et al., 2003; Hu et al., 2009). Their precursors, pro-mAKAP82 and pro-
hAKAP82 were also found in the proximal portion or entire length of the principal 
piece (Turner et al., 1998). The fibrous sheath is an unique and major cytoskeletal 
structure in the principal piece of the flagellum, together with outer dense fibers (ODFs) 
and the axoneme, which is required from sperm motility (Nipper et al., 2006). cAMP-
dependent phosphorylation/dephosphorylation events are critical for the initiation and 
maintenance of sperm flagellar beating. mAKAP82 and hAKAP82 localize to the 
fibrous sheath, influencing sperm motility by controlling cAMP-PKA signal 
transduction. A high homology of sequences was shown among pro-mAKAP82, pro-
hAKAP82 and a 75kDa rat fibrous sheath protein, suggesting conserved structure and 
function throughout AKAP4 family (Turner et al., 1998). The Akap4 transcript is highly 
expressed during early spermatid development, whereas translated AKAP4 associated 
with fibrous sheath only in the late phase of spermatid development. The mature form 
of AKAP4 can bind AKAP3, which is another sperm-specific AKAP (Carr et al., 2001), 
as well as Fibrous Sheath Interacting Proteins 1 and 2 (FSIP1 and FSIP2) (Brown et al., 
2003). AKAP4 can bind both RIα and RIIα of PKA, and target them to the microtubular 
cytoskeleton by AKAP4-tubulin interaction (Nipper et al., 2006). 
1.4.4 AKAP10  
A-kinase anchoring protein 10
①
 (AKAP10, PRKA10, D-AKAP2, D-AKAP-2) is 
a dual-specific AKAP that binds type I and II PKA (Hamuro et al., 2002). AKAP10 has 
a C-terminal PKA binding region with conserved 27-residues (e.g. V
565
 to Q
591
 in 
human AKAP10 [ABB76684.1]) that are sufficient for PKA binding. AKAP10 also 
contains one or two putative RGS domains (regulator of G protein signaling), indicating 
its function in signal transduction (Wang et al., 2001).  
The endogenous AKAP10 protein displayed various subcellular localizations in 
different cell types. For example, a mitochondrial pattern was reported in mouse oocytes 
(Webb et al., 2008), mouse myocyte cell line, and rat cardiomyocyte primary cells 
(Wang et al., 2001). A cytoplasmic staining for AKAP10 was found in a human colon 
cancer cell line (Wang et al., 2001). AKAP10 was also detected near postsynaptic and 
                                                 
①
 http://www.ncbi.nlm.nih.gov/gene/56697 
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presynaptic rat neuromuscular junction (NMJ) and near the actin region in rat muscle 
(Perkins et al., 2001). However, the targeting mechanism has not been clarified yet been 
clarified, while the mitochondrial targeting motif was only assumed to be in the N-
terminus of AKAP10 (Wang et al., 2001). 
AKAP10 plays a role in human heart rhythm control (Tingley et al., 2007). 
Genetic AKAP10 mutations could cause sudden cardiac death (SCD), which is one kind 
of unexpected rapid natural death occurring within one hour after the initial 
symptoms
①
.  
1.5 The function of AKAP1, AKAP4, AKAP10 and AKAP11 in 
genital organs   
AKAPs in different organs execute distinct specific functions. For example, 
AKAP1 is highly expressed in adipocytes, and was suggested to play a role in the 
development of obesity (Merrill and Strack, 2014). AKAP1 in bones may promote bone 
growth and mineralization (Alam et al., 2010). AKAP121 (=AKAP1) down regulation 
has also been suggested to represent an important event in the development of cardiac 
dysfunction inducing heart failure (Perrino et al., 2010). Scaffold protein AKAP1 brings 
PKA to the mitochondria outer membrane to protect neurons from injury (Merrill et al., 
2011), highlighting the importance of studying compartmentalized signaling networks 
in neurodegeneration and neuroprotection (Dagda et al., 2011). In the following 
subsections, the roles of AKAPs in the reproductive system are highlighted.  
1.5.1 Steroid hormone biosynthesis  
The rate-limiting step of steroidogenesis is mediated by the steroidogenic acute 
regulatory protein (StAR) (Dyson et al., 2008). StAR activity facilitates the transfer of 
cholesterol across mitochondrial membranes to provide the substrate for the cytochrome 
P450 side-chain cleavage enzyme (P450scc; CYP11A1). Inside the mitochondria, 
P450scc converts cholesterol to pregnenolone, which is the first steroid formed during 
the synthesis of all steroids (Miller and Bose, 2011). AKAP1 regulates 
posttranscriptional modification and degradation of StAR, especially the intracellular 
levels of Star mRNA (Grozdanov and Stocco, 2012). It is suggested that PKA in 
                                                 
①
 http://www.phosphosite.org/proteinAction.do?id=18193&showAllSites=ture 
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complex with AKAP1 directs the regulation of StAR expression in three ways: 1) PKA 
serves to control the Star promoter; 2) PKA enhances the translation of Star mRNA; 
and 3) PKA promotes StAR phosphorylation and activation (Dyson et al., 2008; 
Gomez-Concha et al., 2011).   
1.5.2 Sperm development 
S-AKAP84 (unique AKAP1 in sperm) accumulates as spermatids undergo 
nuclear condensation and tail elongation (Lin et al., 1995). S-AKAP84 and its splice 
variant AKAP121 (=AKAP1), anchor PKAIIα to the cytoplasmic surface of 
mitochondria. This anchoring has been suggested to be involved in the translocation of 
mitochondria to the site of cytoskeleton assembly in male germ cells. This process 
ultimately may modulate the motility and/or the fertilization capacity of spermatozoa 
(Feliciello et al., 1998). When human AKAP220 (=AKAP11) is expressed in testis, 
AKAP220 switches from granular cytoplasmic pattern to the centrosome in mature 
sperm. Two AKAP4 isoforms, AKAP82 and AKAP110, are testis-specific and major 
structural proteins of the sperm tail principal piece, throughout the fibrous sheath-
transverse ribs and longitudinal columns, and are important for sperm motility (Tasken 
and Aandahl, 2004).  
1.5.3 Oocyte maturation 
Homozygous female AKAP1 knockout mice are subfertile or infertile while 
heterozygous females and all genotype of males exhibit normal fertility. AKAPs play 
dual role in oocyte maturation: 1) the cAMP-PKA dependent growth arrest of oocytes at 
meiosis I prophase needed to be maintained by AKAPs prior to the luteinizing hormone 
surge. 2) after the initiation of oocyte maturation, AKAP1 is responsible for this 
maturation to proceed normally and irreversibly by sequestering PKA catalyzed 
phosphorylation from its targets (Newhall et al., 2006). The mitochondrial localization 
of PKA (YFP-linked catalytic subunit of PKA encoded from microinjected mRNA, 
YFP-PKA
cat
) is required as the oocyte grows from 61µm to 68µm diameter. This 
localization is continuously detectable throughout oocyte maturation until fertilization. 
mRNA levels of both AKAP1 and AKAP10 are markedly reduced in growing oocytes, 
and increase in the germinal vesicle (GV) stage, peak during metaphase II and 
subsequently decrease in the 2-cell embryos stage, suggesting a pattern consistent with 
that observed for the exogenous PKA (YFP-PKA
cat
) localization (Webb et al., 2008). 
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1.5.4 Prostate cancer 
Prostate cancer (PC) remains the most common male cancer in USA. The risk to 
develop PC cancer is increased by male infertility (Tvrda et al., 2015). Compare to the 
healthy tissues (normal prostate as negative control, and normal testis as positive 
control), AKAP4 protein abundance in PC patients biopsies was found to be increased. 
The reason for this aberrant expression pattern is not yet clear. One supportive evidence 
is that AKAP4 mediates calcitonin-induced invasiveness in PC tumor cells (Chiriva‐
Internati et al., 2012).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
1.6 Peroxisomes and infertility  
As mentioned in subsection 1.4.1, AKAP220 in rats was suggested to be present 
in Sertoli cell peroxisomes. Peroxisomes are small single-membrane organelles present 
in all cell types, protecting cells against oxidative stress and lipid toxicity. This 
organelle has been associated with cAMP-responsive events, such as androgen 
biosynthesis and testosterone secretion (Lester et al., 1996). Peroxisomes also play an 
important role in spermiogenesis, spermatogenesis and lipid metabolism including β-
oxidation of very long chain fatty acids (VLCFA) and cholesterol synthesis in Sertoli 
cells of seminiferous tubules (Lüers et al., 2006; Nenicu et al., 2007). The patients with 
peroxisomal biogenesis defects such as Zellweger syndrome, display degeneration in 
Sertoli cells and Leydig cells (Nenicu et al., 2007). Peroxisomes in germ cells were 
found to be functional in the synthesis of polyunsaturated fatty acids (PUFA) which are 
the major component of germ cell phospholipids membrane to protect them against 
oxidative stress. Peroxisomes were also suggested to be involved in the degradation of 
leukotrienes and prostaglandins from paracrine between germ cells and Sertoli cells 
(Dastig et al., 2011).  
1.6.1 Metabolic pathways in peroxisomes involved in male 
fertility 
Functional peroxisomes are essential for normal spermatogenesis and the lipid 
homeostasis of Sertoli cells. Peroxisomes protect Sertoli cells against ROS and lipid 
toxicity. Sertoli cell-specific Pex5 knockout mice were infertile and exhibited a lipid 
accumulation in Sertoli cells (Nenicu et al., 2007). Genetic defects in the peroxisomal 
membrane transporter ABCD1 results in dysfunction of peroxisomal metabolic 
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pathways causing adrenoleukodystrophy/adrenomyeloneuropathy (ALD/AMN) disease. 
The patients with these defects exhibited severe testicular disorders, such as an 
accumulation of VLCFA, abnormal levels of LH and FSH and vacuolated Sertoli cells, 
resulting in poor germ cell maturation and reduced fertility (Dastig et al., 2011; Lüers et 
al., 2006; Nenicu, 2010). ABCD1 (also known as ALDP) is an adrenoleukodystrophy 
protein/lipid transporter of the peroxisomal membrane and also one of the abundant 
transporters in Sertoli cells, which mainly regulates cholesterol side chain oxidation by 
peroxisomal β-oxidation pathway 2 (Nenicu et al., 2007). ABCD1-3 transport the 
different types of fatty acids such as VLCFA, LCFA, 2-methyl-branched chain fatty 
acids, dicarboxylic acids, polyunsaturated fatty acids, leukotrienes and prostaglandins 
into peroxisomal matrix (Colasante et al., 2015). Recently, substrates specificities of 
different ABCD transporters have been analyzed in detail (Ferdinandusse et al., 2014; 
van Roermund et al., 2014; van Roermund et al., 2011). 
 
 
 
Figure 13 Brief overview of major metabolic pathways and peroxins (in number) in peroxisomes of the 
mammalian testis. This picture is adapted from (Colasante et al., 2015; Fahimi and Baumgart, 1999). 
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Deficiencies of two key enzymes, dihydroxyacetonephosphate acyltransferase 
(DAPAT) and alkyl dihydroxyacetonephosphate synthase (ADAPS), involved in 
plasmalogens (PLs) synthesis caused mice spermatogenic arrest and a Sertoli cell-only 
phenotype. DAPAT and ADAPS are peroxisomal proteins, which carry a PTS1 and a 
PTS2 respectively. Another defect in the peroxisomal protein, glyceronephosphate O-
acyltransferase (GNPAT), in mice resulted in atrophic testis (Rodemer et al., 2003). 
Multifunctional protein-2 (MFP-2, also known as HSD17B4) is a peroxisomal protein 
that involved in two β-oxidation pathways to catalyse both straight chain and branched 
chain fatty acids in peroxisomes (Huyghe et al., 2006; Nenicu et al., 2007). MFP-2 
knockout mice developed neutral lipids accumulation in Sertoli cells and testis 
degeneration. This blocked peroxisomal β-oxidation in Sertoli cells might induce the 
seminiferous epithelium disintegration and mice infertility (Huyghe et al., 2006).  
Interestingly CCDC33 protein, a cancer/testis antigen expressed exclusively in 
testis, is a peroxisomal protein containing a putative type 2 peroxisomal targeting signal 
(PTS2) (Kaczmarek et al., 2009). This again suggested the peroxisomal proteins play a 
role in spermatogenesis.   
1.6.2 Peroxisomal matrix protein translocation and import 
machinery 
Peroxisomal proteins are translated on free ribosomes within the cytoplasm. 
Protein translocation and import depend on the presence of peroxisomal targeting signal 
sequences (PTS) in peroxisomal matrix proteins located either at the C-terminus or at 
the N-terminus and interact with specific cytoplasmic receptors (Dastig et al., 2011; 
Lüers et al., 2006).  
The two peroxisomal targeting signals are named PTS1 and PTS2. Most 
peroxisomal matrix proteins contain a C-terminal PTS1, which is recognized by the 
cytoplasmic receptor PEX5p (PEX5Lp in Figure 13 is the long isoform of PEX5p in 
mammals with a tetra-tricopeptide repeat domain). A few peroxisomal matrix proteins 
contain the PTS2 signal and are shuttled by receptor PEX7p. The PTS2 motif is mostly 
located at the N-terminal or less frequently at an internal region of the protein and 
consists of the consensus sequence pattern [RK]-[LVIQ]-X-X-[LVIHQ]-[LSGAK]-X-
[HQ]-[LAF] (where X is any amino acid) (Kaczmarek et al., 2009). Both receptors bind 
peroxisomal matrix proteins and transfer them from the cytosol to the docking complex 
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(PEX13p and PEX14p) on the peroxisomal membrane. However, how the peroxisomal 
proteins travel across the peroxisomal membrane and are released into the peroxisomal 
matrix is still unclear (Islinger et al., 2012; Schrader and Fahimi, 2008).  
1.7 Aims of the thesis   
Although it is well known that the FSH stimulated PKA pathway affects 
spermatogenesis and Sertoli cell functions strongly, until now only one AKAP220 
protein has been identified to be involved in targeted PKA regulation of steroid 
biosynthesis in Sertoli cells. This PKA-anchoring protein in the rat appeared to be 
restricted to the peroxisome because of its PTS1 at the C-terminus. However, it is 
unknown whether PKA is targeted to the peroxisomes and its role in peroxisomes has 
not yet been investigated. Peroxisomes function in cellular β-oxidation of fatty acids, as 
well as LH-responsive testosterone secretion in Leydig cells (Mendis-Handagama et al., 
1992). New information on A-kinase anchoring proteins and their eventual action on 
peroxisomal metabolism will help to understand the role of these organelles in the 
normal physiology of the testis and in the molecular pathogenesis of male infertility. 
Furthermore, understanding the A-kinase anchoring proteins can eventually provide 
insights on coordination of organelles involved in steroidogenesis, such as 
mitochondria, the endoplasmic reticulum and peroxisomes. Finally, it is known that 
PPARα, involved in regulation of many peroxisome genes, is phosphorylated by PKA. 
Therefore, it was hypothesized that the AKAP protein with putative PTS1 signals 
transported to the peroxisomes may influence peroxisome metabolic events related to 
the biological function of a certain cell type.  
Therefore, the main aims of this project were:  
- To analyze whether peroxisome gene transcription is influenced by FSH 
- To analyze whether AKAP220 is really localized in Sertoli cell peroxisomes 
- To characterize A-kinase anchoring proteins with putative C-terminal 
“PTS1” 
- To clone these AKAPs and analyze their subcellular location in Sertoli cells 
- To get more insights on their eventual function in Sertoli cells 
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2 Materials  
2.1 Cell line and medium 
The Sertoli cell line (TM4) and the medium used for the studies are described in 
details in Table 1. 
 
Table 1 Cell line and medium (information from ATCC search and Health Protechtion Agency cell line 
data sheet 50004291) 
Cell line name  TM4 
ATCC
®
 Number CRL-1715™ 
Catalogue No. 88111401 
Lot No. 00C013 
Description  Mouse BALB/c testis Sertoli cell 
Growth Mode Adherent 
Culture Medium Ham’s F12 + DMEM (1:1) + 2mM Glutamin [DMEM/F-12+GlutaMax™-L 
(GIBCO 31331)] + 5% Horse Serum (HS) + 2.5% Foetal Bovine Serum 
(FBS) 
Reactivity From primary culture of Sertoli cell enriched preparations from normal testis 
of a 11-13 day old BALB/c nu/+ mouse. Cells respond to FSH but not LH; 
Plasminogen activator secretion is FSH and also retinoic acid.  
Preservation Freeze medium: 90% culture medium + 10% DMSO  
Storage temperature: liquid nitrogen vapor phase 
 
 
2.2 Routine Materials 
Routine materials used in this thesis are summarized in Table 2.  
 
Table 2 Routine reagents list 
Reagent Name Company / person Cat. No. Application  
Follicle-stimulating 
hormone (FSH) 
Sigma-Aldrich F8174 PKA activator 
Cholera toxin (CT) Sigma-Aldrich C8052 Gs protein activator 
Forskolin (FSK) Sigma-Aldrich F6886 Adenylate cyclase (Ac) 
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activator 
8-Br-cAMP Sigma-Aldrich B5386 cAMP analog 
3-Isobutyl-1-methylxanthine 
(IBMX)  
Sigma-Aldrich I5879 Phosphodiesterase (PDE) 
inhibitor 
H89 dihydrochloride hydrate Sigma-Aldrich B1427 Specific inhibitor of PKA 
Cell Lysis Buffer (10×) Cell Signaling 
Technology® 
#9803 Used for protein isolation 
OptiPrep™ Density 
Gradient Medium 
Sigma-Aldrich D1556 Used for cell and organelle 
isolation 
Immun-Star™ AP Substrate  Bio-Rad Laoratories, 
Inc. 
170-5018 Western blot substrate, 
used for detection  
Precision Plus Protein™ 
WesternC™ Standards 
Bio-Rad Laoratories, 
Inc. 
161-0376 Protein ladder for Western 
blots 
Precision Plus Protein™ 
Standards Dual Color 
Bio-Rad Laoratories, 
Inc. 
161-0374 Protein ladder for Western 
blots 
RNase-ZAP™ Sigma-Aldrich R2020 Cleaning agent for 
removing RNase 
RNA Marker Promega G3191 RNA ladder for gel 
electrophoresis  
Anti-Digoxigenin Roche Applied 
Science 
11 333 062 910 Northern Blot 
SP6 RNA Polymerase Roche Applied 
Science 
10 810 274 001 Northern Blot 
T7 RNA Polymerase Roche Applied 
Science 
10 881 767 001 Northern Blot 
DIG RNA Labeling Mix, 
10× conc. 
Roche Applied 
Science 
11 277 073 910 Northern Blot 
Nylon Membranes, 
positively charged 
Roche Applied 
Science 
11 209 299 001 Northern Blot 
Blocking Reagent Roche Applied 
Science 
11 096 176 001 Northern Blot 
Dispergierer IKA Ultra-
Turrax® T25 basic  
IKA-Werke GmbH & 
Co. KG 
Z404578  High speed homogenizer 
RNase AWAY® MOLECULAR BIO-
PRODUCTS INC 
7000 For eliminating RNase and 
DNA from apparatus and 
tools surfaces 
Diethyl pyrocarbonate 
(DEPC) 
Sigma-Aldrich D5758 Nuclease inhibitor, 0.1% 
DEPC water is used for 
RNA related work  
RNAzol® RT  Sigma-Aldrich R4533 RNA isolation 
RNAlater® RNA 
Stabilization Reagent 
Qiagen  76104 Stabilizing RNA away 
from risk of degradation 
RNeasy Mini Kit  Qiagen  74104 Purification of high-
quality RNA from tissues 
RNeasy Fibrous Tissue Mini 
Kit 
Qiagen  74704 RNA isolation kit for heart 
and muscle tissue 
Superscript™ II Reverse 
Transcriptase 
Invitrogen 18064-022 Reverse transcription  
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Oligo (dT)12-18 Primer Invitrogen 18418-012 Hybridizes to the mRNA 
poly(A) tail and acts as a 
primer for first strand 
cDNA synthesis 
Wasser AccuGENE
®
 LONZA 733-1631 Water, molecular biology 
grade   
10× Taq Buffer, with 15 
mM Magnesium 
5PRIME 2201240 PCR 
Taq DNA polymerase  5PRIME 2900166 PCR 
Deoxynucleotide Mix, 
10mM each dNTP  
5PRIME 2900389 PCR 
10× Pfu Buffer Promega M776A Pfu-PCR 
Pfu DNA polymerase Promega M774A Pfu-PCR 
100mM dATP solution Invitrogen P/N 55082 Pfu-PCR 
Dpn I Promega R623A A restriction enzyme 
which digests methylated 
DNA 
DNase I, Amplification 
Grade 
Invitrogen 18068-015 Digests single / double 
strand DNA 
RNaseOUT™ Ribonuclease 
Inhibitor 
Invitrogen 10777-019 Inhibits RNase A, RNase 
B, RNase C 
BamHI Promega R602A Restrict enzyme digestion 
EcoRI Promega R601A Restrict enzyme digestion 
EcoRV Promega R635A Restrict enzyme digestion 
HindIII Promega R604A Restrict enzyme digestion 
Sal I Promega R605A Restrict enzyme digestion 
SphI Promega R626A Restrict enzyme digestion 
XhoI Promega R616A Restrict enzyme digestion 
Bovine Serum Albumin 
Acetylated (BSA) 
Promega R396A Restrict enzyme digestion 
Buffer B Promega R002A Restrict enzyme digestion 
Buffer D Promega R004A Restrict enzyme digestion 
Buffer K Promega R010A Restrict enzyme digestion 
Universal Agarose BIOSELL BS20.46.500 Electrophoresis for 
checking DNA size  
Agarose LE, low electro-
endosmosis 
Boehringer Mannheim 
GmbH 
1685651 Electrophoresis for DNA 
purification  
NucleoSpin
®
 Gel and PCR 
Clean-up 
MACHEREY-
NAGEL 
REF 740609.50 Gel extraction kit 
Subcloning Efficiency™ 
DH5α Competent Cells 
Invitrogen 18265-017 Heat shock competent 
bacteria 
ElectroTen-Blue Agilent Technologies 200159 Electroporation Competent 
Cells 
NucleoSpin
®
 Plasmid MACHEREY-
NAGEL 
REF 740588.250 Plasmid isolation kit 
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NucleoBond
®
 Xtra Midi EF MACHEREY-
NAGEL 
REF 740420.50 EF-Midi plasmid isolation 
kit  
ViaFect™ Transfection 
reagent 
Promega  E4981 Transfects DNA into cell 
lines with high efficiency 
and low toxicity 
Poly-L-Lysine 
hydrobromide 
Sigma-Aldrich P2636 Poly-lysine coating cover 
slip 
 
2.3 Buffer recipes 
All buffers used in this thesis are summarized in Table 3. 
 
Table 3 Buffer recipes 
Buffer   Stability at °C 
Buffer A (for Western blot) 1.5M Tris, 13.87mM SDS, pH 8.8 4°C 
Buffer B (for Western blot) 500mM Tris, 13.87mM SDS, pH 6.8 4°C 
Separating gel composition 
(12% acrylamide gel) (for 
Western blot) 
8ml 30% acrylamide solution, 2ml ddH2O, 10ml 
Buffer A, 130µl 10% APS, 15µl TEMED 
Immediately 
use  
Collecting gel composition 
(for Western blot) 
1.25ml 30% acrylamide solution, 3.75ml ddH2O, 5ml 
Buffer B, 130µl 10% APS, 15µl TEMED 
Immediately 
use 
5 × Running Buffer (for 
Western blot) 
123.8mM Tris, 1M Glycine, 17.4mM SDS. Dilute it 
into 1× electrophoresis buffer before using 
4°C 
SDS Laemmli Sample Buffer 
(for Western blot) 
3.55ml ddH2O, 1.25ml Tris-HCl (0.5M, pH 6.8), 
2.5ml glycerol, 2ml 10% (w/v) SDS, 0.2ml 0.5% 
(w/v) bromophenol blue 
-20°C 
10×TBS Buffer (for Western 
blot) 
100mM Tris, 1.5M NaCl, pH 8.0 4°C 
1×TBST (0.05% Tween 20) 
(for Western blot) 
Solve 100ml 10× TBS Buffer and 0.5ml Tween 20 
into 1000ml MilliQ H2O 
Room 
temperature 
Stripping Buffer (500ml, pH 
6.8) (for Western blot) 
10ml 10% (w/v) SDS, 62.5ml Tris-HCl (0.5M, pH 
6.8), 427.5ml MilliQ H2O 
4°C 
Homogenizing Buffer (cell 
lysis buffer for peroxisome 
isolation) 
250mM Sucrose, pH 7.4; 5mM MOPS, pH 7.4; 0.1% 
Ethanol, 1mM EDTA; 1mM 6-aminocaproic acid, 
0.2mM DTT, Protease inhibitor mix 1:100   
Prepare freshly  
OptiPrep™ diluent (Solution 
B) 
0.25M sucrose, 10mM EDTA, 1% (v/v) ethanol, 
100mM MOPS-NaOH, pH 7.2 
Immediately 
use  
Working Solution (Solution 
C, 54% iodixanol, ρ = 1.291 
g/ml) 
90% OptiPrep™, 10% Solution B Immediately 
use  
Homogenization medium 
(Solution D) 
0.25M sucrose, 1mM EDTA, 0.1% (v/v) ethanol, 
10mM MOPS-NaOH, pH 7.2 
Immediately 
use  
Narcotic solution (rat 
Anaesthesia) 
0.65ml Ketamin Ratiopharm (Ketamin 100mg/ml); 
0.65ml Rompun (Xylazin 20mg/ml); 0.2ml 
4°C 
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Sedostress (Azepromazin 10mg/ml); 8.5ml 0.9% 
NaCl. Each 0.1ml Narcotic solution is used for 10g 
bodyweight.   
Transfer Buffer (RNA 
gel/nylon membrane 
sandwiches) 
3M NaCl and 341.78mM sodium citrate in 0.1% 
DEPC water, pH 7.0  
Room 
temperature 
1 × Maleic acid buffer (for 
Northern blot) 
0.1M Maleic acid, 0.15M NaCl, pH 7.5 (20°C), 
sterile filtered 
20°C 
Basic Buffer (for Northern 
blot) 
40mM Tris-HCl, pH 7.4; 150mM NaCl 1 week at 4°C 
Antibody Buffer (for 
Northern blot) 
1% Blocking reagent (w/v) in Basic Buffer  2 months at 4°C 
Blocking solution (for 
Northern blot) 
1g Blocking reagent powder (w/v) in 100ml 1 × 
Maleic acid Buffer 
4 weeks at 4°C 
Washing Buffer 1 (test) 0.1% Tween 20 in Basic Buffer, pH 7.4 Not recommend 
Washing Buffer 2 (test) 25mM Na2HPO4, 1% SDS, 1mM EDTA, pH 7.2 Not recommend 
Washing Buffer 3 (test) 0.3% Tween 20 in 1× Maleic acid buffer, pH 7.5 Not recommend 
Washing Buffer 4 (test) 0.1× SSC Not recommend 
Washing Buffer 5 (test) 0.1× SSC, 0.1% SDS Not recommend 
Washing Buffer 6 (test) 0.5× SSC Not recommend 
Washing Buffer 7 (test) 0.5× SSC, 0.1% SDS Not recommend 
Washing Buffer 8 (for 
Northern blot) 
1×SSC: 0.75M NaCl and 0.75M sodium citrate 4°C 
Washing Buffer 9 (test) 1× SSC, 0.1% SDS Not recommend 
Formamide Hybridization 
Buffer (for Northern blot) 
50% formamide (v/v) deionized, 5× SSC, 0.1% N-
lauroylsarcosine (w/v), 0.02% SDS (w/v), 2% 
Blocking solution (v/v) 
4°C 
10 × MOPS Running Buffer 
(for Northern blot) 
0.2M MOPS, pH 7; 50mM sodium citrate, 0.01M 
EDTA 
4°C 
10 × Formaldehyde loading 
Buffer (for Northern blot) 
1mM EDTA, pH 8; 0.25% (w/v) bromphenol blue, 
0.25% (w/v) xylene cyanol, 50% (v/v) glycerol 
20°C 
6× DNA loading Dye 0.25% (w/v) bromphenol blue, 0.25% (w/v) xylene 
cyanol, 30% (v/v) glycerol 
4°C 
Stripping Buffer (for Northern 
blot, but not recommend) 
50% deionized formamide, 5% SDS, 50mM Tris-
HCl, pH 7.5  
4°C 
H3BO3/Na-tetraborate Buffer 
(for coating cover slip) 
0.7mM Lysine, 100mM boric acid, 47.5mM Na-
tetraborate  
4°C 
 
2.4 AKAP plasmids  
Different A-kinase anchoring plasmids were selected and a database search 
performed to find the appropriate IMAGE clones for purchase (Table 4). A plasmid that 
contains partial of Akap11 [NM_012773.2] sequence was used as the template for 
Northern blot probes design. The plasmids of Akap1 [NM_009648.2], Akap4 
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[NM_009651.4] and Akap10 [NM_019921.3] were used for detection primers design 
and myc-tagged AKAPs overexpression.    
 
Table 4 Commercial plasmids information 
Gene 
Symbol 
Company  I.M.A.G.E Vector Cloning Sites Antibiotics  
Akap11 GenomeCube IMAGp998B0715541Q pExpress-1 5s: EcoRV,  
3s: NotI 
Ampicillin 
(50µg/ml) 
Akap1 GenomeCube IRAVp968B01135D pYX-Asc 5s: EcoRI,  
3s: NotI 
Ampicillin 
(100µg/ml) 
Akap4 GenomeCube IRCLp5011A0634D pCR-
BluntII-
TOPO 
5s: TOPO sites,  
3s: TOPO sites 
Kanamycin 
(100µg/ml) 
Akap10 GenomeCube IRAVp968B05107D pSPORT1 5s: SalI,  
3s: NotI 
Ampicillin 
(100µg/ml) 
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2.5 Primers 
All the primers used in this study are listed in Table 5, including verified ones (*) and new designed ones.  
Table 5 List of primers designed and used in this study 
Gene 
Name 
Tageted tamplate  Len. 
(bp) 
Primer 
Lab-ID 
Primer Lab-Name 
 
Sequence (5'- 3') Optimized 
Ann. 
Temp. 
(°C) 
28S rRNA NR_003279 254 G12* rRNA-For1 CCTTCGATGTCGGCTCTTCCTAT 65 
   G14* rRNA-Rev1 GGCGTTCAGTCATAATCCCACAG  
ABCD1 NM_007435 465 D24* ALDP-For2 GAGGGAGGTTGGGAGGCAGT 67 
   D26* ALDP-Rev2 GGTGGGAGCTGGGGATAAGG  
ABCD2 NM_011994.2 406 K19* ABCD2-For3 TGCAAAATTCTGGGGAAGA 58 
   K20* ABCD2-Rev2 TGACATCAGTCCTCCTGGTG  
ABCD3 NM_008991.2 523 L02* HAbcd3for1 CTGGGCGTGAAATGACTAGATTGG 65 
   L03* HAbcd3rev1 AGCTGCACATTGTCCAAGTACTCC  
ACOX1 NM_015729.3 566 D15* Acox1-For1 CTGAACAAGACAGAGGTCCACGAA 60 
 NM_001271898.1 566 D16* Acox1-Rev1 TGTAAGGGCCACACACTCACATCT  
ACOX2 NM_053115.2 688 D17* Acox2-For1 CTCTTGCACGTATGAGGGTGAGAA 60 
 NM_001161667.1 688 D18* Acox2-Rev1 CTGAGTATTGGCTGGGGACTTCTG  
ACOX3 NM_030721.2 813 D19* Acox3-For1 GCCAAAGCTGATGGTGAGCTCTAT 55 
   D20* Acox3-Rev1 AGGGGTGGCATCTATGTCTTTCAG  
Catalase NM_009804.2 833 D49* Catalase-For3 ATGGTCTGGGACTTCTGGAGTCTTC 64 
   D53* Catalase-Rev3 GTTTCCTCTCCTCCTCGTTCAACAC  
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Gpx1 NM_008160.6 197 J64* Gpx1-For1 GGGACTACACCGAGATGAACGA 61 
   J65* Gpx1-Rev1 ACCATTCACTTCGCACTTCTCA  
SOD1 NM_011434.1 153 G40* SOD1-For1 TGGGTTCCACGTCCATCAG 63 
   G42* SOD1-Rev1 ACACCGTCCTTTCCAGCAG  
Pex5 NM_008995.2 508 F47* Pex5-For1 GAGTGAAGAAGCAGTGGCTGCATAC 64 
 NM_175933.2 508 F48* Pex5-Rev1 GGACAGAGACAGCTCATCCCTACAA  
Pex13 NM_023651.4 718 F27* Pex13-For1 GACCACGTAGTTGCAAGAGCAGAGT 65 
   F28* Pex13-Rev1 CTGAGGCAGCTTGTGTGTTCTACTG  
Pex14 NM_019781.2 131 F29* Pex14-For1 CACCTCACTCCGCAGCCATA 60 
   F32* Pex14-Rev1 AGGATGAGGGGCAGCAGGTA  
Pex11α NM_011068.1 420 F20* Pex11alpha-For1 TCAGCTGCTGTGTTCTCAGTCCTT 64 
   F19* Pex11alpha-Rev1 GTACTTAGGAGGGTCCCGAGAGGA  
Pex11β NM_011069.3 590 F21* Pex11beta-For1 ATCTGTCCCTGGCTACGACTCAAG 63 
   F22* Pex11beta-Rev1 AAACTGGAAAGTGTGGAGGCAGTC  
Pex11γ NM_026951.2 682 F23* Pex11gamma-For1 GACTCTGCTTGGTGGTGGACACT 64 
   F24* Pex11gamma-Rev1 TGTCTCTCCCACTCACCTTTAGGC  
PPARα NM_011144.6 584 F68* PPAR alpha-For2 AGACCGTCACGGAGCTCACA 68 
 NM_001113418.1 584 F70* PPAR alpha-Rev2 GGCCTGCCATCTCAGGAAAG  
PPARβ NM_011145.3 363 F71* PPAR beta-For1 CACCGAGTTCGCCAAGAACA 60 
   F72* PPAR beta-Rev1 AGAGCCCGCAGAATGGTGTC  
PPARγ NM_001127330.1 441 F74* PPAR gamma-For2 TCCGTAGAAGCCGTGCAAGA 60 
 NM_011146.3 441 F76* PPAR gamma-Rev2 CACCTTGGCGAACAGCTGAG  
FSHR NM_013523.3 345 L70* Fshr F1 CCAGCCTTACCTACCCCAGT 62 
   L71* Fshr R1 CTGTGGTGTTCCCAGTGATG  
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GAPDH  NM_001289726.1  E12* GAPDH-For1 CACCATGGAGAAGGCCGGGG  
  417 E15* GAPDH-Rev1 GACGGACACATTGGGGGTAG 60 
  440 BK16 T7-GAPDH-R TAATACGACTCACTATAGGGAGAGACGGACACATTGGGGGTAG 
         T7 RNA polymerase promoter 
60 
β-actin NM_007393.3  M29* Mm beta-Actin-
1146F 
GGATCAGCAAGCAGGAGTACGAT  
  120 M30* Mm beta-Actin-
1266R 
CTGCGCAAGTTAGGTTTTGTCAA 62 
  143 BK17 T7-beta-actin-R TAATACGACTCACTATAGGGAGACTGCGCAAGTTAGGTTTTGTCAA 
         T7 RNA polymerase promoter 
62 
StAR NM_011485.4 292 K21* StAR-For1 GTTCCTCGCTACGTTCAAGC 58 
   K22* StAR-Rev1 TTCCTTCTTCCAGCCTTCCT  
AKAP11-
LSP 
NM_012773.2  AZ47 LSP-1240F AATGTTAGAAAGCCAACACC  
  230 AZ48 LSP-1449R GCATAATCTTCGTAAGTGCAG 56 
  253 BK18 T7-LSP-R TAATACGACTCACTATAGGGAGAGCATAATCTTCGTAAGTGCAG 
         T7 RNA polymerase promoter 
56 
AKAP11-
BSP1 
NM_012773.2  AZ49 BSP-3113F ATCTGACTAATACTGCGCTTG  
  308 AZ51 BSP-3399R CTCAGATAAACTACCAACGGAT 56 
  331 BK19 T7-BSP1-R TAATACGACTCACTATAGGGAGACTCAGATAAACTACCAACGGAT 
         T7 RNA polymerase promoter 
56 
AKAP11-
BSP2 
NM_012773.2 893 AZ50 BSP-2528F GCCAGAATGACTTCAAACCAAC 56 
   AZ51 BSP-3399R CTCAGATAAACTACCAACGGAT  
AKAP11-
BSP3 
NM_012773.2 608 AZ50 BSP-2528F GCCAGAATGACTTCAAACCAAC 57 
   AZ52 BSP-3115R CTCAAGCGCAGTATTAGTCAG  
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AKAP11-
rat 
NM_012773.2 1147 AZ57 rAKAP11-2124F CTTCACAGCAAAGGCAGCAG 55 
   AZ58 rAKAP11-3341R ATTCTTTGGCTAACTCCCCTT  
M13 
promotor 
pGEM-Teasy 
plasmid 
266 BE61 M13FS CCCAGTCACGACGTTGTAAAACG 60 
 Express 1 plasmid  190 BE62 M13RS AGCGGATAACAATTTCACACAGG  
AKAP1-N 
terminus 
NM_009648.2 402 BJ25 F1N CGGAGACAAAGCTATGACCC    54 
NM_001042541.1 295 BJ26 R1N CTTGCCAATCAGTCGACCA  
AKAP1-C 
terminus 
NM_009648.2 312 BJ27 F1C TTTGTGACCCTGCCATTCCAA 54 
NM_001042541.1 312 BJ28 R1C AACAGTGCAAAGAAGACCGAA  
AKAP1 
IMAGE 
clone 
IRAVp968B01135D 2573 BH42 AKAP1-Mm-F3B ATAGGATCCGCAATCCAGTTGCGTTCGCTC 
              BamHI 
58 
  BH43 AKAP1-Mm-R3B ATACTCGAGTCAGAGGCTGGCATAGTAGCT 
               XhoI       Stop codon    
 
IRAVp968B01135D 2573 BH48 AKAP1-Mm-F5B ATAGGATCCATGGCAATCCAGTTGCGTTCG 
              BamHI     Start codon 
58 
  BH49 AKAP1-Mm-R5B ATACTCGAGGAGGCTGGCATAGTAGCTGTC 
               XhoI      
 
IRAVp968B01135D  BL03 1-5B-771F GGACTGGAGATGCTGTGTTGG  
IRAVp968B01135D  BL27 1-5B-1420F ACCAAGGACCAGAAGCCAAAG  
IRAVp968B01135D  BL30 AKAP1-Mut-F ATGGTATCACTGTGGAAGTCATCGTGGTCAAC 55 
  BL31 AKAP1-Mut-R GGTTGACCACGATGACTTCCACAGTGATACCATC  
AKAP4-N 
terminus 
NM_009651.4 202 BH58 F4N ACAACAAGATCAGGACCGAA 53 
NM_001042542.2 202 BH59 R4N GAAAAGGCACACAGATCCCTC  
AKAP4-C 
terminus 
NM_009651.4 224 BH60 F4C TGGCCCTGAAGTTATTGTCAACA 53 
NM_001042542.2 224 BH61 R4C TGGCAAACTTCATGACCTCC  
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AKAP4 
IMAGE 
clone 
IRCLp5011A0634D 2550 BH44 AKAP4-Mm-F3B ATAGGATCCATTGCCTACTGTGGTACTACA 
               BamHI 
58 
  BH45 AKAP4-Mm-R3B ATACTCGAGTTACAGGTTAGCGAGAAGCAA 
                XhoI      Stop codon    
 
IRCLp5011A0634D 2550 BH50 AKAP4-Mm-F5B ATAGGATCCATGATTGCCTACTGTGGTACT 
              BamHI    Start codon 
58 
  BH51 AKAP4-Mm-R5B ATACTCGAGCAGGTTAGCGAGAAGCAAGTC 
               XhoI      
 
IRCLp5011A0634D  BL05 4-3B-920F ATTGCTTCGGAGATGGCCCAT  
IRCLp5011A0634D  BL06 4-3B-1830R CACATGGATCTTTGCCCTTGG  
AKAP10-
C terminus 
NM_019921.3 335 BK20 F10C TCCCTGGCTGCTCACGGCTCT 56 
  BK21 R10C AGCTCTTCTTGGGCCTCGTC  
AKAP10 
IMAGE 
clone 
IRAVp968B05107D 1018 BH47 AKAP10-Mm-R3B ATACTCGAGTCATAGCTTTGTAGACTTCTC 
               XhoI      Stop codon    
58 
  BL28 10-3B-355F GAATTCAAAAGTATAGAACAAGATGCAGTG 
      EcoRI 
 
IRAVp968B05107D 1018 BH53 AKAP10-Mm-R5B ATACTCGAGTAGCTTTGTAGACTTCTCTAG 
               XhoI 
58 
  BL29 10-5B-355F GAATTCATGAAAAGTATAGAACAAGATGCA 
    EcoRI    Start codon 
 
myc-GFP-
3B 
pGeneClip hMGFP 
vector 
701 BL48 GFP-BamHI-NoStart ATAGGATCCGGCGTGATCAAGCCCGAC 
              BamHI 
62 
 BE66* RvGfP-XhoI ATACTCGAGTTAGCCGGCCTGGCGGG 
               XhoI       Stop codon    
 
GFP-myc-
5B 
pGeneClip hMGFP 
vector 
701 BE65* fvGfP-BamHI ATAGGATCCATGGGCGTGATCAAGCC 
           BamHI    Start codon 
59 
 BE67* RvGfP-XhoIWoS ATACTCGAGGCCGGCCTGGCGGG 
               XhoI      
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2.6 Antibody list  
All antibodies used in this thesis are listed with appropriate source, catalog 
number and dilution used in the different experiments (Table 6).  
 
Table 6 Antibody dilution list 
Antibody Name Host Sourse (company / person) Catalog ID Dilution  
Anti-Digoxigenin Mouse 
monoclonal 
Ab 
Roche Applied Science 11 333 062 
910 
3 : 5000 (NB) 
AKAP220 (H-
300)  
Rabbit 
polyclonal 
Ab 
Santa Cruz Biotechnology, 
Inc. 
Sc-135335 1 : 200 (WB) 
Oxphos III core 
subunit II 
Mouse 
monoclonal 
Ab 
Molecular Probes, 
Invitrogen 
459220 1 : 5000 (WB) 
Phospho-
(Ser/Thr) PKA 
Substrate  
Rabbit 
polyclonal 
Ab 
Cell Signaling 
Technology® 
#9621 1 : 1000 (WB) 
PKA C-α 
(D38C6)  
Rabbit 
monoclonal 
Ab 
Cell Signaling 
Technology® 
#5842 1 : 1000 (WB);  
1 : 400 (IF) 
Catalase  Rabbit 
polyclonal 
Ab 
Gift from Denis I. Crane, 
School of Biomol. Biophys. 
Sci., Griffith Univ., Nathan, 
Brisbane, Australia 
/ 1 : 500 (IF) 
Myc-Tag (9B11)  Mouse 
monoclonal 
Ab 
Cell Signaling 
Technology® 
#2276 1 : 8000 (IF) 
Pex3  Rat 
polyclonal 
Ab 
made by Dr. Claudia 
Colasante 
/ 1 : 200 (IF) 
Pex14  Rabbit 
polyclonal 
Ab 
Gift from Denis I. Crane, 
School of Biomol. Biophys. 
Sci., Griffith Univ., Nathan, 
Brisbane, Australia 
/ 1 : 100 (IF) 
Superoxide 
dismutase 2 
(SOD2, Mn-SOD)  
Rabbit 
polyclonal 
Ab 
Research Diagnostics, Inc., 
NJ, USA 
RDI-
RTSODMa
bR 
1 : 5000 (IF) 
anti-mouse IgG 
Alkaline 
Phosphatase 
antibody 
Goat  Sigma-Aldrich A3562 1 : 30,000 (IB) 
 
anti-rabbit IgG 
Alkaline 
Phosphatase 
antibody 
Goat  Sigma-Aldrich A3687 1 : 30,000 (WB) 
 
anti-mouse IgG Donkey Molecular Probes A21202 1 : 300 (IF) 
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Alexa Fluor 488 
green 
anti-mouse IgG 
Alexa Fluor 555 
red 
Donkey Molecular Probes A31570 1 : 300 (IF) 
anti-mouse IgG 
Texas Red 
Horse Vector Laboratories TI-2000 1 : 1000 (IF) 
anti-rabbit IgG 
Alexa Fluor 488 
green 
Donkey Molecular Probes, 
Invitrogen 
A21206 1 : 500 (IF) 
anti-rat IgG Alexa 
Fluor 594 red 
Goat Molecular Probes A11007 1 : 300 (IF) 
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3 Methods 
3.1 Bioinfomatic screening for the AKAPs with putative PTS1 signals 
In 1980’s, the Gould and Subramani group started to investigate a peptide 
targeting signal that necessary and sufficient to transport proteins into peroxisomes. 
Through a series of gene mutagenesis, they demonstrated the firefly luciferase contains 
minimal peroxisomal targeting signal consists of three amino acids, Ser (S)-Lys (K)-
Leu (L), at the extreme carboxy terminus. They also suggested this minimal PTS 
tripeptide with consensus sequence was a conserved feature of peroxsomal proteins 
through evolution (Gould et al., 1987; Gould et al., 1989). In order to identify proteins 
of the AKAP family containing a peroxisomal targeting signal 1 (PTS1), a computer 
program was developed to scan all AKAP member sequences for an eventual PTS1 
tripeptide. 
3.1.1 Scan of AKAP sequences for the consensus PTS1 motif 
All known AKAP amino acid sequences were downloaded from UniProt protein 
database, including validated and predicted AKAPs (1306 items in all), to produce a test 
library. Peroxisomal matrix proteins known to contain a real “PTS1 binding site” were 
downloaded from the PTS1 BLOCK
①
 at the “PeroxisomalDB Home” webpage②. Total 
98 PTS1 containing proteins from Homo sapiens, Mus musculus, Saccharomyces 
cerevisiae and Arabidopsis thaliana are highly conserved in evolution. The PTS1 
tripeptide consensus from these 98 proteins was summarized as [A/C/H/K/N/P/Q/S/T]-
[A/H/K/N/Q/R/S]-[F/I/L/M/V]. Within the 1306 AKAPs, the sequence matched by this 
motif were selected and saved into a *.txt file (81 items in all).  
3.1.2 Use of ClustalX 2.0 & MEGA 4.0.2 programs to create an 
evolutionary tree 
The AKAPs sequence file needed to be loaded into the ClustalX 2.0 program to 
accomplish a complete sequence alignment, and saved as *.dnd and *.aln files. 
Thereafter, the program MEGA 4.0.2 was used to convert the *.aln file into a *.meg 
file, which is the MEGA format. The new file of the *.meg format can be indicated as 
                                                 
①
 http://216.92.14.62/diy_PTS1.html 
②
 http://www.peroxisomedb.org/home.jsp  
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“Protein Sequence” by MEGA 4.0.2 and constructed a Phylogeny tree by using the 
“Neighbor-Joining” (NJ) algorithm. The program will execute a self-calculation and 
generate a tree image, which is in a *.tiff format. 
3.1.3 Use of Python 2.7.5 & R i386 3.0.1 programs to test 
AKAP1, AKAP4, AKAP10 through PTS1 predictor  
From the rough PTS1 screening throughout 14 AKAP families, 3 families of 14 
(AKAP1, AKAP4 and AKAP10) were implied to be evolutionary conserved 
“peroxisomal” AKAPs. Then the protein members of these 3 families were respectively 
further analyzed by 1) a PKA binding domain screening and 2) a comparable strict 
PTS1 online prediction.  
PKA binding domain forms a consensus pattern: [AVLISE]-X-X-[AVLIF]-
[AVLI]-X-X-[AVLI]-[AVLIF]-X-X-[AVLISE] (X = any amino acid) (Hundsrucker et 
al., 2010; Skroblin et al., 2010).  
As mentioned in Brocard’s paper, the PTS1 signal is considered to consist of 3 
parts: a crucial C-terminal tripeptide, an upstream tetrapeptide, and a flexible 
approximately 12 amino acid long hinge (Brocard and Hartig, 2006). Their group also 
successfully developed an online tool to predict candidates
①
. Computer programming 
was used for sequence scaning under the Python 2.7.5 environment, and the R i386 
3.0.1 program was used to convert the statistical results generated from Python into 
ostensive graphs. The codes of Python (in blue frame) and R (in purple frame) are 
presented in the end of this thesis (see Chapter 12. Supplemental data S1), and the 
screening workflow was set as follows (this workflow of AKAP1 as the example): 
                                                 
①
 http://mendel.imp.ac.at/mendeljsp/sat/pts1/PTS1predictor.jsp 
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PTS1_pred_score.xls 
AKAP_PTS1_for_R.xls 
AKAP_PTS1_for_R.txt 
Barplot_AKAP1.R 
AKAP1_domain_feature.pdf 
AKAP_true_protein_info.xls 
Download all the AKAP1 protein sequences from NCBI protein database, and save as a *.fasta file 
seq_num_len_des_read-code.py 
seq_num_len_des_read.txt 
Rename that original *.fasta file as “All AKAP1 protein from NCBI-143 seq.fasta” 
Remove_duplicate_seq-code.py 
seq_without_duplicate.txt id_order.txt 
AKAP_domain_selection-code.py 
AKAP_true_protein.txt AKAP_true_protein_info.txt AKAP_false_protein.txt 
PTS1_predictor_filter-code.py 
PTS1_pred_score.txt 
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3.2 Cell culture 
3.2.1 Cell culture routine  
The procedure was slightly modified from the original protocol from ATCC
①
. At 
first passage, cells which have been resuscitated from a frozen stock were split at a ratio 
of 1:3. Thereafter, the culture medium was renewed every 2 to 3 days, until cells were 
fully confluent. For subculturing, the cell layer was briefly rinsed with 0.25% 
trypsin/EDTA 1ml per 200ml flask and incubated at 37°C for 5 minutes to induce the 
detachment. Cells were gently removed and mixed by aspiration and pipetting. The sub-
confluent cultures were split in a concentration of 1×104 cells/cm2, and incubated at 
37°C with 5% CO2.  
3.2.2 Cell number and viability examination 
The Sertoli cell number was determined with a hemocytometer. Trypan blue 
exclusion assays were used to determine the percent survival of the Sertoli cells. The 
procedure was slightly modified from the original Sigma “Protocol 6 – Cell 
Quantification”②. 
The adherent cells needed to be suspended as above described, thereafter, 150µl 
of that cell suspension was transferred into an Eppendorf tube under sterile conditions 
and mixed gently with 150µl of Trypan Blue. The needed hemocytometer and coverslip 
were cleaned by EtOH and ddH2O and air-dried. The chamber was filled with 10µl of 
the stained cell suspension without air bubbles. The cell number was counted under 
20 × magnification with a bright field/phase contrast-equipped inverted light-
microscope. Dead cells were recognised by being blue stained. Ideally, >100 viable 
cells were used for accurate counting. Finally the cell concentration of the Eppendorf 
tube, which was used in the first step before Trypan blue stain, was calculated with the 
following formula: 
Viable cell concentration =  
(total live cell numbers from 4 corner squares)÷4×9
3𝑚𝑚×3𝑚𝑚×0.1𝑚𝑚
× 2 
 
                                                 
①
 http://www.lgcstandards-atcc.org/products/all/CRL-
1715.aspx?geo_country=de#culturemethod 
②
 http://www.sigmaaldrich.com/technical-documents/protocols/biology/cell-
quantification.html 
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3.2.3 Isolation of total RNA from TM4 cells 
According to the experiment requirement, TM4 cells were grown in flasks or 6-
well plates. The whole procedure of total RNA isolation was modified from the Qiagen 
protocol “Purification of Total RNA from Animal Cells Using Spin Technology” in 
RNeasy
®
 Mini Handbook, 4
th
 Edition. For a 200ml flask as an example, cells were 
cultured upto an ideal density, the medium was discarded and 10ml PBS was added for 
rinsing. Then the cells were trypsinized by 0.1-0.25% trypsin at 37°C for 10min. 8ml 
new medium was added to stop the digestion and the cells were resuspended for the cell 
number counting as described above and collected by centrifugation at 300×g for 5min. 
After removal of the supernatant, the cell pellet (ideally < 5×106 cells) was resuspended 
and disrupted in 350µl Buffer RLT (including 1% β-mercaptoethanol, the volume of 
RLT Buffer used depends on the cell number, see page 28 in handbook of Qiagen 
RNeasy Mini Kit) and homogenized by spinning through a QIAshredder column, 
supplied by the Qiagen RNeasy Mini Kit. The mixture of 10µl DNase I (RNase-free) 
and 70µl RDD Buffer (Qiagen) was added onto the column to digest the contaminated 
genomic DNA. Thereafter, the rest procedure was done as described in the 
manufacturer's instruction.  
3.3 RT-PCR 
According to the protocol from Invitrogen “First-Strand cDNA Synthesis Using 
SuperScript™ II RT”①, 2µg total RNA (in 10µl) was reverse transcribed in a 20µl 
reaction mixture at 42°C for 50min using 200U of SuperScript™ II RT and 500ng of 
oligo-dT primers in the 1× first-strand synthesis buffer. The PCR reaction was done in a 
volume of 25µl reaction mixture containing 2µl of cDNA (reverse transcription 
reaction), 18.8µl ddH2O, 2.5µl of 10× PCR Buffer, 0.5µl of 10mM dNTP Mix, 2µl of 
10µM Forward + Reverse primer mixture, 0.2µl of 5U/µl Taq DNA polymerase. The 
PCR conditions were first a 5min denaturation period at 95°C and subsequent 35 cycles 
of denatureation at 95°C for 30 sec, annealing of individual primer pairs at optimal 
temperature for 45 sec, extainsion at 72°C for 1 min and one final extension for 10 min 
at 72°C.  
                                                 
①
 http://tools.lifetechnologies.com/content/sfs/manuals/superscriptII_pps.pdf 
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3.4 SDS-PAGE and Western blots 
According to the protocol in our lab, a standard curve for protein measurements 
was made with the Bradford method with serial BSA gradient dilutions. The adherent 
cells were lysed by Lysis buffer (Cell Signaling) and handled following manufacturer's 
instruction. Thereafter, the protein concentrations of the samples supernatant were 
measured triplicates by using a spectrophotometer at OD595. 50µg of protein samples 
per lane were loaded onto 12% SDS-polyacrylamide gel, together with dual color 
marker in the 1
st
 lane and unstaining marker in the 2
nd
 lane. The proteins were collected 
by electrophoresis at 80V until they reached the separation gel and thereafter separated 
at 120V. The separated proteins were transferred from the SDS-gel onto a 
polyvinylidene fluoride (PVDF) membrane. The membrane was incubated in 10% 
nonfat milk powder at 4°C overnight for blocking of non-specific protein binding sites. 
The next day, the milk was removed and the membrane was incubated with first 
antibody overnight also at 4°C. On the 3
rd
 day morning, the membrane was washed with 
1×TBST 3 times for 10min each at room temperature. The bound primary antibody was 
detected by incubation with an alkaline phosphatase-conjugated secondary antibody for 
1h at RT. The membrane was washed with 1×TBST 5 times for 10min each at RT. 
Immune-Star™ AP was used as substrate to visualize the bands with immunecomplexes 
in the dark room. Western blots were exposed from 30s to 10min to X-ray film to 
visualize the appropriate bands.  
3.5 Peroxisome purification by OptiPrep™ density gradient 
centrifugation 
OptiPrep™ is a 60% (w/v) solution of Iodixanol® in water, density = 1.32 g/ml, 
which is used for density gradient centrifugation to purify subcellular organelles. 
Iodixanol is an ideal medium, since it is non-ionic and non-toxic to cells and 
metabolically inert. The Iodixanol solusion possesses a low viscosity and can be made 
isosmotic at variant densities, which is helpful for a rapid separation of whole cells or 
isolated organelles
①
. It was reported that peroxisomes can be highly purified from other 
organelles by this method (Van Veldhoven et al., 1996). In iodixanol, lysosomes band at 
                                                 
①
 http://www.axis-shield-density-gradient-
media.com/Purification%20of%20subcellular%20organelles.pdf 
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a density of 1.115 g/ml, endoplasmic reticulum band at a density of 1.13 g/ml, 
mitochondria band at a density of 1.13-1.15 g/ml and peroxisomes band at a density of 
1.18-1.20 g/ml (Graham, 2002a; Graham, 2002b). 
The isosmotic gradient should be prepared one day before and immediately 
frozen at -20°C. The gradient is thawed 15min before usage.   
 
Table 7 Properties and preparation of Iodixanol-sucrose solution 
No. % iodixanol ρ (g/ml) Solution C Solution D 
1 18% 1.12 2ml 3ml 
2 25% 1.15 1.82ml 1.68ml 
3 34% 1.19 4.08ml 1.92ml 
4 40% 1.22 2.4ml 0.6ml 
5 48% 1.26 3.84ml 0.16ml 
 
In order to get pure peroxisomal fractions from the TM4 cell culture (~10
7
 cells), 
differential centrifugation was used after homogenization of the cells. The whole 
procedure is depicted in details in Figure 14 A&B.  
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Collect cells from 4 flasks (200ml), 
wash with PBS  
1200 rpm for 10min (Thermo 
Scientific™ Sorvall™ Heraeus Rotor 
75006445) 
Take out the supernatant, and weigh the cell pellet 
Add 3ml Homogeniation Buffer per 1g cells 
Grinding on ice for 1 min (Potter-Elvehjem homogenizer) 
Check the cell lysis by Trypan Blue 
Take 50µl into liquid nitrogen, and keep at -80°C, named H1 
Centrifuge the rest at 100 ×g for 12min at 4°C 
Take 50µl supernatant into liquid nitrogen, and keep at -80°C, named S1. Centrifuge the rest supernatant at 1,900 ×g for 12min at 4°C 
Take 50µl pellet debris into liquid nitrogen, and keep at -80°C, named P1. And discard the rest of the celldebris  
Take 50µl supernatant into liquid nitrogen, and keep at -80°C, named S2. Centrifuge the rest supernatant at 25,000 ×g for 12min at 4°C 
Resuspend pellet in 50µl Homogenization Buffer, put into liquid nitrogen, and keep at -80°C, named P2. 
Take 50µl supernatant into liquid nitrogen, and keep at -80°C, named S3. Centrifuge the rest supernatant at 29000rpm for 1h at 4°C 
(SORVALL® Ultra Pro 80 Refrigerated Ultracentrifuge with Sorvall® AH-629 Swing Buket Rotor) 
Resuspend pellet with enriched peroxisomes in 300µl Homogenization Buffer. Take 50µl into liquid nitrogen and keep at -80°C, named P3.  
The rest 250µl was used for OptiPrep gradient centrifugation. 
Take 50µl supernatant into liquid nitrogen, and keep at -80°C, named S4. 
Resuspend pellet in 50µl Homogenization Buffer, put into liquid nitrogen, 
and keep at -80°C, named P4. 
H1 
S1 
P1 
S2 
P2 
S3 
P3 
S4 
P4 
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 Figure 14 Schematic illustration of peroxisome purification by OptiPrep™ (keep all solutions and carry out all operations at 4°C). 
                   3ml / Tube 
(Immediately freeze at -20°C, take it out just 15min before usage) 
60,000 ×g for 2h30min 
Fractions (6 drops / tube × 12 tubes, 
named B1 - B12) 
(18%) ρ1 = 900 µl 
 
(25%) ρ2 = 630 µl 
 
(34%) ρ3 = 540 µl 
(40%) ρ4 = 270 µl  
(48%) ρ5 = 360 µl 
250µl P3 (light mitochondria + enriched peroxisomes) 
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The fractions were named as follows:  
H1: total homogenate;  
S1: supernatant after 1
st
 centrifugation from H1, containing all organelles and cytosol; 
P1: pellet after 1
st
 centrifugation from H1, mainly containing cell debris; 
S2: supernatant after 2
nd
 centrifugation from S1, mainly containing small 
mitochondria, peroxisomes, lysosomes, microsomes and cytosol;  
P2: pellet after 2
nd
 centrifugation from S1, mainly containing heavy mitochondria and 
nuclei, a few large peroxisomes;  
S3: supernatant after 3
rd
 centrifugation from S2, mainly containing microsomes and 
cytosol;  
P3: pellet after 3
rd
 centrifugation from S2, mainly containing enriched peroxisomes, 
light mitochondria, few lysosomes and microsomes, used for further OptiPrep 
density gradient centrifugation;  
S4: supernatant after 4
th
 centrifugation from S3, mainly containing cytoplasmic 
proteins;  
P4: pellet after 4
th
 centrifugation from S3, mainly containing microsomes and very 
small peroxisomes. 
 
250µl P3 was then added on top of a discontinuous OptiPrep gradient (3ml 18%-
48% iodixanol: 900µl 18%, 630µl 25%, 540µl 34%, 270µl 40% and 360µl 48%) in 
thick-walled polycarbonate tubes. The gradient was centrifuged at 60,000 × g for 
2h30min in a superspeed centrifuge (Thermo Scientific Sorvall
®
 Evolution
™
 RC). 
During centrifugation the gradient became continuous and the peroxisomal fraction 
displayed a smeared white suspended layer in the tube. A needle was carefully inserted 
and lowered to the tube bottom. All fractions (6 drops per tube) were collected of the 
3ml gradient solution by a peristaltic pump into Eppendorf tubes. A total of 12 numbers 
of fractions were collected (named B1-B12) in separate tubes for further protein 
analysis. 
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3.6 Rat dissection and RNA isolation  
3.6.1 Anaesthesia for rats and dissection of different organs 
Five male rats (7 weeks old, 240-260g for each) were used for this study. The 
rats were anaesthetized by intraperitoneal injection of a mixture of Narcotic solution 
(use 0.1ml for 10g bodyweight, Narcotic solution recipe see Table 3). Then the rats 
were soon dissected and organs (brain, heart, kidney, liver, lung, muscle, pituitary, 
spleen, testis) were kept in liquid nitrogen for further total RNA isolation. 
3.6.2 Tissue total RNA isolation 
Before isolation of total RNA, the bench surface, glassware and plastic ware 
were cleaned with RNase AWAY
®
. The rat samples frozen in liquid nitrogen were 
melted on ice. 60mg of tissue should be quickly cut into slices with less than 0.5cm 
thickness and submerged into 600µl RLT Buffer (containing 1% β-mercaptoethanol and 
3% Proteinase K) supplied in the Qiagen RNeasy® Mini Kit. The dispergierer IKA 
Ultra-Turrax
®
 T25 was used to disperse and disrupt the cells from the tissues. Whenever 
another tissue sample was operated, the dispergierer needed to be rinsed with SDS in 
DEPC water for 10 seconds and with 70% ethanol in DEPC water for 10 seconds. 
Thereafter, the tissues were homogenized using the clean dispergierer IKA Ultra-
Turrax
®
 T25, and the cell debris was spun down by centrifugation at 10,000×g for 
3min. The supernatant was transferred into a new tube and 0.5 volumes of pure ethanol 
were added and mixed gently. The mixture from fiber-rich tissues (such as heat and 
muscle) was handeled according to the Qiagen RNeasy
®
 Fibrous Tissue Mini Kit 
protocol
①
, and the other mixtures from easy-to-lyse tissues were handeled according to 
the Qiagen RNeasy
®
 Mini Kit protocol
②
. The total RNA was stored in RNase-free water 
at -80°C and the RNA quality was examined before further use. In this study, the RNA 
quality was checked by running a RNA-Chip with a Bioanalyzer (Figure 15 and 
Supplemental data S2). 
 
                                                 
①
 https://www.qiagen.com/de/resources/resourcedetail?id=8039840d-4815-4375-8933-
bc09247e47c0&lang=en 
②
 https://www.qiagen.com/de/resources/resourcedetail?id=14e7cf6e-521a-4cf7-8cbc-
bf9f6fa33e24&lang=en 
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3.6.3 Ethanol precipitation to concentrate total RNA 
50µl of total RNA sample needed to be mixed with 125µl of 100% ethanol and 
5µl sodium citrate (pH 5.2) and incubated at -20°C for one hour. Thereafter, the mixture 
was centrifuged at 13,000rpm for 30 minutes at 4°C. The supernatant was discarded and 
the pellet was resuspended in 500µl of 70% ethanol for washing. Thereafter, the 
centrifugation was repeated under the same condition and the supernatant was 
discarded. The final RNA pellet was solved in RNase free water and kept in -80°C. 
3.7 Workflow for Northern blotting 
Northern blotting is a method to detect target mRNA by specific RNA probes. 
We planed to eventually reveal distinct alternatively spliced forms of Akap11 transcripts 
([U48288.1] 9.7k bases and [NM_012773.2] 7k bases, Figure 29) by a non-radioactive 
method. Figure 16 depicts a work flow of the probe generation, Northern blotting 
hybridization and detection steps. The RNA probe generation and validation is 
described in details in the following subsection 3.7.1 and 3.7.2.  
  
Figure 15 An example of RNA-Chip results to check the quality of isolated RNAs. 
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Figure 16 workflow of Northern blot 
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3.7.1 Plasmid construction and probe generation by in vitro 
RNA transcription 
The AKAP11 clone3 plasmid was bought from GenomeCube. The plasmid was 
sequenced from both SP6 and T7 promotors until fully overlapping. According to the 
sequence feature analysis of the AKAP11 clone3 plasmid, a fragment of 448bp was 
suitable to design primers for a rat AKAP11 mRNA [NM_012773.2] specific probe. A 
fragment of 2615bp was suitable to design probes for the two rat AKAP11 mRNAs both 
[NM_012773.2] and [U48288.1], available in the NCBI database. As controls, 
sequences for 28S (Lab-ID: G12/14), GAPDH (Lab-ID: E12/15), β-actin (Lab-ID: 
M29/30), StAR (Lab-ID: K21/22) probes were amplified with specific primers. All 
specific PCR products were cloned by TA-cloning into the pGEM-Teasy vector. 
Positive clones were identified by colony PCR and subsequent plasmid sequencing. All 
plasmids were sequenced to identify the orientation and precise length of the insert 
sequences. Thereafter, it was decided which promoter (SP6 or T7) had to be used for 
antisense RNA-probe in vitro transcription. Linearized plasmids were used to generate 
RNA probes according to the instruction of the “DIG RNA Labeling Mix, Roche”①. 
Quality and quantity of the transcripts were analyzed by non-denaturing agarose gel 
electrophoresis and ethidium bromide staining. According to the kit description, the 
signal from the in vitro transcribed RNA band should be about 10 fold stronger than that 
from the DNA used for amplification.  
3.7.2 Dot blot assay for detection of DIG-labeling efficiency  
A dot blot assay was used to determine the labeling efficiency and sensitivity of 
the DIG-labeling reaction. Dilutions of 100ng/µl, 10ng/µl, 2ng/µl, 500pg/µl, 100pg/µl, 
50pg/µl, 25pg/µl, 10pg/µl, 5pg/µl, 2.5pg/µl, 1pg/µl of the DIG-labelled RNA probes in 
sterile RNase-free ddH2O, were spotted in a drop of 1µl for each dilution onto a 
positive-charged nylon membrane. After RNA fixation by 30min baking at 80°C and 
30s UV-treatment at 1.5J/cm
2
, staining of the RNA on the membrane was done in 
0.03% (w/v) methylene blue in 0.3M sodium acetate (pH 5.2) for 1min, followed by 
destaining in DEPC water for 2min. The immunological detection of the labeled probe 
was performed with a chemiluminescence procedure. Ideally, DIG-probes exhibited a 
detectable spot in a concentration as low as 0.1pg/µl. Probes with a detectability of at 
                                                 
①
 http://netdocs.roche.com/DDM/Effective/pdf_0900b2fc80acecf6.pdf 
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least 1pg/µl are required to obtain positive signal on Northern blots. The protocol was 
modified in overall steps from the Roche manufacture’s instruction and Box3in 
Zimmerman’s Nature publication (Zimmerman et al., 2013). 
3.7.3 RNA samples and agarose gel preparation 
The denaturing agarose gel used for RNA electrophoresis was made by 0.1% 
DEPC water, containing 1.8% agarose, 1×MOPS, 6% Formaldehyde and 0.4µg/ml 
Ethidium bromide. 1-10µg RNA was solved in DEPC water, containing 1×MOPS, 6% 
Formaldehyde, 42% Formamide and 1× loading buffer. RNA samples were denatured 
by heating at 65°C for 15min. The electrophoresis was done in 1×MOPS running buffer 
at 20V overnight.  
3.7.4 Protocol of Northern blotting 
1-10µg total RNA sample (Table 17 and 18) in high quality (no degradation, 
“pure” RNA: A260/280 = ~2.0, A260/230 = 2.0~2.2 (Scientific, 2013)) was denatured and 
loaded to a 1% agarose gel and separated by gel electrophoresis at 20V overnight 
(17h30min). The RNA was transferred by capillary blotting (blotting “sandwich”, 
Figure 16) from the gel to a positive-charged nylon membrane. The following Northern 
blotting procedure is a modified form of the instruction of the “DIG Northern Starter 
Kit” and Nature Protocols (Streit et al., 2008; Zimmerman et al., 2013).  
The nylon membrane with the total RNA on top was rinsed with 6×SSC buffer 
for 5min followed by air drying. Thereafter, the membrane was baked at 80°C in an 
oven for 30min (RNA-side-up). Additional RNA fixation was done by cross-linking 
was in a UV-trans-illuminator at 1.5J/cm
2
 for 30s (RNA-side-up). The membrane with 
fixed RNA was rinsed with ddH2O again and stained with Methylene Blue for 1min to 
indicate the position of the RNA marker, 18S and 28S rRNA and reveal the transfered 
total RNA. The blue color could be washed away by ddH2O. To be prepared for the 
RNA hybridization, the membrane should be first rinsed with 6×SSC buffer and then 
incubated in a formamide containing prehybridization buffer (1ml/10cm
2
 membrane) in 
a glass tube for 3h with rotation in a hybridization oven at a constant temperature of 
42°C. The DIG-labeled specific RNA probe was denatured at 65°C for 15min before 
use and kept on ice for 10min. The membrane with total RNAs was incubated with the 
denatured RNA probe at the concentration of 100ng probe/ml hybridization buffer and 
continuously rotated at 42°C in the hybridization oven overnight. The next morning, the 
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hybridization buffer was discarded and the same amount of 2×SSC was added for 5min 
rotation at room temperature. Thereafter, the membrane was rinsed by 1×SSC for 
10min and incubated with Roche protein blocking buffer for 40min. For the 1
st
 antibody 
incubation, mouse anti-DIG monoclonal unconjugated antibody was used at the 
working dilution of 3: 5000 in blocking buffer for 30min at RT. The membrane was 
washed with washing buffer 1×SSC for four times 10min each at RT. The 2nd antibody 
anti-mouse IgG was used at a working dilution of 1: 30,000 in washing buffer for 45min 
incubation. Thereafter, the membrane was washed five times with 1×SSC washing 
buffer for 10min each to remove the unspecific binding. Immune-Star™ AP was used as 
substrate to detect the hybridization signal in the dark room.  
The stripping protocol from Roche suggested to rinse the membrane thoroughly 
in DEPC water and invubate it at 80°C in stripping buffer for 2× 60min, followed 
another 5min rinse thoroughly in 2×SSC buffer. However this stripping protocol proved 
to be not optimal in this study, wherefore this is not recommended and a new one 
needed to be developed. 
3.8 Construction of myc-tagged AKAP plasmids and expression in 
TM4 cells  
By the bioinfomatic screening for the AKAPs with putative PTS1 signals, we 
were able to find three potential conserved “peroxisomal” AKAP subfamilies (AKAP1, 
AKAP4 and AKAP10) in the first round rough screening (Figure 17). Eventhough the 
tripeptide “SKL”-variant was contained in all species analyzed, the PTS1 finder used in 
in the second round PTS1 screening did recognize these signals as putative peroxisomal 
targeting signal 1, but not jadged them as peroxisomal AKAPs (Figure 38-40). 
Subcellular localization of a protein should, however, not only rely on computer 
predictions, but also revealed by experimental comfirmation. Since our group had 
already bought many commercially available antibodies against several peroxisomal 
proteins which showed various cross-reactions with other non-specific proteins in 
homogenates, we decided to clone several interesting AKAP-families members with 
putative “SKL”-variants. Therefore, AKAPs with different myc tags were constructed 
and myc-tagged GFP was used as control for the protein overexpression in Sertoli cells. 
For each AKAP and the GFP control, two types of recombinants were used for the 
Page | 65  
 
expression analysis and subcellular localization: myc tag at the amino-terminus & myc 
tag at the carboxyl-terminus of the fusion protein.   
3.8.1 Construction of myc-tagged AKAPs and GFP plasmids 
Three IMAGE clones (Table 4 pYX-Asc-AKAP1, pCR-Blunt II-TOPO-AKAP4, 
and pSPORT 1-AKAP10) were selected and purchased from GenomeCube as the 
templates for whole length amplification of AKAP1, 4 and 10. At the same time, the 
pGeneClip™ hMGFP vector was used as the template for the recombinant positive 
control. Thereafter, for two types vectors expression primers were designed (Table 5). 
Two Taq-PCRs were performed (Table 8) to amplify whole GFP cDNA (684bp) and 
Six Pfu-PCRs were performed (Table 9) to amplify accurately the AKAP complete 
cDNAs (Akap1 cDNA 2589bp; Akap4 cDNA 2565bp; Akap10 cDNA 1131bp). 
 
Table 8 Taq-PCR reaction 
 Reagent Volume 
 Taq PCR 10× Buffer 2.5µl 
 dNTP mix (10mM each) 0.5µl 
GFP_3B(BL48/BE66); GFP_5B(BE65/BE67) primer mix (10µM) 2µl 
 Taq DNA polymerase (5U/µl) 0.5µl 
pGeneClip™ hMGFP Vector [AY744386.1] plasmid (5ng/µl) 2µl 
 LONZA H2O 18µl 
  25µl 
 
Taq-PCR procedure: 95°C for 2min initiate denaturation, followed by 35 cycles 
of denaturation at 95°C for 30s, annealing at 58°C for 30s, elongation at 72°C for 
5min30sand one final extension step at 72°C for 5min. 
 
Table 9 Pfu-PCR reaction 
 Reagent Volume 
 10× Pfu Buffer 2.5µl 
 dNTP mix (10mM each) 0.5µl 
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AKAP1_3B(BH42/BH43); AKAP1_5B(BH48/BH49); AKAP4_3B(BH44/BH45); 
AKAP4_5B(BH50/BH51); AKAP10_3B(BL28/BH47); AKAP10_5B(BL29/BH53) 
primer mix (10µM) 2µl 
 Pfu DNA 
polymerase(2U/µl)  
0.5µl 
AKAP1_IMAGE [BC065135.1]; AKAP4_IMAGE [BC130271.1]; 
AKAP10_IMAGE [BC054105.1] 
plasmid (5ng/µl) 2µl 
 LONZA H2O 18µl 
  25µl 
 
The Pfu-PCR procedure was as follows: initial denaturation at 95°C for 2min, 
followed by 35 cycles of 95°C for 30s denaturation, 58°C for 30s annealing, 72°C for 
5min30s elongation and a final extention step at 72°C for 5min. 
Compared to the Taq DNA polymerase, at one hand, Pfu polymerase possesses a 
higher thermostability and fewer false proofreading properties, because Pfu is able to 
correct errors by its 3’-5’ exonuclease activity during DNA amplification. At the other 
hand, DNA products made by Pfu are not useful in direct TA cloning, since they are 
lacking of “A (adenine)” 3’overhangs at their blunt ends. Therefore, blunt end PCR 
fragment ligation needs an extra “dATP” addtion to the blunt end.  
All the Pfu-PCR products were therefore purified by regular gel extraction 
method. 7µl of the eluted PCR fragment was mixed with 1µl Taq PCR 10× Buffer 
(25mM MgCl2), 1µl 2mM dATP, 5 units of Taq DNA polymerase, and deionized H2O 
(LONZA H2O) to a final volume of 10µl. Thereafter, this 10µl mixture was incubated at 
70°C for 30min to add an extra “dATP” to the blunt end. This procedure for blunt end 
PCR fragment ligation was slightly modified from Promega protocol
①
.  
Following the regular TA cloning procedure, a 12µl ligation reaction including 
5µl of the PCR fragment mixture, 1µl pGEM-T easy vector, 5µl 2× ligation buffer and 
1µl T4 ligase was incubated at 4°C overnight (14-16 hours).  
The two types of GFP ligation were transformed into E.coli (see subsection 
3.8.2) and sent to verify the sequences. Thereafter, the two types of GFP were 
subcloned into the expression vector pCMV-3B and pCMV-5B, respectively (Table 10 
                                                 
①
http://www.promega.com/~/media/files/resources/promega%20notes/62/cloning%20bl
untend%20dna%20fragments%20into%20the%20pgem-t%20vector%20systems.pdf 
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and Table 11). These two types recombinants were sequenced to make sure that GFP 
was in-frame with the myc-tag. The transfection of two types myc-tagged GFP were to 
double assess the cytoplasmic localization of GFP by its green fluorescence and the 
myc-tag by indiect red fluorescence with a mouse anti-myc secondary antibody 
(subsection 3.8.4-3.8.6). With this procedure, a perfect colocalization of GFP and the 
myc-tag was observed, suggesting that the used anti-myc antibody was excellent and 
suitable to use for the detections of the myc-tagged AKAP constructs.  
The procedure for the three AKAP-recombinant plasmid constructions was 
following similar protocols as ones for the GFP contructs. Only AKAP1 needed an 
additional point mutation assay before being ligated into the expression vectors 
(subsection 3.8.3) because of an unexpected stop codon mutation.  
 
Table 10 Restriction enzyme digestion of GFP and 3 AKAPs (4h incubation at 37°C) 
Reagent  Volume  Reagent  Volume  Reagent  Volume  
LONZA H2O Xµl LONZA H2O Xµl LONZA H2O Xµl 
AKAP1-pGEM-T 
(total 3.75µg)  
Yµl AKAP4-pGEM-T 
(total 3.75µg)  
Yµl AKAP10-pGEM-T 
(total 3.75µg)  
Yµl 
RE 10× Buffer B 5µl RE 10× Buffer B 5µl RE 10× Buffer D 5µl 
Acetylated BSA 0.5µl Acetylated BSA 0.5µl Acetylated BSA 0.5µl 
BamHI (10U/µl) 1.25µl BamHI (10U/µl) 1.25µl EcoRI (10U/µl) 1.25µl 
XhoI (10U/µl) 1.25µl XhoI (10U/µl) 1.25µl XhoI (10U/µl) 1.25µl 
 50µl  50µl  50µl 
Reagent  Volume  Reagent  Volume  Reagent  Volume  
LONZA H2O Xµl LONZA H2O Xµl LONZA H2O Xµl 
GFP-pGEM-T (total 
3.75µg)  
Yµl pCMV-3B or pCMV-
5B (total 3.75µg)  
Yµl pCMV-3B or pCMV-
5B (total 3.75µg)  
Yµl 
RE 10× Buffer B 5µl RE 10× Buffer B 5µl RE 10× Buffer D 5µl 
Acetylated BSA 0.5µl Acetylated BSA 0.5µl Acetylated BSA 0.5µl 
BamHI (10U/µl) 1.25µl BamHI (10U/µl) 1.25µl EcoRI (10U/µl) 1.25µl 
XhoI (10U/µl) 1.25µl XhoI (10U/µl) 1.25µl XhoI (10U/µl) 1.25µl 
 50µl  50µl  50µl 
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Table 11 Ligation reaction (overnight incubation at 4°C) 
Reagent  Volume   
Digested and purified insert fragment (total 500ng) Xµl  
Digested and purified vector fragment (total 200ng) Yµl  
10× ligation Buffer 2µl  
T4 ligase 1µl  
 20µl  
 
 
3.8.2 Procedures for bacterial transformation 
3.8.2.1 Heat shock procedure  
The LB/Ampicillin
r
 (100µg/ml) plates were prepared freshly and store in the 
clean bench prior to use. 5µl ligation reaction were added into 50µl DH5α competent 
cells aliquot and mixed gently by pipetting. After 20 minutes incubation on ice, a 90 
seconds heat-shock was performed in a water bath with a constant temperature of 42°C. 
The shocked cells were immediately chilled on ice for 2 minutes. 200µl of SOC 
medium were added to grow the transformed cells at 37°C for 30 minutes incubation. 
During the incubation period, a mixture of 100µl LB, 20µl IPTG (1M) and 40µl X-gal 
(2%) was spreaded onto the Amp
r
 plates, followed by air drying. The complete 255µl 
transformation culture of the tube was spread onto the Amp
r
 plate. A plasmid as the 
positive control had been previous transformed efficiently and an Amp
r
 plate with 
DH5α alone was used as the negative control. After an overnight incubation at 37°C, the 
blue white screening was used to identify successfully ligated clone. This protocol was 
slightly modified from the original protocol of promega
①
.  
3.8.2.2 Electroporation procedure 
Efficient introduction of DNA into bacteria is critical for the success of many 
molecular biology procedures. The electroporation method for transforming E.coli cells 
                                                 
①
https://www.promega.com/~/media/files/resources/protcards/pgem%20t%20and%20pg
em%20t%20easy%20vector%20systems%20quick%20protocol.pdf 
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can produce efficiencies greater than those achieved with the best chemical methods
①
, 
especially for large plasmids (4.1kb-6.9kb). Commericial avialable ElectroTen-Blue
®
 
cells needed only to be thawed and mixed with DNA prior to electroporation.  
The genotype of bacteria DH5α used for heat shock transformation is F– 
Φ80lacZΔM15 Δ(lacZYA-argF) U169 recA1 endA1 hsdR17 (rK–, mK+) phoA supE44 
λ– thi-1 gyrA96 relA1②. The DH5α exhibits no antibiotic resistance. However, some 
electroporation competent cells possess resistance to antibiotics.  
The electroporation competent cell used in our lab is called “EletroTen-Blue®”. 
It is a derivative of the XL1-Blue MRF  ´strain that can withstand much higher levels of 
electrical current. This increases the survival of the cells during electroporation, and 
thus the efficiency of the ligated constructs transformation. In addition, EletroTen-Blue 
strain genotype is Δ(mcrA)183 Δ(mcrCB-hsdSMR-mrr)173 endA1 supE44 thi-1 recA1 
gyrA96 relA1 lac Kan
r
 [F  ´ proAB lacI
q
 ZΔM15 Tn10 (Tetr )],  which are resistant to 
both kanamycin and tetracycline. Thus plasmids that carry the Kanamycin-resistance or 
Tetracycline-resistance selection marker cannot be propagated in this strain
③
.  
Moreover, from the structural point of view, Neomycin whose chemical 
structure is similar to Kanamycin (Table 12) can also not be used for selection of 
transformed EletroTen-Blue clones. Therefore, the expression plasmids pCMV-Tag 3B 
and pCMV-Tag 5B could not be used for this electroporation procedure, since they have 
Neo
r
/Kan
r
 selection, while the clonning vector pGEM-T, ideal for Amp
r
 selection, was 
suitable for EletroTen-Blue cells.  
 
 
 
 
 
 
 
 
                                                 
①
 http://www.chem.agilent.com/library/usermanuals/Public/200159.pdf 
②
 http://www.lifetechnologies.com/de/de/home/life-science/cloning/competent-cells-for-
transformation/chemically-competent/dh5alpha-genotypes.html 
③
 http://www.chem.agilent.com/library/usermanuals/Public/200159.pdf 
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Table 12 Chemical structure of commen used antibiotics 
Antibiotics Tetracycline Kanamycin 
Structure 
 
 
Antibiotics Neomycin Ampicillin 
Structure 
  
 
3.8.3 Point mutation assay 
Aligned with AKAP1 mRNA variant 2 [NM_001042541.1], the sequenced 
AKAP1_IMAGE clone cDNA [BC065135.1] contained 2 mutation points: 
TAA(STOP)1993GAA(Glu) and TCT(Ser)2208TCC(Ser). The second point mutation 
(C2208T) caused no amino acid change, which could be neglected. But the first point 
mutation (G1993T) caused an extra STOP codon, which had to be mutated back to the 
original base pairs. 
Table 13 AKAP1-Mutation-PCR reagent 
 Reagent  Volume  
 10× Pfu Buffer 5µl 
 dNTP mix (10mM each) 0.8µl 
AKAP1_Mut_F (10pmol/µl) / AKAP1_Mut_R (10pmol/µl) primer mix (10µM) 2µl 
pGEM-T-AKAP1_3B; pGEM-T-AKAP1_5B  plasmid (20ng/µl) 1µl 
 Pfu DNA polymerase 1µl 
 DMSO 2.5µl 
 LONZA H2O 38µl 
  50µl 
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The Mut-PCR procedure was as follows: initial denaturation at 94°C for 
1min30s followed by 18 cycles of 94°C for 30s denaturation, 55°C for 1min annealing, 
68°C for 13min elongation and a final extention step at 68°C for 13min. 
1 tube of PCR reagent without Mut-Primers was set as the negative control. The 
DNA template was digested completely by DpnI and no colony were observed on Amp
r
 
plate. Unmutated plasmids had been previous transformed efficiently to DH5α as 
positive control to verify the transformation procedure. 
 
Table 14 AKAP1-Mutation-PCR Dpn I digestion (4h incubation at 37°C)  
 Reagent  Volume  
pGEM-T-AKAP1-3B_Mut; pGEM-T-AKAP1-5B_Mut  Purified mutation plasmid  42µl 
 10× Buffer B 5µl 
 BSA (10mg/µl) 0.5µl 
 DpnI  2.5µl 
  50µl  
 
15µl digested plasmids (samples or negative control) or 5µl ligated plasmids 
(positive control) were transformed to DH5α by the heat shock procedure (see 
subsection 3.8.2.1). Clones with the correct mutated sequence verified by sequencing 
were subcloned into expression vectors pCMV-3B and pCMV-5B (Table 10 and Table 
11). 
3.8.4 Coating cover slips with poly-L-lysine 
10mg of poly-L-lysine was dissolved in 100ml H3BO3/Na-tetraborat buffer (see 
Table 3 Buffer recipes). The solution needed to be sterilized through 0.22µm Millipore 
filtration. Moreover, 12mm cover slips were sterilized by 4h baking at 180°C. All the 
glassware and materials used were sterile and all operations performed in a laminar 
hood. The cover slips were incubated in poly-L-lysine solution in a 3.5 mm Petri dish 
overnight. On the next morning, the poly-L-lysine solution was removed by aspiration 
and the cover slips were incubated with sterile water in Petri dish for 5h at RT. 
Thereafter, the coated cover slips were rinsed with sterile water twice and air dried in 
the hood prior to storage at 4°C.  
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3.8.5 Transient transfection of TM4 cells  
One day before transfection, the TM4 cells need to be sown on the poly-L-lysine 
coated coverslips at a density of 5×104 cell/well with 500µl serum containing medium 
in a 24-well plate. After 24h growth (37°C, 5%CO2), cells were approximately 75% 
confluent. Transient transfection was then carried out according to the Promega protocol 
by using the ViaFect™ Transfection Reagent①. For this study, all the plasmids for 
transfection were purified with an endotoxin-free plasmid DNA purification kit 
(NucleoBond
®
 Xtra Midi EF, Macherey-Nagel Co.). 500ng plasmid DNA (myc-GFP 
plasmids used as positive control) and 3µl reagent were mixed with 500µl serum free 
medium per well. The transfection efficiency on TM4 cells was about 15% after one-
day growth. On the second day of transfection, the cells were ready for 
immunofluorescence staining. 
3.8.6 Immunofluorescence protocol 
TM4 cells, grown on poly-L-lysine coated coverslips for 48h, were fixed with 
4% paraformaldehyde in PBS for 30min at room temperature. After 3 times washing 
with warm PBS for 10min each, cells were treated with 1% glycin or/and 0.1% Triton 
X-100 for permeablization. Cells were washed 3 times with PBS for 5min each, and 
blocked for 1h in 1% PBSA with 0.05% Tween, thereafter incubated with primary 
antibody (dilutions described in Table 6) overnight at room temperature. The next day, 
cells were washed 3 times with PBS for 5min each, followed by 1h secondary antibody 
incubation in the dark. Thereafter, cells were washed with PBS for 10min, followed by 
nuclear staining and final washing of 2×10min. The coverslips were mounted with the 
cell-side down onto glass slides with Mowiol 4-88 containing propylgallat mixture as 
anti-bleaching agent. The staining pattern was checked and pictures were taken with a 
fluorescence microscope (Leica DMR) or a laserscan confocal microscope (Leica TCS 
SP2) using 63× oil immersion objectives.  
 
 
  
                                                 
①
https://www.promega.de/~/media/files/resources/protcards/viafect%20transfection%20
reagent%20quick%20protocol.pdf 
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4 Results 
Follicle-stimulating hormone (FSH)-mediated flux through metabolic pathways 
is controlled by secondary modification of proteins such as phosphorylation and 
dephosphorylation at specific subcellular locations. This regulation has been shown for 
mitochondrial cholesterol influx to occur via the AKAP1-StAR interaction. However, 
very limited knowledge is available to date on the direct control of these metabolic 
pathways in peroxisomes.  
4.1 AKAP family members with putative PTS1 signals 
Since a previous report showed that AKAP11 is probably localized to the 
peroxisome, it is interesting to determine whether other proteins of AKAP family are 
putative peroxisomal proteins. Therefore, I screened for AKAP isoforms with putative 
peroxisomal targeting signals.  
4.1.1 AKAP sequence retrieval and PTS1 search matrix  
All known AKAP sequences (1306 sequences) from diverse species were 
retrieved from “UniProt” database① followed by the screening for a putative C-terminal 
PTS1. Only the C-terminal tripeptide was used to screen for the putative C-terminal 
PTS1, since it is the crucial portion for peroxisome import. After removing the 
duplicates, 531 different tripeptides were left over from all AKAP sequences 
(Supplemental data S3). 
For classification of all variants of possible PTS1 signals, all known PTS1 
binding sites from the “Peroxisomal Target Signal Predictor (PTSP)” were downloaded 
(Supplemental data S4) and summarized into a Combination Matrix (Table 15).  
 
 
 
 
 
                                                 
①
 http://www.uniprot.org/uniprot/ 
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Table 15 Summarized PTS1 tripeptides derived from the “Peroxisomal Target Signal Predictor (PTSP)” 
 PTS1 tripeptides in standard amino acid 1-letter code 
AHL CKL PRL SNL 
AKF CRL QAL SQL 
AKI HKL SHL SRI 
AKL HRL SKI SRL 
ANL KKL SKL SRM 
ARL NKL SKM SSL 
ASL PKL SKV THL 
 
4.1.2 Phylogenetic analysis of AKAP proteins containing a 
putative PTS1 signal 
Using the combination matrix for conserved PTS1 substitutions, 81 AKAP 
proteins with possible PTS1 ends were identified and used to generate a phylogenetic 
tree (Figure 17). The AKAPs clustered into six large groups belonging to the AKAP1, 
3, 4, 10, 11, 14 and 17A families, while two sequences distributed into distinct groups 
as individual entities. An unexpected finding was that the short form of AKAP11 from 
the rat (sp|Q62924|AKAP11 Rat-CRL) clustered into a separate group. Interestingly, 
AKAP family members within the described groups displayed similar PTS1 signals, 
suggesting that the signal was conserved during evolution and that they might be real 
peroxisomal targeting signals.    
 
A A F 
C H I 
H K L 
K N M 
N Q V 
P R   
Q S   
S     
T     
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AKAP3 
AKAP17A 
AKAP10 
AKAP14 
AKAP1 
AKAP11 
Figure 17 Phylogenetic tree of AKAPs with putative PTS1 
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By analysis of the EST expression profile I found that the AKAP1, 4, 10 
families are highly expressed in testis (Figure 41-42). The sequence and the 
phylogenetic analysis of these AKAPs indicated that they might contain a putative 
PTS1 signal, however, these proteins were reported to be localized to the mitochondria 
or other subcellular sites and not the peroxisome (see subsection 1.4.2-1.4.4). However, 
peroxisomal localization of proteins has been overlooked quite frequently in the past 
and some peroxisomal protein isoforms have multiple subcellular locations (Islinger et 
al., 2009). Therefore, it was speculated that depending on the cellular requirements and 
developmental stages, AKAPs might be localized in different subcellular compartments 
(e.g. mitochondria and peroxisome). In section 4.6, the subcellular location of myc 
epitope tagged AKAP1, AKAP4 and AKAP10 in TM4 Sertoli cell line were analyzed.  
4.2 TM4 Sertoli cell culture stimulation with FSH treatment 
To study the regulation of the peroxisomal compartment by FSH signaling and 
AKAPs, a good cell culture model was established.  
4.2.1 Cell culture condition optimization  
Follicle-stimulating hormone (FSH) binds to the its receptor on the plasma 
membrane of Sertoli cells of the testis and granulosa cells of the ovary, thereby 
initiating an intracellular signaling cascade inducing the activation of PKA to 
phosphorylate downstream target proteins, which are essential for the regulation of 
androgen and progesterone production and sperm motility (Tasken and Aandahl, 2004; 
Walker and Cheng, 2005). It is known that peroxisomes play an important role in 
spermatogenesis and oxidative stress protection in the testis (Dastig et al., 2011) and 
that Sertoli cells in the testis contain high levels of metabolic peroxisomal proteins 
(Nenicu et al., 2007). However, it was not known whether peroxisomes or peroxisomal 
genes are affected by activation of the FSH signaling pathway. To study potential effect 
of FSH on the peroxisomal compartment, the mouse Sertoli cell line-TM4 cells were 
purchased from the ATCC. The exact cell culture condition of the TM4 Sertoli cells was 
established by seeding them at different densities (Table 16) 
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Table 16 Optimization of cell density to obtain a monolayer of TM4 cells on Day 4-6 
 The 1
st
 set  Density of cells 
seeded per ml 
Day 4  Day 6 
A Group 2 × 10 No cells Almost no cells, all cells are round 
B Group 2 × 102  Very few cells Still no connection, too many round 
cells 
C Group 2 × 103  No cluster, no connection Some part is monolayer, some part 
no connection 
D Group 2 × 104  Some part is monolayer, 
some part is multilayer 
Too full 
E Group 2 × 105 Multilayer, overgrown Too full 
F Group 2 × 106  Too full Too full 
The 2
nd
 set   Density of cells 
seeded per ml 
Day 4 Day 5 
G Group 3 × 103  No connection, single cell Most part no connection, some part 
is monolayer 
H Group 6 × 103  Some part is monolayer, 
some part is single cell 
Most part is monolayer, some part no 
connection 
I Group 1.2 × 104  Monolayer, perfect! Half part is monolayer, half part is 
multilayer 
  
The best monolayer at Day 4 was obtained with a seeding density of 2.34×103 
cells/cm
2
 = 9 × 103 cells/ml. This experimental condition was used further for 
stimulation of TM4 Sertoli cells with FSH stimulation.  
4.2.2 Effect of FSH stimulation on the peroxisome gene 
expression 
After optimization of the culturing conditions, TM4 cells were treated with 
increasing FSH concentration (W0 = 0ng/ml, W1 = 10ng/ml, W2 = 100ng/ml, W3 = 
1000ng/ml). From all four experimental groups (W0, W1, W2, W3), total RNA was 
isolated, reverse transcribed and used for semiquantitative analysis of mRNA 
expression of genes involved in peroxisomal biogenesis and proliferation, antioxidative 
enzymes and lipid metabolism (Figure 18-24).  
 
 
 
  
 Page | 78 
 
 
 
FSH receptor is present in TM4 cells. The FSH stimulation of TM4 cells worked 
well with 1000ng/ml, since Star gene was upregulated, whereas GAPDH and FSHR 
were not altered (Figure 18). The calculations for Figure 18-24 were made with the 28S 
rRNA values from Figure 18. 
 
 
 There is a clear indication for the Pex11α, the inducible form of the PEX11 
proteins, whereas the other family members were not changed (Figure 19). 
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Figure 18 Measurement of the mRNA of internal control and positive controls by conventional RT-PCR 
Figure 19 Alterations of mRNA levels of peroxins on peroxisome proliferation 
Figure 20 Alterations of mRNA levels of peroxins on peroxisomal matrix protein import 
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In comparison to the Pex11α gene, some maker genes for peroxisomal matrix 
protein import (Pex5, Pex14) were not altered while Pex13 showed a slight upregulation 
in gel measurements (Figure 20). 
 
 
 
FSH treatment leads to the upregulation of the catalase expression, whereas 
Gpx1 and Sod1 were not altered. This is of interest, since catalase is the only one 
protein involved in anti-oxidation metabolism that is exclusively present in 
peroxisomes, whereas Gpx1 and Sod1 are also present in other cellular compartments 
(Figure 21).  
 
 
 
From the three Acyl-CoA oxidase mRNAs, only the one of Acox2 showed a 
significant upregulation (Figure 22). This is of interest, since this enzyme is involved in 
the conversion of the cholesterol side-chain, whereas the other members of the Acox 
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Figure 21 Quantification of alterations of mRNA levels of antioxidative enzymes by conventional RT-PCR 
Figure 22 Alterations of mRNA levels of Acyl-CoA oxidases by FSH treatment 
 Page | 80 
 
family degrade mainly straight chain- and branched chain fatty acids (Baumgart et al., 
1996b). 
 
 
 
ABCD1-ABCD3 are the members of ATP-binding cassette (ABC) transporters 
superfamily in peroxisomal membrane and play a role in transporting fatty acids for the 
lipid metabolism into the peroxisomal matrix. From the fatty acid transporters ABCD1-
ABCD3, mainly ABCD2 is upregulated by the increasing FSH stimulation. These 3 
members of ABCD proteins were found to have overlapping substrates as well as 
distinct specificities (van Roermund et al., 2014). ABCD1 (also called ALDP) 
preferentially transported saturated VLCFA such as C24:0 and C26:0 as substrates for 
β-oxidation activity, and the X-ALD patients (X-linked adrenoleukodystrophy) with 
genetic defective ABCD1 exhibit the accumulation of VLCFA in plasma. The 
substrates of ABCD2 (also called ALDRP) were C22:0 and also unsaturated VLCFA 
such as C24:6 and C22:6 (van Roermund et al., 2011). ABCD3 (also called PMP70) 
was suggested to transport long branched chain fatty acids, long-chain unsaturated- and 
dicarboxylic fatty acids (C27 bile acids) across the peroxisomal membrane, which is 
important for bile acid biosynthesis (Ferdinandusse et al., 2014; van Roermund et al., 
2014). 
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Figure 23 Conventional RT-PCR results of alterations of mRNA levels of fatty acid transporters 
Figure 24 Measurement of PPAR 
transcription factors after treatment 
with different concentration of FSH 
Page | 81  
 
Since many peroxisomal genes are regulated by PPARs, PPARα, -β, -γ 
expression in TM4 Sertoli cells were also analyzed. Indeed, the mRNAs of all PPAR 
family members were expressed in Sertoli cell line, with the PPARβ mRNA showing 
the strongest signal (Figure 24). PPARα performs multiple functions in the liver, heart 
and blood vessel wall, and is also known to be activated by FSH to compose 
phospholipids in germ cells. PPARβ is present ubiquitously and plays a role in glucose 
homeostasis and fatty acid oxidation. PPARγ is mainly expressed in mature Sertoli 
cells, adipocytes and skeletal muscles and takes part in anti-diabetic and anti-
atherosclerotic mechanisms (Kota et al., 2005; Thomas et al., 2010). PPARs are also 
known to be involved in the regulation of fertility. However, there was no major change 
in their mRNA levels after FSH treatment.  
4.3 Isolation of peroxisomes from TM4 cells  
AKAP220, the short form of AKAP11 in the rat (a single frame in the Figure 
17), was the only AKAP protein to be reported in peroxisomes. I tried to repeat and 
establish the peroxisomal localization in our laboratory to study effects of FSH-
stimulation of this protein on the peroxisomal compartment. However, this protein 
clustered singly into a separate group from all other AKAP family members in the 
phylogenetic tree. It was speculated that there might be a problem with the peroxisomal 
localization of this protein reported by Scott group (Lester et al., 1996). Therefore, 
attempt was made to localize this protein from highly purified peroxisomal fractions by 
antibody-based test. To localize AKAP11 in peroxisomes, the differential centrifugation 
and OptiPrep density gradient centrifugation were used to isolate pure peroxisomal 
fractions followed by detection with a commercially available anti-AKAP220 antibody.                                               
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Figure 25 Peroxisome marker PEX14p (60 kDa) distribution. H1: homogenization; S1: supernatant after 
1
st
 centrifugation from H1; P1: pellet after 1
st
 centrifugation from H1, mainly contains cell debris; S2: 
supernatant after 2
nd
 centrifugation from S1; P2: pellet after 2
nd
 centrifugation from S1, mainly contains 
heavy mitochondria and some peroxisomes; S3: supernatant after 3
rd
 centrifugation from S2; P3: pellet 
after 3
rd
 centrifugation from S2, mainly contains light mitochondria and enriched peroxisome, using for 
the further density gradient centrifugation; S4: supernatant after 4
th
 centrifugation from S3, mainly 
contains cytoplasm substance; P4: pellet after 4
th
 centrifugation from S3, mainly contains microsome and 
small peroxisome. Then P3 was taken for 2h30min OptiPrep density gradient centrifugation. B1 to B12 
are the 12 tubes fraction of handled OptiPrep through constant speed pump. 
Figure 26 Western blot of AKAP220 (AKAP220 should be 220 kDa). The samples H1to P4 and B1 to 
B12 are the same as Figure 25. 
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 An excellent antibody against PEX14p, a peroxisomal membrane protein of the 
docking complex (Figure 13), was used to analyze the distribution of peroxisomes in the 
different fractions obtained after differential centrifugation and density gradient 
centrifugation in Western blots.  
PEX14p-labelling was very specific, except in the fraction P1 with the cell 
debris, revealing the high quality of the antibody used. The main protein band was 
found at the expected molecular weight of 60kDa, as expected for PEX14p (Grant et al., 
2013). Peroxisomes were enriched in P3, the typical fraction where most of the 
organelles were found. This fraction is frequently called enriched peroxisomal fraction 
and corresponds to the “light mitochondral” fraction, since it also contains the small 
mitochondria. In comparison, the heavy mitochondrial faction (P2), exhibiting also 
large peroxisomes, is less intensively labelled as well as the microsomal fraction (P4), 
in which very small peroxisomes were described by electron microscopy (Baumgart, 
1997). The strong labelling of the supernatant S4 suggested that during the isolation 
procedure of peroxisomes from TM4 cells, some peroxisomes broke. The stronger 
peroxisomal enrichment in the gradient is found in fraction B7 and B8. Broken 
organelles were also observed in the soluble fraction at the top of the gradient, indicated 
by some degradation bands in addition to the PEX14p signal.  
Attempts to localize AKAP220 in different subcellular fractions with the anti-
AKAP220 antibody (Santa Cruz Biotechnology, Inc.) did not give any satisfactory 
results. The antibody detected a plethora of different cross-reactive protein bands, but 
the expected 220kDa band was labelled very weakly. The strongest signal intensity was 
observed for most of the bands in S4, the final supernatant with cytoplasmic proteins.  
Based on the results from the Western blot analysis and the peculiar single 
localization of the short rat AKAP form into a separate group in the phylogenetic tree 
(Figure 17), it appears that the results described by Scott and colleagues (Lester et al., 
1996) with the antibody made against the C-terminal part of the rat AKAP11 protein 
might be incorrect. Indeed, careful analysis of the data presented in the paper revealed 
several discrepancies. First, they used the TM3 and TM4, which are mouse Leydig cell 
line and mouse Sertoli cell line, respectively (Harrison et al., 2001), as rat testis cell 
lines to test for rat AKAP220 subcellular distribution study. Second, the mRNA of the 
rat AKAP11short from their study was 9748bp in length [U48288.1] containing a 5’-
untranslated region (UTR) of 5406bp and an open reading frame (ORF) of 3387bp that 
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encodes a 1129 amino acid polypeptide. However, analysis of this mRNA [U48288.1] 
showed that it contains a 5’-UTR of 5411bp and the position of ORF is 5411-8800 
(Figure 29). Third, for the expression of a partial AKAP220 of 368 amino acids in E. 
coli, they amplified a 1104-bp fragment by PCR, which was encompassing the coding 
region of the original AKAP220 cDNA flanked by artificially NdeI and BamHI sites at 
the 5’ and 3’ ends, respectively. However, alignment of this primer pair with the 
AKAP220 mRNA [U48288.1] showed the forward primer aligned at the position of 
8483 and the reverse primer at the position of 8950, which produced an only 467bp 
amplicon and 150 bases out of the ORF. Therefore, this incorrect primer pair is assumed 
to have negative effect on their analysis.   
4.4 Analysis of AKAKP11 (=AKAP220) cDNA with genomic 
sequences   
Since the commercial anti-AKAP11 rat antibody was not specific against its 
target protein, there was a plan to generate a self-made antibody. For this purpose, we 
searched for suitable fragments of this protein as the antigen epitope residues by 
screening the gene and protein databases for AKAP11. However, the alignment of 
various AKAP11 cDNAs showed that sequences from human [NM_016248.3], mouse 
[NM_001164503.1] and rat long isoform [NM_012773.2] are highly conserved. It also 
revealed that the rat short isoform [U48288.1] does not obey the conservation rule of 
AKAP11 evolution. Therefore, it was determined to further analyze the correlation of 
the Akap11’s cDNA/mRNA and genome (Figure 27). 
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 ORF: 176-5881 
 ORF: 202-5886 
 ORF: 7-5685 
 ORF: 5411-8800 
Figure 27 BLAST Results of Akap11 mRNAs from Genome Database of human [NM_016248.3], mouse 
[001164503.1], rat (long [NM_012773.2] and short [U48288.1]), respectively. The exons in red are the 
identical sequence in both distinct rat Akap11 mRNAs. The lower short form was published by Scott 
group and the protein was suggested to be localized in peroxisomes. 
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The first AKAP220 antibody was made by Prof. Scott’s group and published in 
1996 in the Journal of Biological Chemistry, where the rat AKAP220 protein short 
isoform was identified. But from Figure 27, the existence of AKAP11_rat-short mRNA 
[U48288.1] and protein isoform [Q62924.1] are questionable.  
By BLAST searching the Akap11-human mRNA [NM_016248.3] against the 
Human Genome Database
①
, the exons of the Akap11-human mRNA were localized on 
chromosome 13 [NW_001838073.2]. By BLAST searching the Akap11-mouse mRNA 
[NM_001164503.1] against the Mouse Genome Database
②
, all exons of the Akap11-
mouse mRNA were localized on chromosome 14 [NT_039606.8]. Similarly, by BLAST 
searching Akap11-rat-long isoform mRNA [NM_012773.2] against the Rat Genome 
Database
③
, all the exons of Akap11-rat-long form mRNA were localized on 
chromosome 15 [NW_003811910.1]. Furthermore, [NM_012773.2] and [NP_036905.2] 
are mentioned as corresponding mRNA and protein on the Akap11 tag [Rattus 
norvegicus (Norway rat)] (Gene ID: 498549, updated on 1-Feb-2015)
④
 in the NCBI 
Gene database. 
However, when a BLAST search was performed for the Akap11-rat-short form 
mRNA [U48288.1] originally published by the Scott group, against the Rat Genome 
Database as above, the Akap11-rat-short form mRNA was divided into three parts. The 
1
st
 part of the mRNA sequence [U48288.1] was identified on chromosome 2 
[NW_003806694.1], the 2
nd
 part on chromosome 12 [NW_003811086.1], and the 3
rd
 
part on chromosome 15 [NW_003811910.1]. Also, our analysis showed that the 
putative mRNA [U48288.1] was not only including exons from other genes, but also 
introns (survival motor neuron protein [NM_022509.1] and EIA-binding protein p400 
[NM_001107149.1]). In addition, there were two smaller fragments (2724-2745 and 
4822-4842, in orange) identified that couldn’t be found on any chromosome (Figure 
27). According to the definition in the book “Gene Cloning and Manipulation” (Howe, 
2007), these two fragments contain EcoRI linkers (Figure 28) 
                                                                                                                                                                           
                                                 
①
http://blast.ncbi.nlm.nih.gov/Blast.cgi?PAGE_TYPE=BlastSearch&BLAST_SPEC=OG
P__9606__9558&LINK_LOC=blasthome 
②
http://blast.ncbi.nlm.nih.gov/Blast.cgi?PAGE_TYPE=BlastSearch&BLAST_SPEC=OG
P__10090__9559&LINK_LOC=blasthome 
③
http://blast.ncbi.nlm.nih.gov/Blast.cgi?PAGE_TYPE=BlastSearch&BLAST_SPEC=OG
P__10116__10621&LINK_LOC=blasthome 
④
 http://www.ncbi.nlm.nih.gov/gene/498549#genomic-regions-transcripts-products 
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Taken together with the other identified mistakes, the report of Scott and 
colleagues (Lester et al., 1996) described an artificial recombinant clone of Akap11 that 
does not exist in nature, in which clone three different genes were fused together via 
EcoRI-linkers during the cDNA library construction.   
4.5 Northern blotting 
To analyze alternatively spliced variants of AKAP11 and to prove that the short 
form AKAP11 [Q62924.1] is indeed not existing in rat testis or pituitary gland contrary 
to previous report from Scott and colleagues (Lester et al., 1996), it was planned to 
detect the expression of all possible isoforms of Akap11 [NM_012773.2] and 
[U48288.1] in different rat tissues by Northern blot hybridization. 
4.5.1 Total RNA preparation for Northern blotting  
Total RNA was isolated from the following rat tissues: testis, brain, lung, 
kidney, heart, liver, skeletal muscle, spleen, pituitary. 
 
Table 17 Total RNA was isolated using combined methods, and the RNA quality was checked by RNA-
Chip analysis 
Number Sample (date) Tissue weight RNA Concentration Volume A260/280 A260/230 
1 Brain-V (18.04) 60mg 307.4 ng/µl 50 µl 2.08 2.18 
2 Liver-V (18.04) 60mg 2148.2 ng/µl 50 µl 2.03 2.04 
3 Muscle-V (18.04) 60mg 529.5 ng/µl 50 µl 2.08 2.24 
4 Liver-V (17.04) 80mg 562.9 ng/µl 80 µl 2.04 1.57 
5 Kidney-V (17.04) 80mg 340.9 ng/µl 80 µl 2.10 2.03 
6 Spleen-V (18.04) 80mg 1276.4 ng/µl 80 µl 1.95 2.20 
7 Pituitary-II (24.04) 20mg 445.9 ng/µl 50 µl 2.08 1.72 
Figure 28 The sequence in the orange frame shows two potential EcoRI linkers in mRNA [U48288.1]. 
Sequence alignment was done between the position of (2723-2746) and (4821-4843) in [U48288.1]. 
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8 Testis-V (24.04) 80mg 884.9 ng/µl 50 µl 2.09 2.18 
9 Heart-V (18.04) 80mg 111.5 ng/µl 80 µl 2.13 1.66 
11 Brain-V (17.04) 80mg 164.3 ng/µl 80 µl 2.08 2.04 
12 Pituitary-III (24.04) 20mg 190.6 ng/µl 50 µl 2.10 1.86 
14 Muscle-V (26.04) 60mg 153.7 ng/µl 30 µl 1.77 2.25 
15 Liver-II (05.03) 20mg 545.9 ng/µl 40 µl 2.07 2.06 
16 Testis-V (17.04) 80mg 378.1 ng/µl 80 µl 2.11 2.00 
17 Spleen-II (05.03) 20mg 211.1 ng/µl 40 µl 2.08 1.82 
19 Testis-II (06.03) 20mg 243.5 ng/µl 40 µl 2.10 1.70 
20 Brain-II (05.03) 20mg 118.9 ng/µl 40 µl 2.08 1.39 
22 Liver-V (18.04) 80mg 816.4 ng/µl 80 µl 2.08 1.77 
23 Testis-II (05.03) 20mg 476.6 ng/µl 40 µl 2.07 1.55 
25 Kidney-V (09.05) 80mg 128.0 ng/µl 30 µl 1.77 2.52 
27 Brain-V (09.05) 20mg 84.3 ng/µl 40 µl 2.08 1.37 
29 Spleen-V (09.05) 20mg 211.1 ng/µl 40 µl 2.08 1.82 
30 Lung-V (17.04) 80mg 281.9 ng/µl 40 µl 2.08 2.17 
 
4.5.2 Specific RNA probe generation and validation  
The mRNA of Akap11short [U48288.1] has a length of 9748nt comprising both 
the 3’- and 5’-UTRs. The ORF is located between nucleotide 5411 and 8800 of the 
mRNA sequence. The 3’-UTR is so long that is rare in nature (>5.4kb). The mRNA of 
Akap11long [NM_012773.2] has a length of 6950nt including the 3’- and 5’-UTR 
regions. The ORF is located between nucleotide 7 and 5685 of the mRNA sequence. 
The two Akap11 mRNAs share a common region with 99% identity with 8 gaps 
(position 4843-8864 in Akap11short [U48288.1], and position 1608-5633 in Akap11long 
[NM_012773.2]).  
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After a search at the GenomeCube co., one Akap11 EST clone was 
subsequenced to be 100% identical with the fragment from 1161 to 4222 in Akap11long 
[NM_012773.2], also including a partial common region (1608 to 4222). This clone was 
used to generate the specific probes for Northern blot hybridization to identify eventual 
Akap11 alternative splicing (Figure 29). 
 
 
 
 
  
                                                                                                                                                                  
Figure 29 Schematic illustration of the alignment and position of Akap11 rat mRNA [NM_012773.2], 
[U48288.1], Akap11 EST clone3 vector and designed primers. Four fragments from the AKAP11 
clone3 plasmid that could be used for hybridization probes generation are LSP (230bp), BSP1 (308bp), 
BSP2 (893bp) and BSP3 (608bp). LSP: Long Akap11 specific probe; BSP: Both Akap11 specific 
probe; NC: negative control. 
 Page | 90 
 
                                                             
Figure 30 Constructed plasmids maps, including Akap11 rat mRNA specific hybridization probes LSP (230bp), BSP1 (308bp), BSP2 (893bp) and BSP3 (608bp) and 
housekeeping gene probes, such as GAPDH (417bp), β-actin (120bp), 28S rRNA (254bp), and StAR (292bp).                                                                      
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All vectors were linearized with appropriate restriction enzymes and 
digoxigenin-labelled RNA probes generated by in vitro transcription as described in 
methods (see subsection 3.7.1). The quality of the hybridization probes was verified 
using dot blot assay to estimate RNA-probe concentration and DIG-labeling efficiency, 
prior to in situ hybridization. 
 
 
 
Figure 31 Plasmids linearization for in vitro transcription. C: supercoiled plasmid; -L: antisense 
linearized plasmid to generate antisense RNA probes; +L: sense linearized plasmid to generate sense 
RNA as positive template control. Plasmid size: LSP (3247bp), BSP1 (3325bp), BSP2 (3910bp), BSP3 
(3625bp), GAPDH (3435bp), β-actin (3138bp), StAR (3309bp), 28S rRNA (3271bp), AKAP11 clone3 
(7170bp). The 1kb DNA ladder (Promega) was used as the DNA marker  
Figure 32 Sensitivity of DIG-labeled antisense RNA probes were verified by dot blot assay.  
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The intensity of the DIG-labeled probe spots depends on the yield of probe 
synthesized during the labeling reaction during in vitro transcription. It depends on the 
amount, size, and purity of the DNA template (linearized plasmids shown in Figure 31). 
By detecting of the DIG-labeled RNA with a dot blot, also the detection system, 
antibody and developing agent were tested. Gradient dilutions of DIG-labeled RNA 
were spotted on a positively charged nylon membrane (Figure 32). After heat- and UV 
crosslinking of the RNA on the membrane, immunological detection was done by using 
a mouse anti-DIG-antibody in combination with a goat anti-mouse IgG secondary 
antibody labelled with alkaline phosphatase and subsequent enzyme staining. Our 
probes could detect 1-2.5pg RNA, which is sufficiently sensitive for a Northern blot
①
.  
Concerning the specificity and sensitivity of this technique, “rare mRNA can be 
detected in 0.1µg of total RNA” by the DIG-labelled non-radioactive Northern blotting 
method (DIG Northern Starter Kit Instruction Manual, Roche)
②
.  
 
 
 
                                                 
①
https://lifescience.roche.com/wcsstore/RASCatalogAssetStore/Articles/DIG_AN1_03.1
2.pdf 
②
 http://post.queensu.ca/~chinsang/lab-protocols/handbooks-and-manuals/dig-
northern.pdf 
Figure 33 Test of 9 different types of washing buffer with 2 distinct dilutions of anti-DIG concentration 
 
8a          8b 
   
  8c            8d 
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The recipes of 9 types of washing buffers are shown in Table 3, and the 
combined 2 kinds of anti-DIG concentration are High anti-DIG (60ng anti-DIG/ml 
antibody buffer) and Low anti-DIG (4ng anti-DIG/ml antibody buffer), respectively. 
When the washing buffer 8 was used, the membrane 8a appeared as a blank membrane 
without the spotted RNA incubated in High anti-DIG as the negative control of 
membrane 8c. The membrane 8b was a blank membrane without the spotted RNA 
incubated in Low anti-DIG as the negative control of membrane 8d. The membrane 8c 
was a membrane containing 1µl of spotted DIG-labelled RNA (4ng) incubated in High 
anti-DIG. The membrane 8d was a membrane with 1µl of spotted DIG-labelled RNA 
(4ng) incubated in Low anti-DIG. All the membranes were run concurrently using the 
different 9 washing conditions and the conditions used for the membrane 8c “Washing 
Buffer 8 + High anti-DIG” (with √ mark) yielded the optimal result.  
After checking the labelling efficiency in the spot assay, a rat tissue RNA dot 
blot was used to test the hybridization efficiency of the DIG-labeled RNA. The 
concentration of DIG-labeled RNA probes required was between 20ng/ml (for abundant 
mRNA detection, e.g. housekeeping gene) and 100ng/ml (for rare mRNA detection). 
Four gradient amounts of total RNA from three different tissues were spotted on 
Nylon membranes to analyze the hybridization efficiency, using the probes described in 
Figure 32. Hybridization was carried out as described in methods (see subsection 3.7.4). 
100ng DIG-labelled Akap11 antisense RNA was used as positive signal control for all 
the blots. 1µg non-labelled Akap11 sense RNA was used as positive template control for 
LSP and BSP1 blots.  
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Dots were visible on the membrane labelled with the antisense RNA probe for 
the detection of the 28S rRNA, indicating that the probe bound correctly to the RNAs 
from different tissues (Figure 34). Also, the positive signals from the membranes 
probed with LSP and BSP1 indicated that the antisense probes bound to the non-
labelled Akap11 sense template correctly. Thus, the absence of signal from the probed 
tissue RNAs suggested that the amount of the Akap11 mRNA in the total RNAs was 
below the detection limit.    
Figure 34 Rat tissue total RNA dot blot hybridization with 4 probes. Left side: methylene blue staining 
of the membranes; Right side: corresponding hybridizations. The total RNAs used were from rat kidney, 
spleen, testis. The specific RNA hybridization probes used were antisense DIG-labelled RNA of 28S, 
Gapdh, Akap11 [NM_012773.2], Akap11 [NM_012773.2] and [U48288.1]. 100ng DIG-labeled Akap11 
was used as positive signal control and 1µg non-labeled Akap11 sense RNA was used as the positive 
template control for LSP and BSP1. 
Page | 95  
 
4.5.3 Rat tissue total RNA Northern blot test  
 
 
 
 
Figure 35 showed that, the whole procedure for non-radioactive Northern 
blotting with DIG-labelled probes worked as expected. Different RNA probes were 
used to label Northern blots of total RNA isolated from different tissues. However, only 
the 28S rRNA control probe hybridization was working well while no positive signals 
were obtained from the other probes. There are 2 possible explanations for the 
observation. First, the target sense RNA template (e.g. Akap11) is below the detection 
limit. In contrast, the 28S rRNA is one of the highest expressed RNAs, therefore its 
amount is within the detection limit of the assay. Around 80% of total RNA is rRNA, 
15% is tRNA, and some of the rest includes non-coding RNA, thus, protein-coding 
mRNA is less than 5% (Lodish et al., 2000). Second, the use of the T7 promoter for the 
28S rRNA probe generation supported the efficient in vitro transcription compared to 
SP6 promoter used for the other probes (LSP, BSP1, BSP2, BSP3, GAPDH, β-actin, 
StAR) (Logel et al., 1992). Suggestion for next trial would be to load more total RNA 
(>10µg/well) and to use higher amounts of labelled probes in the hybridization reaction.    
Figure 35 Total RNA separation by electrophoresis in a 1.8% formaldehyde-agarose gel using 1× 
MOPS running buffer at 20V for 17.5 hours. Methylene blue staining was used to check the transferred 
RNA on the membrane, followed by hybridization with the 28S rRNA probe. M: RNA marker 
(Promega) 6µl/lane; Lane1: 2# liver 5µg; Lane2: 6# spleen 5µg; Lane3: 3# muscle 3µg; Lane4: 4# liver 
3µg; Lane5: 8# testis 3µg; Lane6: 22# liver 3µg (# from Table 17, the RNA quality of these 6 samples 
see Chapter 12. Supplemental data S2) 
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4.5.4 Rat total RNA RT-PCR 
Because the detection of different Akap11 mRNA form with LSP and BSP1 
using the Northern blot did not work as expected, and from the the report that that RT-
PCR detection is more sensitive than Northern blotting hybridization (Fehr et al., 2000; 
Streit et al., 2008), the RT-PCR was used to identify the amount of Akap11 mRNA in 
total RNA from rat tissues (Table 17).  
                                                                                                                                 
 
 
 
Akap11 could be detected with all primer pairs in the different tissues (Figure 
36). The expression of the RNA was highest in the pituitary RNA, which is logical and 
interesting, since the putative false AKAP11 clone from Scott and colleagues was also 
isolated from a cDNA library constructed from pituitary mRNA. Additionally, brain, 
testis and spleen exhibited relative high amount of Akap11 expression, whereas this 
mRNA was only expressed in low amount in heart muscle and in intermediate quantity 
in skeletal muscle, liver, kidney and lung.  
The primer pair “Akap11-LSP” for the 5’ part of the mRNA did not amplify the 
Akap11 product in the same amounts as “BSP1-3”, since an oligo-dT based RT-PCR kit 
Figure 36 Distribution profile of Akap11 mRNA in different rat organs. Lane1: 9# Heart; Lane2: 11# 
Brain; Lane3: 12# Pituitary; Lane4: 14# Muscle; Lane5: 16# Testis; Lane6: 20# Brain; Lane7: 22# 
Liver; Lane8: 25# Kidney; Lane9: 29# Spleen; Lane10: 30# Lung (# from Table 17); Lane11: 1ng 
AKAP11 plasmid clone3 used as positive template control for LSP, BSP1, BSP2, BSP3. As described in 
Figure 29, LSP probe is in position of 1240-1449, 230bp; BSP1 is 3113-3399, 308bp; BSP2 is 2528-
3399, 893bp, BSP3 is 2528-3115, 608bp. 
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was used for the cDNA amplification. For a long mRNA as Akap11 mRNA, it is better 
to use a random primer based reverse-transcription kit when it is necessary to amplify 
the 5’ part of the mRNA. Regardless of the lower sensitivity of amplification, the 
pattern of the tissue distribution for the Akap11-LSP primer pair remained similar, 
depicting pituitatry, testis, brain and spleen as the tissues with higher expression of 
Akap11. 
4.5.5 Concentrated total RNA and PCR-generated probes  
Since Akap11 mRNA was detectable in RT-PCR, the possibility that Akap11 
primers/probes did not work was excluded. The next solution is to precipitate total 
RNAs to get concentrated template, or elute it by polyT columns to get pure mRNAs for 
Northern blotting. 
 
Table 18 Total RNA precipitation 
Sample  RNA concentration A260/280 A260/230 
Brain  416.8 ng/µl 2.01 2.21 
Heart  369.7 ng/µl 1.91 2.38 
Liver 378.4 ng/µl 2.03 2.00 
Lung  360.6 ng/µl 1.90 2.38 
Kidney  1024.1 ng/µl 2.08 2.21 
Muscle  2648.2 ng/µl 2.08 2.20 
Pituitatry  3122.2 ng/µl 2.09 2.17 
Spleen  3163.0 ng/µl 1.98 2.26 
Testis  3340.4 ng/µl 2.11 2.21 
                                      
 
 
 
Figure 37 Alternative method of template 
generation for in vitro RNA transcription. 
PCR product with T7 promotor could be 
used as template instead of linearized 
plasmid to further produce RNA probes. The 
size of PCR products was 23bp longer than 
RNA probes, for instance GAPDH = 440bp; 
β-actin = 143bp; LSP = 253bp; BSP1 = 
331bp. 
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This is a PCR-based technique for the preparation of RNA-probes. T7 RNA 
polymerase promoters were introduced at the 5’-end of gene-specific oligonucleotide 
primers enabling direct in vitro transcription of purified PCR-fragments. The amount of 
the DIG-labelled transcripts generated from PCR-templates was equivalent to those 
derived from a linearized plasmid. Selection of interesting clones can be dramatically 
accelerated by avoiding cloning and plasmid preparation steps using the PCR-approach, 
avoiding the uncertain promoter problem from TA-cloning vectors. However, the 
minimal length of the PCR-fragment should be at least 300bp as shorter probes are less 
sensitive (David and Wedlich, 2001). Due to time limitation, this Northern blotting 
assay was not continued and the cloning of AKAP1, -4 and -10 was started. 
4.6 Basal analysis and over expression of AKAP1, AKAP4, AKAP10 
in TM4 cells 
The last 3 amino acids of AKAP1, AKAP4 and AKAP10 suggested they may 
contain PTS1 signals (Figure 17). Therefore, the following were carried out: 1) the 
tissue distribution and differences in expression of the mRNAs for these AKAPs; 2) 
cloning of the AKAPs in mammalian expression vectors; 3) to overexpress different 
myc-tag versions of the AKAPs in TM4 cells; and 4) analysis of the subcellular 
localization of the AKAPs and subsequent effect on peroxisome and mitochondria. Due 
to the unavailability of reliable antibodies for the detection of these AKAPs, the N- and 
C-terminals myc-tag versions of these AKAPs were used for the overexpression 
experiments.  
4.6.1 Basic analysis of AKAP1, AKAP4, AKAP10  
The putative C-terminal PTS1 “SKL-variant”-tripeptide of mouse AKAP1 is 
“ASL”, whereas “ANL” and “TKL” were found in mouse AKAP4 and AKAP10, 
respectively. However, it was reported that a PTS1 is not solely consisting of the C-
terminal tripeptide (Brocard and Hartig, 2006). From this research group, an on-line 
PTS1 predictor was made available for public use
①
. Therefore, an analysis could be 
done by computer programming (see Supplemental data S1) to show the possible 
“trend” for a putative PTS1 signal throughout the 3 AKAP family members. 
                                                 
①
 http://mendel.imp.ac.at/mendeljsp/sat/pts1/PTS1predictor.jsp 
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Figure 38 PTS1 prediction of all AKAP1 family members present in different species (For a larger figure, 
see Supplemental data S5, color page 156). Light blue bars --- the length of AKAP1 proteins; green block 
--- position of PKA-binding domain; red block --- position of predicted PTS1 signal.  
 Page | 100 
 
  
 
 
 
 
Figure 39 PTS1 prediction of all AKAP4 family members present in different species (For a larger 
figure, see Supplemental data S5, color page 157). Light blue bars --- the length of AKAP4 proteins; 
green block --- position of PKA-binding domain; red block --- position of predicted PTS1 signal. 
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Figure 40 PTS1 prediction of all AKAP10 family members present in different species (For a larger 
figure, see Supplemental data S5, color page 158). Light blue bars --- the length of AKAP10 proteins; 
green block --- position of PKA-binding domain; red block --- position of predicted PTS1 signal. 
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For the prediction, the both verified- and predicted AKAP protein sequences 
were included. Because minimal 12 residues of the C-terminus was required as the 
query sequence by the online tool, the last 20 amino acids of AKAP protein members 
were used for the PTS1 prediction. Indeed, 52% members of AKAP1 and 48% members 
of AKAP10 were predicted to be peroxisomal. The prediction for the last 20 amino 
acids of mouse AKAP1 [O08715.4] with a putative PTS1 end “-ASL” as well as the 
mouse AKAP10 [O88845.3] with “-TKL” were also to be targeted to peroxisomes, but 
not their full sequences. Although none of AKAP4 was predicted to be a peroxisomal 
protein, the mouse AKAP4 [Q60662.1] with a known PTS1 end “-ANL” was predicted 
to be in “twilight zone”. 
Based on the prediction result, it appears as the 3 mouse AKAPs (AKAP1, 
AKAP4 and AKAP10) may have a chance to target to peroxisomes. Moreover, the data 
from EST sources in NCBI showed that mouse AKAP1, AKAP4 and AKAP10 were the 
highly expressed endogenous proteins in testis (Figure 41). 
①
  
 
 
 
From Figure 41 based on mouse, Akap1 transcripts are highly expressed in ovary 
and testis, which reflects its potential role in reproduction. Akap4 mRNA is expressed 
                                                 
①
 AKAP1: http://www.ncbi.nlm.nih.gov/UniGene/ESTProfileViewer.cgi?uglist=Mm.2969, 
  AKAP4: http://www.ncbi.nlm.nih.gov/UniGene/ESTProfileViewer.cgi?uglist=Mm.1498, 
            AKAP10: http://www.ncbi.nlm.nih.gov/UniGene/ESTProfileViewer.cgi?uglist=Mm.274404   
Figure 41 Akap1, Akap4 and Akap10 distribution profile (approximate expression pattern inferred from 
EST sources in NCBI)
 ①
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only in testis, which suggested its specific function in spermatogenesis. Akap10 mRNA 
is mainly expressed in connective tissue, ovary, testis and thyroid.  
 
 
 
 
Among all Akaps mRNA profile in mouse testis, the highest expressed AKAP-
candidates were AKAP1, -4 and -10, suggesting their possible roles in male fertility 
(Figure 42). In order to experimentally confirm the results from the EST database 
searching, pairs of primers were designed to check the expression level of endogenous 
Akap1, Akap4 and Akap10 in mouse testis (Figure 43).  
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AKAPs mRNA expression profile in mouse testis 
(EST profiler from NCBI Unigene)  
         Figure 42 Akap1, Akap4 and Akap10 mRNA are high expressed in testis. 
 Page | 104 
 
 
 
 
 
The results showed that Akap1, Akap4, Akap10 mRNA were highly transcribed 
in mouse testis, and AKAP1 was also highly expressed in brain in agreement with 
Figure 43 Test of designed primers for Akap1, Akap4, Akap10, and their expression level in different 
mouse organs. Br: Brain; Li: Liver; Lu: Lung; Ki: Kidney; Te1: Testis from mouse1; Te2: Testis from 
mouse2; Te3: Testis from mouse3; S+g: Sertoli cell + germ cell mixture; LC: Leydig cell line MLTC-1; 
SC: Sertoli cell line TM4; pla: the constructed plasmid with required gene fragment, used as positive 
template control. 
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previous reports (Dagda et al., 2011; Dyson et al., 2008; Hu et al., 2009; Webb et al., 
2008). It was also observed that Akap1 as well as Star mRNA were highly abundant in 
mouse seminiferous tubules (mixture of Sertoli cell + germ cells) and the TM4 Sertoli 
cell line. This was unexpected since AKAP1 has only been found in Leydig cells in the 
male where AKAP1 regulated StAR protein activity in mitochondria (Dyson et al., 
2008). This observation raised several questions such as: What is AKAP1 function in 
Sertoli cells? Is it also localized at the mitochondria surface with Star mRNA and 
protein? What happens if the protein is mistargeted?  
Akap4 and Akap10 mRNAs were apparently only expressed in germ cells in 
testis, but not in the TM4 Sertoli cell line or in MLTC-1 Leydig tumor cells. Whether 
these AKAPs are expressed at low levels in Sertoli cells or Leydig cells has to be 
verified in the future by using isolated primary cells from the testis and higher amounts 
of cDNA as input template.        
  
 
 
 
As described in the introduction (see subsection 1.2.3), the phosphorylation 
signal pathway in Sertoli cell is strongly influenced by FSH induction. But the three 
Akaps which control the PKA-dependent phosphorylation cascade in TM4 cell line 
showed almost no effect by FSH stimulation. Akap4 and Akap10 were hardly detectable 
in TM4 cell. Although Akap1 was expressed quite strongly in TM4 cells, its function 
and regulation still remains a mystery. Whether the PKA substrate Star and StAR 
Figure 44 Test expression of 
Akap1, Akap4, Akap10 in TM4 
Sertoli cell line under the gradient 
FSH dose treatment (see Figure 
18). Lane1: 5ng corresponding 
plasmids were used as positive 
template control for PCR 
detection. All the PCRs were run 
35 cycles.     
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protein in Sertoli cells are regulated in the same way as in Leydig cells is also a 
question.  
4.6.2 Cloning and immunolocalization of myc-tagged AKAPs 
The myc tag is a 10-amino acid polypeptide tag (NH2-EQKLISEEDL-COOH) 
derived from the c-myc protein and it is frequently used for the localization of 
recombinant proteins. The myc-tag system is widely used to facilitate the detection or 
purification of fusion proteins. Mouse anti-myc antibodies are also well developed for 
immunochemistry. Two different types of vectors were used to monitor recombinant 
proteins expression with the myc-tag attached to the target protein at either the N- or C-
terminus (pCMV-3B, pCMV-5B) (Terpe, 2003). Because the PTS1 signal is at C-
terminus of the protein, two kinds of expression vectors were used for immunodetection 
to confirm whether a possible PTS1 signal is really functional. In contrast, 
mitochondrial targeting signals are frequently localized at the N-terminus of a protein 
and cleaved during the import into the mitochondria
①
 (Emanuelsson et al., 2001). 
                                                 
①
 http://www.fastbleep.com/biology-notes/31/172/978 
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Figure 45 The instruction of myc-tag recombined plasmids generation (inserts are: GFP, AKAP1, AKAP4 and AKAP10) 
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The procedure for subcloning of myc-tagged GFP- and AKAP-fusion proteins 
had been described in detail in the methods (section 3.8). To check the localization of 
fusion protein in vivo, the critical point is the specific binding of the antibody against 
the tag in fusion protein. Two positive control plasmids, pCMV-GFP-3B and pCMV-
GFP-5B, were constructed to test the functionality of the vectors to express the desired 
protein in TM4 cells. The myc-tag was fused to the N-terminus and C-terminus of the 
GFP, respectively.  
GFP (green fluorescent protein) is a 238-residues green fluorescent protein with 
an emission peak at 509 nm, and it is widely used as a reporter of expression (Tsien, 
1998). GFP was previously thought to have non- or low toxicity and exhibit no 
interference with any biological processes (Olivares-Fuster et al., 2002; Welsh and Kay, 
1997). Therefore, many engineering GFP variants were generated for biological 
monitoring (Hoffman, 2008; Murphy et al., 2011). However, recently, some side effects 
of GFP were reported from in vitro and in vivo studies, such as cytotoxicity and 
apoptosis induction (Koike et al., 2013). Thus, in this thesis the myc-tag, which 
exhibited small size (only 10 amino acids) and no side effect, was used instead of GFP 
to track the fused AKAP proteins. 
GFP is a cytoplasm protein with no targeting signal at any terminus, hence the 
attached myc-tag should not interfere with its cytoplasmic localization. This 
arrangement will also allow the co-localization of GFP and the myc-tag in the both two 
constructs, which was confirmed in Figure 46 (myc-GFP and GFP-myc). These two 
GFP fusion constructs were also used to optimize the transfection conditions and the 
staining conditions for the anti-myc tag antibody labelling.   
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N-myc-GFP 
(GFP-3B) and GFP-C-
myc (GFP-5B) were both 
expressed in the 
cytoplasm and also 
nucleus, whilst the anti-
myc antibodies only 
mainly stained the 
cytoplasm. These results 
can be explained in two 
ways. First, the binding 
of the antibodies to the 
outer region will make the penetration to the interior of the cells and nucleus more 
difficult for next sets of antibodies. The second possibility is that the permeabilization 
of the nuclear pores after fixation of the cells during the immunofluorescence staining 
caused the poor penetration of antibodies into the nucleus, whereas the GFP-myc 
recombinant protein was transported in the living cell during the cell culture into the 
nucleus prior to the fixation already. The general entry permeabilization conditions for 
primary and secondary antibodies into mitochondria with a double membrane (outer and 
inner mitochondrial membrane, see Figure 48D-F. SOD2 in the mitochondrial matrix) 
and also into peroxisomes with a single limiting membrane (see Figure 48A-C. catalase 
staining in the peroxisomal matrix) gave excellent results.   
Figure 46 Co-localization test 
for the myc-tagged GFP-fusion 
proteins as positive controls, 
N-terminal myc-labelled GFP 
(GFP-3B) plasmid and C-
terminal myc-labelled GFP 
(GFP-5B) plasmid. A and B 
were taken with a 63 × 
objective of the conventional 
fluorescence microscopy 
(Leica DMR). C and D were 
taken with a 63× objective of 
the confocal laser scanning 
microscopy (CLSM) (Leica 
TCS SP2). 
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It was suspected that the AKAP1, -4, -10 contain a putative PTS1 targeting 
signal at the C-terminus, and AKAP1 and AKAP10 have been suggested to contain a 
mitochondrial targeting motif in the N-terminus, it was necessary to visualize 
peroxisomes and mitochondria in the TM4 cell line under ordinary growth conditions 
(Figure 47 and Figure 48). Peroxisomes are numerous in TM4 cells (Figure 47A-D) can 
be well labelled with PEX14p (Figure 47C-D), a protein marker for peroxisomes that 
was strongly labelling in Sertoli cells in the testis (Grant et al., 2013; Nenicu et al., 
2007).  
 
 
 
PEX3p was less 
expressed and peroxisomal 
staining was only possible 
with high antibody 
concentrations, leading to 
more background (Figure 
47A-B). TM4 cell 
peroxisomes are a mixture 
of round, rod-shaped and 
elongated, tubular 
organelles that are distributed around the nucleus and sometimes form clusters or small 
network-like structures. In the TM4 cell processes, peroxisomes showed a 
heterogeneous pattern, with some processes exhibiting many peroxisomes until the end 
of the cellular extension (Figure 47C) and others exhibiting only few stretched 
organelles (Figure 47A), suggestive of a transport via microtubules in this region. 
 
Figure 47 Immunofluorescence 
images showing peroxisomal 
membrane staining (A-D) in 
untreated TM4 cells. 
Micrographs were taken with a 
63 ×  objective of the 
conventional fluorescence 
microscopy (Leica DMR). 
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Staining for catalase provided a similar pattern in TM4 cells as for PEX14p 
(Figure 47C-D). Catalase was sometimes more enriched in the large, round and 
peripheral part of tubular peroxisomes (bright end) whereas less staining of the tubules 
in between was noted, which could even be better identified in less intensively stained 
peroxisomes (Figure 48B-C). Large clusters and network-like structures were also 
visible with the catalase staining (Figure 48A and C). Mitochondria were well stained 
with the anti-SOD2 antibody in TM4 cells (Figure 48D-F). Large differences were 
observed between the different TM4 cells in the same culture, with some cells 
exhibiting very long mitochondria in the cell periphery, which seem to extend from a 
perinuclear mitochondrial reticulum. Similar to catalase also SOD2 seems to be 
enriched in some matrix parts in the very long mitochondria (Figure 48D). In other TM4 
cells (Figure 48E), mitochondria are arranged in a complete network up to the leading 
lamella of the cell (insert in Figure 48E: perinuclear mitochondrial network). In the 
Figure 48 Immunofluorescence images showing peroxisomal (A-C) and mitochondrial (D-F) matrix 
staining in untreated TM4 cells. Micrographs were taken with a 63× objective of the conventional 
fluorescence microscopy (Leica DMR).  
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backward pole with an elongated extension, single long mitochondria were stretched 
underneath the plasma membrane and seemed to be transported along microtubules. 
Some TM4 cells contained a very dense mitochondrial network with rather small 
distances and high levels of SOD2 (Figure 48F). 
 
 
 
 
Inhibition of the mitochondrial targeting with the N-terminal myc-tag did not 
promote the targeting of the recombinant AKAP1 protein to peroxisomes (Figure 49A-
C). In some cases, larger and nicely extended cells were observed in the cell cultures. 
These cells did not exhibit a high overexpression of the recombinant N-myc-AKAP1 
protein. N-myc-AKAP1 was observed in a network-associated pattern without an 
association with peroxisomes (see Figure 49C), although peroxisomes were always 
Figure 49 Double-immunofluorescence images of the myc-tag and PEX14p, revealing that both myc-
tagged AKAP1 fusion proteins did not co-localize with peroxisomes. Micrographs were taken with a 
63× objective of the conventional fluorescence microscopy (Leica DMR).  
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located at the areas of weakly labeling N-myc-AKAP1. Since some parts of the nuclear 
membrane seemed to be positively labelled with the anti-myc antibody (Figure 49C), 
the association of N-myc AKAP1 with the cytoplasmic face of the endoplasmic 
reticulum could be possible, but this has to be proven in the future with anti-ER-marker 
antibodies. In cells overexpressing AKAP1-C-myc, a typical mitochondrial pattern was 
observed. With the C-terminal myc-tag, a putative peroxisomal targeting would be 
blocked, since the PTS1 must be a “free” tripeptide signal at the extreme C-terminus to 
ensure the targeting of proteins into the peroxisomal matrix. In these cells, however, 
some peroxisomes exhibited very extended elongated structures with a size and 
appearance similar to mitochondria (see Figure 49F). 
 
 
 
Figure 50 Double-immunofluorescence showing that N-terminal myc-tagged AKAP1 (AKAP1-3B) did 
not co-localize with mitochondria (Figure 50A-C), but C-terminal myc-tagged AKAP1 (AKAP1-5B) 
co-localized with mitochondria (Figure 50D-F). Micrographs were taken with a 63× objective of the 
conventional fluorescence microscopy (Leica DMR). 
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Also, in the co-localization staining for mitochondria, the recombinant AKAP1 
protein with a myc-tag at the N-terminus (N-myc-AKAP1) exhibited a cytoplasmic 
localization with enrichment in some areas of the periphery, whereas the AKAP1 
protein with a C-terminal myc-tag (AKAP1-C-myc) was targeted to mitochondria, as 
shown by the overlapping of myc and SOD2 stains. In cultures with overexpressed N-
myc-AKAP1, a clear downregulation of SOD2 was noted in transfected cells, whereas 
some untransfected cells exhibited a much stronger SOD2 labelling, suggesting a 
difference in the reaction to oxidative stress between transfected and non-transfected 
cells. AKAP1-C-myc targeted to all mitochondria in a similar level, whereas the SOD2 
was clearly localized only in some parts of these mitochondria. The insert in Figure 50F 
depicts a TM4 cell with ring-shaped mitochondria, in which the SOD2 was also 
heterogeneously localized. The overall heterogeneity of SOD2 localization in the 
mitochondria of “lipofected” TM4 cells seemed to be much higher than in regular 
control cells without any transfection (compare to Figure 48D-F). At higher 
magnifications, the punctate mitochondrial pattern could be identified in some cases as 
longer organelles, only labelled strongly at some parts with SOD2, forming “beads on a 
string”-like patterns inside the cells. The mitochondrial network in cells with high 
overexpression of AKAP1-C-myc was very dense and exhibited small organelles. 
CLSM examinations of the immunofluorescence preparations revealed similar 
results as obtained by conventional fluorescence microscopy, therefore only the 
overlays of different examples of transfected cells are presented. 
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The overexpressed recombinant N-myc-AKAP1 protein clearly localized to 
special parts of the cytoplasm and network-like structures (Figure 51A), partially 
covering the nucleus (Figure 51B), suggesting that certain parts of the ER-system could 
be labelled. The mitochondrial network in N-myc AKAP1 overexpressing cells seemed 
to be slightly less extended to the periphery and more centrally localized in the 
perinuclear area. Moreover, the long mitochondria observed in the cytoplasmic region 
underneath of the nuclear region of non-transfected neighboring cells (Figure 51A) were 
Figure 51 CLSM images of double-immunofluorescence for myc and SOD2, 
showing that N-terminal myc-tagged AKAP1 (AKAP1-3B) did not co-localize with 
mitochondria (Figure 51A-B), unlike the C-terminal myc-tagged AKAP1 (AKAP1-
5B) (Figure 51C-D). Micrographs were taken with a 63× objective of the confocal 
laser scanning microscopy (Leica TCS SP2). 
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less frequently observed in transfected cells. Mitochondria were localized in N-myc-
AKAP1 free areas, sometimes closely covered by N-myc-AKAP1 positive structures 
(Figure 51A & B). In strong AKAP1-C-myc overexpressing cells, AKAP1 was targeted 
to the complete mitochondrial population, whereas SOD2 was heterogeneously 
distributed, therefore in addition to the yellow color indicative of the overlapped stains, 
red and green colored mitochondria were clearly visible at higher magnifications 
(Figure 51C). In very strong AKAP1-C-myc overexpressing cells, mitochondria were 
rounded up and single organelles or packaged in a very dense network. Cells with lower 
expression of AKAP1-C-myc exhibited already proliferated mitochondria and a denser 
network than non-transfected TM4 cells. In addition, they exhibited a strong SOD2 
staining of the entire mitochondrial network, therefore they appeared green even though 
a weak red staining of the low expressed AKAP1-C-myc in mitochondria was present 
(Figure 51D). 
 
 
Figure 52 Double-immunofluorescence preparations for myc and SOD2, showing that the two types of 
myc-tagged AKAP4 were both expressed in the cytoplasm and did not co-localize with mitochondria in 
TM4 cell line. Micrographs were taken with a 63 ×  objective of the conventional fluorescence 
microscopy (Leica DMR). 
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Both overexpressed recombinant AKAP4 proteins were localized in the 
cytoplasm and reduced the abundance of mitochondrial SOD2 in transfected cells. In 
addition, the level of SOD2 was high in the mitochondria of neighboring TM4 cells that 
were not transfected with the AKAP4-C-myc protein. 
 
 
Cells expressing intermediate levels of AKAP4 in the cytoplasm contained a 
more centrally localized mitochondrial network with lower levels of SOD2, especially 
when the N-myc AKAP4 was overexpressed. Only two positive cells were found 
overexpressing AKAP4-C-myc. The first one exhibited a collapsed perinuclear 
Figure 53 CLSM images of double immunofluorescence preparations for myc and SOD2, showing that 
the both types of myc-tagged AKAP4 fusion proteins localized within the cytoplasm but not to 
mitochondria in TM4 cell line. Micrographs were taken with a 63× objective of the confocal laser 
scanning microscopy (Leica TCS SP2). 
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mitochondrial network with only very few mitochondria extrusion (Figure 53C). The 
second cell appeared more normal, however, exhibited lower SOD2 levels than the 
neighboring non-tansfected cells. 
 
 
In the N-myc AKAP10 overexpression experiments some giant cells were 
present. All cells exhibited a mainly cytoplasmic N-myc-AKAP10 staining, with some 
positive small and round organelles (Figure 54C). These dots did not colocalized with 
peroxisomes that were labelled for PEX14p (Figure 54C). The overall peroxisomal 
appearance and distribution pattern in these cells was also not altered. Most of the cells 
exhibited round to rod-shaped peroxisomes and less tubules. 
 
 
Figure 54 Double-immunofluorescence preparation for myc and PEX14p, showing that N-terminal 
myc-tagged AKAP10 (AKAP10-3B) did not co-localize with peroxisomes. Micrographs were taken 
with a 63× objective of the conventional fluorescence microscopy (Leica DMR). 
Figure 55 Double-immunofluorescence preparation for myc and SOD2, showing that the N-terminal 
myc-tagged AKAP10 (AKAP10-3B) did not co-localize with mitochondria. Micrographs were taken 
with a 63× objective of the conventional fluorescence microscopy (Leica DMR). 
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N-myc-AKAP10 was also localized in the cytoplasm, but did not lead to the 
reduction of mitochondrial number or the reduction of SOD2. AKAP10-C-myc 
overexpression seemed to be toxic since no positive transfected cells within 24 hours. 
The transfected cells probably died due to apoptosis, which might have been induced by 
altered mitochondrial function. To determine whether N-AKAP10 would have an effect 
on mitochondria and apoptosis induction, therefore earlier time-points after the 
transfection have to be used in future experiments. 
 
 
 
 
In comparison to neighboring non-transfected cells, cells with low N-myc-
AKAP10 expression in the cytoplasm exhibited a less dense mitochondria network and 
a lower SOD2 labelling. The contrast of the AKAP10 and SOD2 staining was enhanced 
to aid better visualization of the mitochondrial network in the insets (Figure 56A). Cells 
with high N-myc-AKAP10 expression most probably went into apoptosis (round cell in 
Figure 56B with only few mitochondria). 
  
Figure 56 CLSM images of a double immunofluorescence preparation for myc and SOD2, showing 
that the N-terminal myc-tagged AKAP10 (AKAP10-3B) did not co-localize with mitochondria. 
Micrographs were taken with a 63× objective of the confocal laser scanning microscopy (Leica TCS 
SP2). 
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5 Discussion 
5.1 AKAP220 (-CRL) is probably an artifact 
The A-kinase anchoring proteins (AKAPs) constitute a protein family that tether 
PKA and other enzymes to various specific subcellular locations, and play a critical role 
in the regulation of the cellular physiological metabolism. In 1996, a rat isoform of 
AKAP11 which was previously called rat AKAP220 [Q62924.1] due to its molecular 
mass, was reported to be localized in peroxisomes through a PTS1 signal (“-CRL”) and 
supposed to take part in testicular peroxisomal functions and phosphorylation events by 
Prof. Scott’s group, an AKAP research pioneer (Lester et al., 1996). As a peroxisome 
research group, this particular “peroxisomal” AKAP was interesting for us. However, 
during this thesis we revealed that this putative peroxisomal rat AKAP11 [Q62924.1] is 
an artifact, that was mistakenly identified in the literature.       
First, a functional structure of a protein should be evolutionary conserved 
throughout the entire family of the protein (Nasir et al., 2014). It is unlikely that just one 
member possesses some functional domain not present in any other members of related 
species. From the information obtained from the literature and the screening of all 
AKAPs (Figure 17), we found that the reported sequence of rat AKAP11 [Q62924.1] is 
the only one with a distinct C-terminal end containing a putative PTS1 signal in the 
entire AKAP11 family, and clusters into a separate protein subfamily in the 
evolutionary tree.  
Second, the result of the mRNA BLAST showed that the mRNA [U48288.1] of 
rat AKAP11 [Q62924.1] is not derived from a single chromosome, but combines three 
non-related gene fragments from three distinct chromosomes by two EcoRI linkers 
(Figure 27-28). In the 1990’s, EcoRI linker was frequently used for self-made cDNA 
library constructions, which could have been the source of the contamination. Although, 
“trans-splicing” events exist in nature that mRNA might be not 100% derived following 
exons order in genome (Caudevilla et al., 1998; Flouriot et al., 2002; Yang and Walsh, 
2005). However, one mRNA from 3 separate chromosomes (2, 12 and 15) is very 
unlikely (Figure 27). Moreover, in the right exon from chromosome 15, an artificial 
frame shift (position: 8864-9726) in the cDNA clone caused an upper STOP codon, 
leading to the “-CRL” PTS1 signal.     
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Third, the antibody against AKAP220 used in Scott’s paper was produced by the 
cloned artificial recombinant partial AKAP220 plasmid. Using this antibody, a double 
immunofluorescence staining showed the peroxisomal localization of AKAP220. 
Moreover, the antibody used in the Scott’s paper is polyclonal, meaning that this 
antibody was composed of an antibody mixture targeted to different epitopes on rat 
AKAP220. This mixture most likely also contained antibody that recognized the 
tripeptide (“-CRL”) in the C-terminus of rat AKAP220. Antibodies against the C-
terminal PTS1 signal, such as “-SKL”, are frequently used to stain peroxisomal protein 
efficiently and will clearly label many proteins in the peroxisomal compartment (Stelzig 
et al., 2013). The “-CRL” could also be potentially found at the C-terminus of other 
peroxisomal proteins which could be then detected by this antibody. Therefore, during 
the bioinformatics work for this thesis, the complete protein database of the rat was 
searched for a “CRL-STOP codon”. Indeed, with the advice from the Swiss Institute of 
Bioinformatics, a rat peroxisomal protein Acot4 [D3ZIQ1] (421aa, 46kDa) was found 
with a “-CRL” tripeptide at the C-terminal end. This could be an explanation for the 
detected peroxisomal staining for rat AKAP220 presented in Scott’s paper.  
We therefore suggest that the rat AKAP220 [Q62924.1] which was described to 
be a peroxisomal protein because of its “-CRL” putative PTS1 signal, is an artifact, 
resulting from a non-accurate self-made cDNA library construction. This hypothesis is 
practically proved by our findings of the EcoRI linker at two different positions inside 
of the rat AKAP11 recombinant cDNA clone (Figure 28). Similar mistake was common 
in that period, due to technical limitations and the lack of the shared database 
information that we are able to access nowadays. For example, a shorter cloned mouse 
AKAP10 gene was generated also due to an artificial cDNA library or false sequencing, 
causing a frame shift and a wrong STOP codon (Wang et al., 2001).  
5.2 PTS1 prediction is useful for searching novel peroxisomal 
proteins  
The peroxisomal enzyme composition in distinct organs and cell types is 
heterogeneous and varies strongly (Grant et al., 2013). Due to the limitation in pure 
peroxisome isolation from different cell types, the peroxisome proteome research still 
depends on the computational prediction to identify low abundance peroxisomal 
proteins. The C-terminal PTS1 tripeptides (“-SKL” variants) are the most important part 
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of the PTS1 signal and widely used as the first strategy to screen for potential new 
peroxisomal matrix proteins (Hayashi et al., 1997; Ma and Reumann, 2008).  
However, the larger the database tested or the bigger the PTS1 tripeptides 
pattern matrix applied, the more candidates would be generated as well as the more 
false positive hits obtained. Because this screening algorithm excludes the analysis of 
other critical factors on the individual candidate, such as 1) upstream amino acid 
residues close to the PTS1 tripeptides, 2) other possible organelle targeting signals 
ahead or overlapping the PTS1 signal, and 3) the unpredictable C-terminal exposure 
efficiency. In 2008, a study applied a PTS1 tripeptides pattern matrix ([SAPC]-[KR]-
[LMI]) to screen an Arabidopsis protein database and obtained 7 potential plant 
peroxisomal kinases from that screening. However, 4 candidates were verified with 
functional PTS1 only when they were partially expressed as oligopeptides, but not as 
full-length fusions which remained in the cytoplasm. The other 3 of the 7 sequences 
were incorrectly predicted through experimental validation (Ma and Reumann, 2008). 
Also a mammalian PTS1 motif was proposed ([SACKN]-[KRHQNS]-[LI]) (Amery et 
al., 2000). In this thesis, we applied a broad-ended PTS1 consensus ([ACHKNPQST]-
[AHKNQRS]-[FILMV]) and a test database for AKAPs, and obtain 3 AKAP families 
with potential PTS1 signals which were highly expressed in the testis (Table 15 and 
Figure 17&41-42).  
Furthermore, our second screening which included the upstream residues of the 
PTS1 terminus suggested a low possibility of peroxisomal proteins throughout these 3 
AKAP families (Figure 38-40). Basic residues located close to PTS1 tripeptides play an 
enhancing role for the peroxisomal targeting, while acidic amino acids are functionally 
inhibitory instead, especially the critical residue at the 4
th
 last position (Amery et al., 
2000; Ma and Reumann, 2008). For example, a GFP construct derived from human 2-
methylacyl-CoA racemase, which coded GFP-KVKASL, localized very well in 
peroxisomes. Amery and colleagues showed that a nonpolar side chain amino acid point 
mutant GFP-KVGASL displayed a cytoplasmic fluorescence (Amery et al., 2000).  
In this respect, a closer look on the 3 individual mouse AKAPs was taken:  
The mAKAP1 [O08715.4] contains the reported PTS1 variant “-ASL” (Amery 
et al., 2000), but without positive charged Lysine (Lys, K) at the 4
th
 last position, on the 
contrary one negatively charged Aspartic acid (Asp, D) and 3 uncharged amino acids 
(Ser-Tyr-Tyr, SYY) upstream were found which might be inhibitory on the peroxisomal 
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targeting signal (Figure 38). In addition, mAKAP1 also contains a mitochondrial 
targeting signal in the N-terminal 30 residues, which maintains higher priority and is 
exposed first during translation.  
Eventhough mAKAP4 [Q60662.1] also contains a prototypical PTS1 tripeptide 
“-ANL”, the presence of one Aspartic acid (Asp, D) and 3 hydrophobic amino acids 
(Trp-Leu-Leu, WLL) upstream might reduce the peroxisome targeting ability (Figure 
39).  
The C-terminal end “-TKL” in mAKAP10 [O88845.3], considered as a putative 
PTS1 signal here (Figure 40), has been suggested to act as typical class I PDZ-binding 
motif (“-STKL”) conserved among species (Tingley et al., 2007). PDZ domains are 
abundant and diverse and mediate protein-protein interactions. More than 200 types of 
structures are present to recognize the C-terminus of binding proteins, such as the C-
terminal end of Shaker-type K
+
 channels (Kvl1.4) and N-methyl-D-aspartate receptor 2B 
(NMDA) (Lee and Zheng, 2010; Saras and Heldin, 1996). The PDZ-binding motif can 
serve as signal peptide to target proteins to membrane receptor complexes (Hamuro et 
al., 2002). Moreover, AKAP10 was shown to localize at a highly specialized region of 
the plasma membrane in mouse kidney proximal tubular cells. This PDZ-binding motif 
in AKAP10 could be recognized by PDZ domain-containing proteins, which might 
influence phosphorylation of PKA substrates located in close proximity to the plasma 
membrane. For example, PDZK1, a protein with multiple PDZ domains, connects 
plasma membrane proteins and acts as an anchoring site for AKAP10 via its PDZ-
binding motif (Gisler et al., 2003a; Gisler et al., 2003b). Thus, the putative PTS1 signals 
of these 3 AKAPs can hardly be functional under non-pathological conditions.   
The on-line PTS1 predictor in the second round revealed that the mouse 
AKAP1, 4, 10 are probably not the targeted to peroxisomes (Figure 38-40), which was 
also confirmed by overexpression of AKAP1-pCMV-3B, AKAP4-pCMV-3B and 
AKAP10-pCMV-3B in this study (Figure 49-56). Thus, this web tool seems to be 
relatively reliable to predict the targeting possibility. In addition, a combined computer 
programming code (see Supplemental data S1) was developed for large amount 
sequence screenings. The programming languages named Python and R were used, both 
of which are easy to learn for beginners and are open-source free software for 
worldwide users (Prechelt, 2000; Tippmann, 2015). In this study, Python was used for 
screening PKA binding domain and PTS1 signals throughout the whole AKAP1, 4, and 
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10 family members in the protein database, and R was used for transferring results into 
pictures to be easily read. The code (Supplemental data S1) is free offered for any user, 
who has interest to have a predicted overview of sequence feature before executing 
experiments.  
5.3 Exceptions to the rules of PTS1 prediction:  alternative targeting 
of peroxisomal matrix proteins  
Not all the sequences indicated by the PTS1 predictor are peroxisomal protein. 
Also, some peroxisomal proteins did not follow the general algorithm of defined PTS1 
prediction, such as the proteins that contain “hidden” PTS1 signals, which are only 
appended by translational readthrough extension. For instance, lactate dehydrogenase, a 
cytoplasmic enzyme, was described in peroxisomes in 1996 (Baumgart et al., 1996a), 
however, nobody knew its targeting mechanism to the organelles. Last year, it was 
described that lactate dehydrogenase B (LDHB) contains a PTS1 signal at the C-
terminal end that cannot be recognized by any available PTS1 prediction programs, 
because it is located after the STOP codon. Only when translational read-through 
occurs, it will be functional and will target LDHB to peroxisomes (Baumgart et al., 
1996a; Schueren et al., 2014).  
Some proteins don’t contain a PTS1 signal, but are also transported into 
peroxisomes by binding a partner which contains a PTS1. For example, Cu/Zn 
superoxide dismutase 1 (SOD1) is an enzyme without any targeting signal, while its 
binding partner, the “copper chaperone of SOD1” (CCS), contains a weak PTS1 (“-
AHL”). Therefore, SOD1 is co-imported by CCS into peroxisomes via a “piggyback” 
import-mechanism. When expressed together, SOD1 will be shuttled into peroxisomes 
by interacting with CCS. When a defect in the SOD1-CCS association occurs, for 
example by a mutation in the PTS1 end of CCS or in the peroxisomal import receptor 
PEX5p, both SOD1 and CCS remain in the cytoplasm (Islinger et al., 2009).  
Some proteins can display dual localization under different situations. In rat, L-
alanine: glyoxylate aminotransferase 1 (AGT1) is in mitochondria, and its N-terminal 
22 residues were considered to be a putative mitochondrial targeting signal. In human, 
AGT1 lost these 22 amino acids during evolution and is targeted to peroxisomes. 
However, in primary hyperoxaluria type I patients, the AGT1 is transferred again back 
to mitochondria, caused by a point mutation in the initiation codon ATG to ATA 
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(Takada et al., 1990). A protein with real dual subcellular localization is human 2-
methylacyl-CoA racemase, which is a protein containing both mitochondrial and 
peroxisomal targeting signals (Amery et al., 2000). 
5.4 AKAP1 and mitochondrial fragmentation  
It was reported in the literature that in many cell types (neurons, cardiomyocyte, 
etc.) the overexpression of AKAP1 could promote phosphorylation and inhibition of the 
pro-apoptotic BAD protein (Affaitati et al., 2003; Merrill and Strack, 2014). PKA 
phosphorylates BAD at Ser
155
, which blocks BAD binding of Bcl-2 and inhibits 
apoptosis. Mitochondrial dysfunction is associated with apoptosis, indicating that 
mitochondrial-anchoring of PKA is critical for cell survival (Carlucci et al., 2008). 
Moreover, overexpression of AKAP1 and Ser
637
-phosphorylation of Drp1 was 
neuroprotective, promoting mitochondrial elongation by fusion (Cribbs and Strack, 
2007; Merrill et al., 2011). In conclusion, high cellular AKAP1 levels were suggested to 
promote mitochondrial elongation or aggregation, and to reduce fragmentation or 
apoptosis (Kim et al., 2011). 
Although it was shown that AKAP1 overexpression is good for the 
mitochondrial morphology and cell survival, in our case the extra myc-tag might hinder 
it. In this thesis, when AKAP1-pCMV-5B (C-term myc-tagged AKAP1) was over-
expressed in TM4 cells, some cells displayed more fragmented mitochondria (Figure 
51C-D). It was reported that AKAP1 with a defect in the KH domain induced changes 
in the mitochondrial morphology that appeared collapsed and rounded up rather than the 
normal elongated rod-like shape (Rogne et al., 2009). When the KH domain is 
phosphorylated by PKA, it is active to bind and stabilize RNA or ssDNA, such as Star, 
Sod2 and ATP synthase F0-f mRNAs. A KH domain mutant is associated with some 
diseases, such as fragile X mental retardation syndrome and paraneoplastic opsoclonus-
myoclonus-ataxia (POMA) neurodegenerative syndrome (Rogne et al., 2009). It is 
suggested that the C-terminal myc tag of recombinant AKAP1 may spatially hinder the 
KH domain phosphorylation or its mRNA association, possibly reducing mitochondrial 
protein content and inducing mitochondrial fragmentation.  
Moreover, mislocalized AKAP1 reduced oxidative ATP synthesis and 
mitochondrial membrane potential (ΔΨm) and increased oxidative stress resulting in 
cell death, and the AKAP1 knockdown induced mitochondrial fragmentation and 
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apoptosis (Perrino et al., 2010). Thus, AKAP1 was suggested to play an important role 
in restoration of mitochondrial respiratory function, reduction of mitochondrial ROS 
and reduction of mitochondrial fission. However, in this study when AKAP1-pCMV-3B 
(N-term myc tagged AKAP1) was over-expressed in TM4 cells, the cells displayed 
normal elongated tubular mitochondria (Figure 51A-B). Additionally, the peroxisomal 
morphology remained unaffected regardless of the AKAP that was transfected. 
5.5 Mitochondrial fusion and fission mechanisms 
The mitochondria fusion and fission machinery is tightly controlled by protein 
phosphorylation. Mitochondrial fusion is controlled by three GTPase: Mitofusion1 
(Mfn1), Mitofusion2 (Mfn2) and optic atrophy 1 (OPA1). Mfn1 and Mfn2 are anchored 
in the mitochondrial outer membrane (MOM), and OPA1 is localized to the 
intermembrane space and involved in the control of the cristae structure. The 
mitochondrial fission process is regulated by a cytosolic GTPase dynamin-related 
protein 1 (Drp1) and a small outer mitochondrial membrane binding protein Fis1. Fis1 
is also responsible for peroxisomal division, which is discussed in following section 5.6.  
As mentioned in section 5.4, Drp1 is inactivated by PKA phosphorylation at 
Ser
637
, which inhibits its GTPase activity. Inactivated Drp1 promotes elongation of 
mitochondria and enhances cellular resistance to pro-apoptotic stimuli. De-
phosphorylation of Drp1 phospho-Ser
637
 by CaN (also called PP2B), an AKAP1 
binding partner, induces mitochondrial fragmentation and cell death. When active, 
dephosphorylated Drp1 rapidly cycle between cytosol and mitochondria, suppressing 
mitochondria fusion into the cell protective reticulum (Merrill et al., 2011). AKAP1 at 
the mitochondrial membrane provides docking sites for the C-terminus of Drp1, as well 
as the central domain of PKA holoenzyme, which are indispensable for regulating 
mitochondrial morphology (Kim et al., 2011). Thus, it could be another possible 
explanation for the transfected AKAP1-myc induced mitochondria fragmentation. The 
C-terminal myc-tag might block the Drp1 docking site in AKAP1, wherefore, active 
Drp1 remain in the cytosol, a process inhibiting mitochondrial fusion and maintaining a 
punctate mitochondrial pattern.  
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5.6 Connection between peroxisomes and mitochondria  
Distinct sets of enzymes are present in peroxisomes and mitochondria for lipid 
β-oxidation in animals, the fatty acid degradation still needs the cooperation of both 
organelles, because shortened fatty acids from peroxisomes are broken down in 
mitochondria (Colasante et al., 2015). For example, the peroxisomal acyl-CoA oxidases 
and the mitochondrial acyl-CoA dehydrogeneases originated from a common ancestor 
gene (Baumgart et al., 1996b).  
The division processes of peroxisomes and mitochondria also influence each 
other by shared fission proteins, such as PMD1 (Peroxisomal and Mitochondrial 
Division Factor 1), dynamin GTPases DLP1, Fis1 (Fission factor 1) and Mff 
(Mitochondrial fission factor). Fis1 promotes both mitochondrial and peroxisomal 
division, targets to peroxisomes by a PEX19p shuttle and contacts with PEX11α and 
PEX11β (Schrader et al., 2011). Mitochondria and peroxisomes also cooperate in anti-
viral signaling and defense (Islinger et al., 2012). For example, mitochondrial antiviral 
signaling adaptor (MAVS) is also a dual-localized protein. When HIV-RNA attached on 
MAVS sites, the MAVS localized at peroxisomes (Berg et al., 2012). When peroxisome 
biogenesis is defective, the mitochondria also exhibit a dysfunction (Baumgart et al., 
2001). For this reason, when defect AKAP1 causes mitochondrial dysfunction, 
repercussions might also affect peroxisomes.    
Peroxisome proliferator-activated receptors (PPARs) are ligand-activated 
transcription factors. PPARs and their heterodimeric partner (retinoid X receptor, RXR) 
regulate target gene expression by binding the peroxisome proliferator responsive 
elements (PPREs) present in its promoter. Lipid metabolism is under the control of 
PPARs and PGC-1α (PPARγ coactivator-1α) in both peroxisomes and mitochondria 
(Colasante et al., 2015; Finck, 2007). For example, PPARs regulated the transcripts 
level of the acyl-CoA oxidase 1 (ACOX1) in peroxisomal β-oxidation and carnitine-
palmitoyltransferase (CPT1), acyl-CoA dehydrogenease (ACDH) and 3-ketoacyl-
coenzyme A thiolase (THIO) in mitochondrial β-oxidation (Colasante et al., 2015). 
PPARs also play an important role in β-oxidation of fatty acids in testis, which 
associated with testicular functions (steroids synthesis). This subfamily consists of 3 
isotypes: PPARα, -β and -γ. PPARα was known to be upregulated by FSH in the testis. 
However, PPARγ/RXRγ complex is dominantly expressed in mature Sertoli cells 
(Thomas et al., 2010). In addition, PPARγ regulates the lipolytic response by 
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influencing the mRNA level of PKAcatα, Akap1, lipase gene Pnplaz (ATGL) and Lipe 
(HSL). It was showed that PKAcatα and Akap1 mRNA were downregulated in adipose 
tissues of humans. Moreover, a luciferase assay confirmed this PPARγ regulation 
mechanism by identifying PPRE motifs at -600bp in the PKAcatα promoter (5’-
CGACCCTTGACCC-3’) and at >7kb in the Akap1 promotor (5’-
AGGGAAGAGGTCA-3’) (Rodriguez-Cuenca et al., 2012). In the testis, lipids are not 
only acting as energy source, but also as composition of spermatozoa membrane, such 
as long-chain fatty acids. Therefore, it is important to study male fertility by making a 
further clarification on the role of PPARγ-AKAP1 in lipid metabolism between 
mitochondria and peroxisome in the Sertoli cell. 
5.7 The role of AKAP1-StAR interaction in Sertoli cells 
It is known that AKAP1 anchors PKA to the mitochondrial outer membrane to 
phosphorylate the StAR protein. Phosphorylated StAR transports cholesterol from the 
outer to the inner mitochondrial membrane, thereafter the cholesterol is converted by 
P450scc (cholesterol side-chain cleavage enzyme, also called CYP11A1) to 
pregnenolone, which is the rate-limiting step in steroidogenesis (Castillo et al., 2014). 
This bioprocess occurs under the stimulation of LH in the theca of interstitial ovary 
cells in the female and Leydig cells of the testis in the male (Figure 57 upper portion). 
However, there are limited studies on the FSH and StAR expression in Sertoli cells. 
One study in 1998 reported that the regulation of FSH to StAR was not associated with 
cholesterol delivery and pregnenolone production but was rather associated with free 
fatty acid import into mitochondria (Gregory and DePhilip, 1998). Here we showed that 
the Akap1 and Star mRNAs are expressed in the TM4 Sertoli cell line and that the 
overexpressed AKAP1 protein is localized in mitochondria in these cells under standard 
cell culture conditions for TM4 cells. We were also able to confirm that FSH 
stimulation resulted in elevated StAR protein amounts in TM4 Sertoli cells (Figure 43-
44&51). To get a better understanding on steroidogenesis regulation, it would be 
interesting to explore further questions, such as: a) the role of AKAP1 and StAR in 
mitochondria in Sertoli cells, b) whether AKAP1 and StAR are also expressed in 
granulosa cell in the ovary of female (Figure 57 lower portion). Due to time restrictions, 
we were not able to test out any other experimental conditions, such as lipid treatment, 
hypoxia or other conditions that might provoke an additional targeting of AKAP1 to 
peroxisomes.                                 
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①
 http://www.kegg.jp/kegg-
bin/highlight_pathway?scale=1.0&map=map04913&keyword=FSH%20LH%20StAR 
Figure 57 Testis steroidogenesis pathway cooperated between Leydig cell and Sertoli cells. This 
schematic representative picture includes the integrated information from literatures (Misra et al., 2002; 
Wahli et al., 1995; Walker and Cheng, 2005), KEGG Pathway Database
①
 and findings and hypothesis 
from this thesis. 
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5.8 AKAP4 detection and in vitro localization 
AKAP4 plays a conserved role in spermatogenesis throughout mammalian 
evolution. A study on Akap4 gene characterization in a marsupial showed that, Akap4 
was not observed in any stage of the juvenile developing testis, and could only be 
detected in adult testis but not in any other adult tissue. The AKAP4 2.9kb mRNA was 
present in the cytoplasm of round and elongated spermatids. After the cleavage of the 
precursor pro-AKAP4, the mature AKAP4 protein was then transferred and targeted to 
the principal piece of the flagellum in the sperm tail, confirming the same observation 
by Nipper in 2006 (Hu et al., 2009; Nipper et al., 2006).  
Unfortunately, a good model system of germ cell lines to study spermatogenesis 
up to spermatozoa development is not available (Lüers et al., 2006). Only GC2 cell is an 
available spermatocyte cell line, however the cells died early after transfection 
experiments (non-published data of our group). Also other groups experienced this 
problem and had used somatic cell lines (NIH3T3 and HEK293) for overexpression 
studies of an AKAP4-GFP function protein. A series of AKAP4-GFP fusion 
constructions were expressed. The presence of the pro-domain, the GFP-pro-AKAP4 
fusion protein displayed a diffuse cytoplasmic localization. The mature GFP-AKAP4 
fusion protein showed a punctate cytoplasmic pattern instead. It was shown that the 
pattern of fusion protein localization was dependent on neither the type of cell line, nor 
the position of GFP (N- or C-termini) (Nipper et al., 2006). So the AKAP4 targeting 
signal sequence is probably not located in N- or C-terminus, but was suggested to be 
localized in the middle piece (Hu et al., 2009).  
Consistent with these observations, Akap4 mRNA was solely detected in mouse 
testis tissue in this study (Figure 43), but not in any other organs or TM4 cell line which 
was derived from immature mouse Sertoli cells (Figure 44). The expression of either N-
term or C-term myc-tagged full length AKAP4 in TM4 cells proved to be extremely 
difficult and seemed to interfere with their viability. We were able to detect only one or 
two transfected cells which displayed a cytoplasmic staining in TM4 cells (Figure 52-
53). In comparison to NIH3T3 and HEK293, transfections of full-length AKAP4 in 
TM4 cells seemed to be detrimental for the cell survival. 
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6 Outlook (future plan) 
Many different external stimulations could initiate the cAMP generation and 
PKA activation. To get an appropriate downstream response it is critical to maintain a 
healthy and balanced cellular state. AKAPs enhance the efficiency of cAMP signal-
transducing pathways by tethering PKA near sites of cAMP generation or PKA targets, 
and rigidly control the downstream response through specific spatial and temporal 
expression (McConnachie et al., 2006). Further research on the precise functional 
residues of AKAP complex and its tertiary and quaternary structure, could be a solution 
for gene cure application in medicine. For example, we supposed that the myc-tag in the 
C-terminus hindered the spatial structure of the AKAP1 KH domain. Further studies 
using overexpression of the recombinant AKAP1 without the KH domain or replaced 
with a junk sequence could verify whether it exerts an influence on its localization and 
the observed low SOD2 levels in mitochondria. A series of point mutation assays could 
provide answers concerning the critical binding residues.      
AKAPs form signal transduction units, “transduceosomes”, which include not 
only protein kinases and phosphateases, but also adenylate cyclase (AC), PDE and 
mRNA. For example, AKAP1 and other binding partners form a “transduceosome” 
complex at the OMM that organizes different signaling enzymes, receptors, adaptor 
molecules and mRNAs. The “transduceosome” focuses and functionally integrates 
distinct transduction pathways, placing the enzymes into specific sub-cellular contexts 
and optimizing signaling events on co-localized effectors. This type of regulation, based 
on protein modification, can rapidly adapt mitochondrial activity to changes in 
metabolic demands and nutrients availability (Carlucci et al., 2008). At present, 3 
recombinant AKAPs plasmids have been constructed with both N- and C-terminal myc 
tag (Figure 45). Further co-immunoprecipitation assays and construction of deletion 
mutants could be used for “transduceosome” research of AKAP1, 4 and 10, in order to 
reveal their binding partners and signaling pathway cross-talks.    
Taken together, the data on AKAP1, 4 and 10 suggests their important role on 
precise regulation of cellular phosphorylation events. Future studies will focus on 
AKAPs sequence feature and metabolic pathway regulation mechanism.  
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7 Summary 
Sertoli cells in the testis regulate spermatogenesis and are involved in the 
molecular pathogenesis of male infertility, an increasing problem worldwide. They are 
controlled by testosterone and FSH signaling, which increases the intracellular cAMP-
levels, leading to the activation of protein kinase A (PKA) and downstream 
phosphorylation events. Compartmentalization of PKA-dependent phosphorylation is 
controlled by a variety of distinct A-kinase anchoring proteins (AKAPs), tethering PKA 
by high affinity binding to a particular subcellular location. In this respect, it is of 
interest that rat AKAP220, partially homologous to the AKAP11 family, was described 
in peroxisomes of rat Sertoli cells, essential organelles for maintenance of normal lipid 
homeostasis and spermatogenesis regulation in this cell type.  
Therefore, the aims of this thesis were to analyze the effects of FSH treatment on 
peroxisomal gene expression, to characterize the effect of PKA-AKAP220 signaling on 
peroxisomes and to eventually discover new AKAP family members localized in this 
cell organelle or in mitochondria in Sertoli cells. Mouse TM4 Sertoli cells were used as 
cell culture model system to study the effects of FSH signaling on the peroxisomal and 
mitochondrial compartment. Since it is well established in the literature that the 
mitochondrial steroidogenic acute regulatory protein (StAR) is stimulated by LH-
receptor/PKA-AKAP-signaling in testicular Leydig cells, the Star mRNA expression 
was assessed in TM4 Sertoli cells. Indeed, the Star gene was expressed in TM4 Sertoli 
cells and its expression level was also FSH-regulated. With optimized cell culture and 
FSH-treatment conditions, the gene expression for a variety of peroxisomal biogenesis 
and metabolic proteins was analyzed. FSH-treatment induced the expression of Pex11α, 
Pex13, Cat, Acox2, and Abcd2 mRNAs, encoding proteins involved in proliferation, 
matrix protein import, ROS and lipid metabolism in peroxisomes, demonstrating that 
the organelle is influenced by FSH signaling. To verify the peroxisomal localization of 
AKAP220 (=AKAP11) and to study its effects on FSH-PKA-mediated spermatogenesis 
regulation, this protein was localized with a commercial antibody in different 
subcellular fractions and highly purified peroxisomes of TM4 cells. However, our 
follow-up experiments with Western blots, bioinformatic evolutionary tree analysis for 
conserved PTS1 signals in AKAPs, and sequence alignments between Akap11 cDNA 
and genome sequences revealed that the reported cloned rat Akap220 cDNA as well as 
the subsequent results of AKAP220 subcellular localization were artifacts.  
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Furthermore, during the series of experiments on rat Akap11 mRNAs in our 
laboratory, total RNA from a variety of rat tissues was isolated and the tissue-specific 
Akap11 gene expression was analyzed with specific sets of primer pairs, which revealed 
the highest Akap11 mRNA levels in the testis, pituitary, total brain and spleen and 
intermediate levels in liver, lung, heart and skeletal muscle. The same primers were 
used for subcloning parts of Akap11 in plasmid vectors for in vitro transcription of DIG-
labelled cRNA-probes for Akap11 as well as corresponding mRNA controls. A non-
radioactive Northern blot method was established, which can be used for future 
experiments on alternative splicing of Akap mRNAs.  
During the intensive bioinformatics screenings with partially program developed 
from Python and R in this study, new AKAP proteins (AKAP1, AKAP4 and AKAP10) 
were identified with a putative peroxisomal targeting signal 1 (PTS1), which were also 
highly expressed in testis as shown by RT-PCR analysis. Thereafter, series of 
subcellular localization experiments were performed to confirm the PTS1 prediction 
results. For this purpose, the complete open reading frames of mouse Akap1, Akap4 and 
Akap10 cDNAs were cloned into two different myc-tag vectors for expression of N- or 
C-terminal myc-tagged fusion proteins in TM4 Sertoli cells. As controls, myc-tagged 
GFP constructs were made in the same plasmid vectors, which were used for 
optimization of TM4 cells transfection and detection of the expressed fusion proteins by 
immunofluorescence with an anti-myc antibody. The expressed N- or C-terminal myc-
tagged fusion proteins of all AKAPs (AKAP1, AKAP4 and AKAP10) were detected 
and tried to colocalize with mitochondria or peroxisomes by using double-
immunfluoresecence with antibodies against myc/SOD2 or myc/PEX14p, followed by 
analysis with conventional fluorescence microscopy or confocal laser scanning 
microscopy (CLSM). Only AKAP1-C-myc exhibited a typical mitochondrial 
distribution pattern and colocalization with SOD2 and exerted strong effects on the 
appearance of the mitochondrial network, whereas all other constructs exhibited a 
cytoplasmic localization pattern. Effects on SOD2 regulation in mitochondria were also 
noted. There was no co-localization of any of the fusion proteins with peroxisomes, 
suggesting that the putative C-terminal PTS1 in the AKAPs is not functional. In N-myc-
AKAP10 preparations, the peroxisomes exhibited a more rod-shaped and less tubular 
pattern and giant cells were present. The absence of a single cell with AKAP10-C-myc 
expression indicates induction of cell death with yet unknown mechanism.  
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In conclusion, this thesis established the basic methods and the necessary 
recombinant tools were established to analyze the functions of several AKAPs in a 
Sertoli cell model system. AKAPs with putative C-terminal targeting signals (AKAP1, 
AKAP4, AKAP10) were not targeted to peroxisomes, but exerted strong effects on 
mitochondria or cell survival. How these proteins exert these effects on a molecular 
basis and whether other AKAP families are involved in the control of peroxisomal 
metabolism remains to be elucidated in the future. 
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8 Zusammenfassung 
Sertoli-Zellen im Hoden regulieren die Spermatogenese und wirken an der 
molekularen Pathogenese männlicher Infertilität mit, einem zunehmenden 
medizinischen Problem weltweit. Sie werden durch Testosteron und den FSH-
Signalweg kontrolliert, der den Anstieg von intrazellulärem cAMP induziert, zur 
Aktivierung der Proteinkinase A (PKA) führt und nachfolgende 
Phosphorylierungsreaktionen auslöst. Die subzelluläre Lokalisierung PKA-abhängiger 
Phosphorylierungsprozesse wird  durch verschiedene „A-kinase anchoring“-Proteine 
durchgeführt, die PKA durch hochaffine Bindung in spezifischen zellulären 
Kompartimenten verankern.  Hierbei ist von Interesse, dass AKAP220 (=AKAP11) in 
Sertoli-Zellen der Ratte in Peroxisomen beschrieben wurde, essentiellen Zellorganellen 
in diesem Zelltyp zur Aufrechterhaltung der Homöostase des  Lipidstoffwechsels und 
der Regulierung der Spermatogenese. 
Deshalb waren die Ziele dieser Dissertation, die Auswirkung von FSH auf die 
peroxisomale Genexpression sowie die Auswirkungen der PKA-AKAP220-
Signalkaskade auf Peroxisomen aufzudecken und eventuell neue AKAP-
Familienmitglieder in dieser Zellorganelle oder in Mitochondrien zu charakterisieren. 
Maus TM4 Sertoli-Zellen wurden als Zellkulturmodell zum Studium der FSH-Effekte 
auf das peroxisomale und mitochondriale Kompartiment etabliert. Weil aus der 
Literatur bekannt ist, dass das „steroidogene akut regulatorische Protein“ (StAR) durch 
den LH-receptor/PKA-AKAP-Signalweg in testikulären Leydig-Zellen stimuliert wird, 
wurde die Star mRNA-Expression in TM4-Sertoli-Zellen untersucht. Tatsächlich, war 
die Star-Gen-Expression in TM4 Sertoli-Zellen vorhanden und auch die FSH-
vermittelte  Regulierung des Star-mRNA-Spiegels konnte nachgewiesen werden. Nach 
Optimierung der Zellkulturbedingungen und der FSH-Konzentrationen, wurde die 
Expression einer großen Anzahl von Genen für Biogenese- und metabolische Proteine 
der Peroxisomen analysiert. FSH-Behandlung führte zur erhöhten Expression von 
Pex11α-, Pex13-, Cat-, Acox2- und Abcd2-mRNAs, die Proteine für Proliferation,  
Matrixproteinimport,  ROS-und Lipid-Stoffwechsel in Peroxisomen kodieren, was die 
Beeinflussung dieser Zellorganelle durch den FSH-Signalweg demonstriert.  Um die 
peroxisomale Lokalisation von AKAP220 nachzuweisen und dessen Effekt auf die 
FSH-/PKA-vermittelte Spermatogeneseregulierung auszutesten, wurde versucht, dieses 
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Protein mittels eines gekauften Antikörpers in unterschiedlichen subzellulären 
Fraktionen und hochgereinigten Peroxisomenfraktionen nachzuweisen. Jedoch 
erbrachten alle Folgeexperimente mit Western blots, bioinformatischer 
Evolutionsanalyse von AKAP-Proteinen mit konservierten PTS1-Sigalen sowie 
Sequenzvergleiche zwischen Akap11-cDNA und -Genomsequenzen, dass die 
beschriebene, klonierte Ratte Akap220-cDNA sowie auch alle nachfolgenden Resultate 
über die subzelluläre Lokalisation des AKAP220-Proteins, Artefakte in der publizierten 
Literatur darstellten. 
Innerhalb der  Serie von Experimenten zur Akap11-mRNA-Expression in 
unserem Labor, wurden eine große Anzahl von Gesamt-RNA-Proben aus verschiedenen 
Rattenorganen isoliert und die gewebsspezifische Expressionsanalyse der Akap11-
mRNA unter Verwendung spezifischer Primerpaare analysiert, welche die höchsten 
Akap11-mRNA-Spiegel in Gesamt-RNA aus Hoden, Hypophyse, Gehirn (gesamt) und 
Milz erbrachte, gefolgt von mittelhohen Mengen in Leber, Lunge, Herz und 
Skelettmuskel. Mithilfe der gleichen Primerpaare wurde die Subklonierung von 
verschiedenen Akap11-Anteilen in Plasmidvektoren zur Herstellung von DIG-
markierten cRNA-Proben für Akap11 durchgeführt, entsprechende Vektoren für  interne 
Kontrollen kloniert und eine nichtradioaktive Northern Blot-Methode etabliert, mit 
deren Hilfe in zukünftigen Experimenten alternative Spleißformen von Akap-mRNAs 
nachgewiesen werden können. 
Während der intensiven bioinformatischen Analysen mit teilweise selbst 
geschriebenen Softwareprogrammen, wurden neue AKAP-Proteine (AKAP1, AKAP4, 
AKAP10) mit potentiellen peroxisomalen Zielerkennungssignalen (PTS1, „peroxiosmal 
targeting signal 1“) identifiziert, die auch in hoher Menge im Hoden vorkommen, wie 
durch RT-PCR-Analyse gezeigt wurde. Um die bioinformatische PTS1-Vorhersage zu 
verifizieren, wurden im Folgenden Serien von Experimenten zur subzellulären 
Lokalisation dieser Proteine durchgeführt. Für diesen Zweck wurden jeweils die 
proteinkodierenden Regionen PCR-amplifizierter Akap1-, Akap4- und Akap10 –cDNAs 
der Maus in zwei unterschiedliche myc-Tag-Vektoren zur Expression N- und C-
terminaler myc-Fusionsproteine in TM4 Sertoli-Zellen kloniert. Als Kontrollvektoren 
wurden myc-Tag-GFP-Konstrukte der gleichen Vektoren hergestellt, die die 
Optimierung der TM4 Sertol-Zell-Transfektion und der Detektion der myc-
Fusionsproteine durch Immunfluoreszenz mittels eines  anti-myc-Antikörpers 
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ermöglichten.  Die exprimierten N- und C-terminalen myc-Fusionsproteine aller 
AKAPs (AKAP1, AKAP4, AKAP10) wurden durch Doppelimmunfluoreszenz mit 
Antikörpern gegen myc/SOD2 oder myc/PEX14p detektiert und versucht, mit 
Mitochondrien oder Peroxisomen zu kolokalisieren. Alle Doppelimmunfluoreszenz-
Präparate wurden mittels konventioneller Fluoreszenzmikroskopie und konfokaler 
Laserscanning-Mikroskopie (CLSM) ausgewertet. Nur das exprimierte AKAP1-C-myc-
Protein zeigte ein typisch mitochondriales Verteilungsmuster, kolokalisierte mit SOD2 
und induzierte starke Veränderungen des mitochondrialen Netzwerks, während alle 
anderen exprimierten Fusionsproteine eine cytoplasmatische Lokalisation aufwiesen. 
Kolokalisation der exprimierten Fusionsproteine mit Peroxisomen wurde nicht 
gefunden, was für die fehlende Funktionalität der putativen PTS1-Sequenz am C-
terminalen Ende der AKAPs für den Import in Peroxisomen spricht. Jedoch wies das 
morphologische Organellenmuster der Peroxisomen in N-myc-AKAP10-
exprimierenden Zellen vermehrt runde und weniger tubuläre Formen auf. 
Interessanterweise wurde in parallelen Experimenten keine einzige Zelle mit AKAP10-
C-myc-Expression nachgewiesen, was für die Induktion von Zelltod durch dieses 
Fusionsprotein mittels eines bisher unbekannten Mechanismus spricht.  
Zusammenfassend lässt sich feststellen, dass in dieser Dissertation die 
grundlegende Methodik und die notwendigen rekombinanten Werkzeuge zur Analyse 
der Funktionen verschiedener AKAPs in einem in einem Sertoli-Zellkultur-Modell 
etabliert wurden. AKAPs mit putativen PTS1-Sequenzen (AKAP1, AKAP4, AKAP10) 
wurden nicht in Peroxisomen importiert, lösten jedoch starke Effekte in dem 
mitochondrialen Netzwerk und auf das Zellüberleben aus. Wie diese Proteine diese 
Effekte auf molekularer Ebene auslösen und ob andere AKAP-Familien in die Kontrolle 
des peroxisomalen Metabolismus eingeschaltet sind, soll in der Zukunft aufgeklärt 
werden. 
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9 List of abbreviations 
ABC ATP-binding cassette 
ABP Androgen-binding protein 
AC Adenylyl cyclase 
ACDH Acyl-CoA dehydrogenease 
ACOX1 Acyl-CoA oxidase 1 
ADAPS Alkyl dihydroxyacetonephosphate synthase 
AKAP A-kinase anchoring protein 
Ago2 Argonaute 2 
AGT1 Glyoxylate aminotransferase 1 
ALD/AMN disease Adrenoleukodystrophy/Adrenomyeloneuropathy disease 
Amp Ampicillin 
AR Androgen receptor 
ARE Androgen response elements 
ARTs Assisted reproductive techniques 
AQP2 Aquaporin 2  
AVP Arginine vasopressin  
BTB Blood-testis barrier 
BSA Bovine Serum Albumin Acetylated 
Ca
2+
 Calcium 
CaM Calmodulin 
cAMP Cyclic adenosine monophosphate 
CaN (PP2B) Calcium-activated Ser/Thr phophoatase calcineurin 
CCS Copper chaperone of SOD1 
CLSM Confocal  laser scanning microscopy 
CNG (cNGC) Cyclic nucleotide gated ion channel 
COX Cytochrome c oxidase 
CPT1 Carnitine-palmitoyltransferase 
CREB cAMP response element binding protein 
CT Cholera toxin 
DAPAT Dihydroxyacetonephosphate acyltransferase 
D/D domain Dimerization/docking domain 
DEPC Diethyl pyrocarbonate 
Drp1 Dynamin related protein 1 
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DIG Digoxigenin 
eSpt elongated spermatids 
Siah2 E3 ubiquitin-protein ligase 7 in absentia homolog 2   
SOD1 Cu/Zn superoxide dismutase 1 
EDAs Endocrine disrupting agents 
EGF Epidermal growth factor 
Epac Exchange proteins directly activated by cAMP (cAMP-activated GTP-exchange factors) 
EST Expressed sequence tag 
F0-f ATP synthase F0 complex 
FGF Fibroblast growth factor 
Fis1 Fission factor 1 
FSH Follicle-stimulating hormone 
FSHR Follicle-stimulating hormone receptor 
FSIP1 Fibrous Sheath Interacting Proteins 1 
FSK Forskolin 
GNPAT Glyceronephosphate O-acyltransferase 
GPCR G protein-coupled receptor 
GSK-3β Glycogen synthase kinase 3β 
GV stage Germinal vesicle stage 
HGNC Human genome organization nomenclature committee 
HIF-1α Hypoxia induced factor 1α 
HIV-1 RT HIV-1 reverse transcriptase 
IBMX 3-Isobutyl-1-methylxanthine 
IGF-1 Insulin-like growth factor-1 
IMAGE Intergrated Molecular Analysis of Gonomes and their Expression 
IQGAP1 IQ domain GTPase-activating protein 1 
IVF in vitro fertilization 
KH domain K homology domain 
LDHA Lactate dehydrogenase A 
LDHB Lactate dehydrogenase B 
LPL Lipoprotein lipase 
LH Luteinizing hormone 
LHR Luteinizing hormone receptor 
MAVS Mitochondrial antiviral signaling adaptor 
Mff Mitochondrial fission factor 
Mfn1 Mitofusion1 
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MFP-2 (HSD17B4) Multifunctional protein-2 
MIS Mullerian-inhibiting substance 
MnSOD (SOD2) Manganese superoxide dismutase 
MOM Mitochondrial outer membrane 
MVBs Multivesicular bodies 
MYCBP (AMY-1) c-myc binding protein 
NMDA N-methyl-D-aspartate receptor 2B 
NMJ Neuromuscular junction 
ODFs Outer dense fibers 
OPA1 Optic atrophy 1 
OPLs Oral premalignant lesions 
P450scc 
(CYP11A1) 
cytochrome P450 side-chain cleavage enzyme 
PBS Phosphate-buffered saline 
PC Prostate cancer 
PCR Polymerase-chain reaction 
PDE Phosphodiesterase 
PGC-1α PPARγ coactivator -1α 
PKA Protein kinase A 
PMD1 Peroxisomal and Mitochondrial Division Factor 1 
POMA Paraneoplastic opsoclonus-myoclonus-ataxia 
PP1 Protein phosphatase 1 
PPARγ Peroxisome proliferator-activated receptor γ 
PPRE Peroxisome proliferator responsive element 
PTC Peritubular cells 
PTPD1 Protein tyrosine phosphatase D1 
PTS1 Peroxisomal targeting signal 1 
PTSP Peroxisomal Target Signal Predictor 
PUFA Polyunsaturated fatty acids 
PVDF Polyvinylidene fluoride 
RIAD RI-anchoring disruptor 
RIIBD RII-binding domain 
RB protein Retinoblastoma protein 
rSpt round spermatids 
RXR Retinoid X receptor 
SC Sertoli cells 
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SCD Sudden cardiac death 
SDS-PAGE Sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
Siah2 Seven in absentia homolog 
Spc Spermatocytes 
Spg Spermatogonia 
StAR Steroidogenic acute regulatory protein 
TDS Testicular Dysgenesis Syndrome 
THIO 3-ketoacyl-coenzyme A thiolase 
TSHR Thyroid-stimulating hormone receptor 
TGF Transforming growth factor 
TSHR Thyroid-stimulating hormone receptor 
3’-UTR 3’ untranslated region 
V2R Vasopressin type 2 receptor  
VLCFA Very long chain fatty acids 
WHO world health organization 
 
  
  
Page | 143  
 
10 Figure index 
Figure 1 Schematic illustration of testis structure (Figure 1A) and the hypothalamic-
pituitary-testicular axis (Figure 1B). ......................................................................... 9 
Figure 2 FSH stimulated cAMP-PKA signaling pathway (Figure 2A) and localization 
of PKA Cα in different cell types of a seminiferous tubule in the testis of a 120d-
old wild-type mouse (Figure 2B1) and in TM4 Sertoli cells (Figure 2B2-2B3)....... 11 
Figure 3 AKAPs assemble the key enzymes and factors ............................................... 15 
Figure 4 Alignment of the PKA RII-binding regions of the indicated AKAPs and 
artificial disruptor peptides derived......................................................................... 16 
Figure 5 Crystal structure (PDB ID: 2HWN) ................................................................. 17 
Figure 6 Schematic diagram of hAKAP220 ................................................................... 19 
Figure 7 Schematic diagram of AKAP220 complex leading function in cell migration21 
Figure 8 Schematic diagram of mouse AKAP1 (AKAP121) ......................................... 23 
Figure 9 Structure of a KH domain (PDB ID: 2ANR). .................................................. 23 
Figure 10 A model illustrating post-transcriptional and post-translational regulation of 
StAR. ....................................................................................................................... 25 
Figure 11 A model illustrating of AKAP1 scaffold complex on the mitochondrial outer 
membrane ................................................................................................................ 27 
Figure 12 Normal sperm structure .................................................................................. 28 
Figure 13 Brief overview of major metabolic pathways and peroxins (in number) in 
peroxisomes of the mammalian testis. This picture is adapted from (Colasante et 
al., 2015; Fahimi and Baumgart, 1999). .................................................................. 33 
Figure 14 Schematic illustration of peroxisome purification by OptiPrep™ (keep all 
solutions and carry out all operations at 4°C). ........................................................ 57 
Figure 15 An example of RNA-Chip results to check the quality of isolated RNAs. .... 60 
Figure 16 workflow of Northern blot ............................................................................. 61 
Figure 17 Phylogenetic tree of AKAPs with putative PTS1 .......................................... 75 
Figure 18 Conventional RT-PCR of internal control and positive control .................... 78 
 Page | 144 
 
Figure 19 Conventional RT-PCR results of alterations of mRNA levels of peroxins on 
peroxisome proliferation ......................................................................................... 78 
Figure 20 Conventional RT-PCR results of alterations of mRNA levels of peroxins on 
peroxisomal matrix protein import .......................................................................... 78 
Figure 21 Conventional RT-PCR results of alterations of mRNA levels of antioxidative 
enzymes ................................................................................................................... 79 
Figure 22 Conventional RT-PCR results of alterations of mRNA levels of Acyl-CoA 
oxidases ................................................................................................................... 79 
Figure 23 Conventional RT-PCR results of alterations of mRNA levels of fatty acid 
transporters .............................................................................................................. 80 
Figure 24 Conventional RT-PCR results of PPAR transcription factors ....................... 80 
Figure 25 Peroxisome marker PEX14p .......................................................................... 82 
Figure 26 Western blot of AKAP220 ............................................................................. 82 
Figure 27 BLAST Results of Akap11 mRNAs from Genome Database ....................... 85 
Figure 28 The sequence in the orange frame shows two potential EcoRI linkers in 
mRNA [U48288.1]. ................................................................................................. 87 
Figure 29 Schematic illustration of the alignment and position of Akap11 rat mRNA . 89 
Figure 30 Constructed plasmids maps, including Akap11 rat mRNA specific 
hybridization probes LSP (230bp), BSP1 (308bp), BSP2 (893bp) and BSP3 
(608bp) and housekeeping gene probes, such as GAPDH (417bp), β-actin (120bp), 
28S rRNA (254bp), and StAR (292bp). .................................................................. 90 
Figure 31 Plasmids linearization for in vitro transcription. ............................................ 91 
Figure 32 Sensitivity of DIG-labeled antisense RNA probes were verified by dot blot 
assay (40s exposure)................................................................................................ 91 
Figure 33 Test of 9 different types of washing buffer with 2 distinct dilutions of anti-
DIG concentration (40s exposure) .......................................................................... 92 
Figure 34 Rat tissue total RNA dot blot hybridization with 4 probes ............................ 94 
Figure 35 Total RNA separation by electrophoresis ...................................................... 95 
Figure 36 Distribution profile of Akap11 mRNA in different rat organs. ...................... 96 
Page | 145  
 
Figure 37 PCR product with T7 promotor ..................................................................... 97 
Figure 38 PTS1 prediction of all AKAP1 family members in different species ............ 99 
Figure 39 PTS1 prediction of all AKAP4 family members in different species, ......... 100 
Figure 40 PTS1 prediction of all AKAP10 family members in different species, ....... 101 
Figure 41 Akap1, Akap4 and Akap10 distribution profile ............................................ 102 
Figure 42 Akap1, Akap4 and Akap10 mRNA are high expressed in testis. ................. 103 
Figure 43 Test of designed primers for Akap1, Akap4, Akap10, and their expression 
level in different mouse organs ............................................................................. 104 
Figure 44 Test expression of Akap1, Akap4, Akap10 in TM4 Sertoli cell line ............ 105 
Figure 45 The instruction of myc-tag recombined plasmids generation (inserts are: 
GFP, AKAP1, AKAP4 and AKAP10) .................................................................. 108 
Figure 46 Co-localization test for the myc-tagged GFP-fusion proteins as positive 
controls, N-terminal myc-labelled GFP (GFP-3B) plasmid and C-terminal myc-
labelled GFP (GFP-5B) plasmid. .......................................................................... 110 
Figure 47 Immunofluorescence images showing peroxisomal membrane staining (A-D) 
in untreated TM4 cells........................................................................................... 111 
Figure 48 Immunofluorescence images showing peroxisomal (A-C) and mitochondrial 
(D-F) matrix staining  in untreated TM4 cells.. .................................................... 112 
Figure 49 Double-immunofluorescence showing for the myc-tag and PEX14p, 
revealing that both myc-tagged AKAP1 fusion proteins did not co-localize with 
peroxisomes.. ......................................................................................................... 113 
Figure 50 Double-immunofluorescence showing that N-terminal myc-tagged AKAP1 
(AKAP1-3B) was not co-localized with mitochondria (Figure 50A-C), but C-
terminal myc-tagged AKAP1 (AKAP1-5B) was (Figure 50D-F).. ...................... 114 
Figure 51 CLSM images of double-immunofluorescence for myc and SOD2, showing 
that N-terminal myc-tagged AKAP1 (AKAP1-3B) was not co-localized with 
mitochondria (Figure 51A-B), but C-terminal myc-tagged AKAP1 (AKAP1-5B) 
was (Figure 51C-D).. ............................................................................................. 116 
 Page | 146 
 
Figure 52 Double-immunofluorescence preparations for myc and SOD2, showing two 
types of myc-tagged AKAP4 were both expressed in the cytoplasm and did not co-
localize with mitochondria in TM4 cell line.. ....................................................... 117 
Figure 53 CLSM images of double immunofluorescence preparations for myc and 
SOD2, showing two types of myc-tagged AKAP4 fusion proteins which were both 
localized with cytoplasm and did not target to mitochondria in TM4 cell line.. .. 118 
Figure 54 Double-immunofluorescence preparation for myc and PEX14p, showing that 
N-terminal myc-tagged AKAP10 (AKAP10-3B) did not co-localize with 
peroxisomes.. ......................................................................................................... 119 
Figure 55 Double-immunofluorescence preparation for myc and SOD2, showing that 
the N-terminal myc-tagged AKAP10 (AKAP10-3B) did not co-localize with 
mitochondria.......................................................................................................... 119 
Figure 56 CLSM images of a double immunofluorescence preparation for myc and 
SOD2, showing that the N-terminal myc-tagged AKAP10 (AKAP10-3B) did not 
co-localize with mitochondria.. ............................................................................. 120 
Figure 57 Testis steroidogenesis pathway cooperated between Leydig cell and Sertoli 
cells........................................................................................................................ 130 
 
 
 
 
 
 
 
 
 
Page | 147  
 
11 Tabel index 
Table 1 Cell line and medium (information from ATCC search and Health Protechtion 
Agency cell line data sheet 50004291) ................................................................... 36 
Table 2 Routine reagents list .......................................................................................... 36 
Table 3 Buffer recipes .................................................................................................... 39 
Table 4 Commercial plasmids information .................................................................... 41 
Table 5 List of primers designed and used in this study ................................................ 42 
Table 6 Antibody dilution list ......................................................................................... 47 
Table 7 Properties and preparation of Iodixanol-sucrose solution ................................. 55 
Table 8 Taq-PCR reaction .............................................................................................. 65 
Table 9 Pfu-PCR reaction ............................................................................................... 65 
Table 10 Restriction enzyme digestion of GFP and 3 AKAPs (4h incubation at 37°C) 67 
Table 11 Ligation reaction (overnight incubation at 4°C) .............................................. 68 
Table 12 Chemical structure of commen used antibiotics .............................................. 70 
Table 13 AKAP1-Mutation-PCR reagent....................................................................... 70 
Table 14 AKAP1-Mutation-PCR Dpn I digestion (4h incubation at 37°C) ................... 71 
Table 15 Summarized PTS1 tripeptides derived from the “Peroxisomal Target Signal 
Predictor (PTSP)” .................................................................................................... 74 
Table 16 Optimization of cell density to obtain a monolayer of TM4 cells on Day 4-6 77 
Table 17 Total RNA was isolated using combined methods, and the RNA quality was 
checked by RNA-Chip analysis .............................................................................. 87 
Table 18 Total RNA precipitation .................................................................................. 97 
 
  
 Page | 148 
 
12 Supplemental data 
S 1 Python codes used in this study (see subsection 3.1.3) 
seq_num_len_des_read-code.py: 
from Bio import SeqIO 
AKAP_file = 'All AKAP1 protein from NCBI-143 seq.fasta' 
Read_file = 'seq_num_len_des_read.txt' 
Handle = open(Read_file,'w') 
Handle.write("seq_index\t" + "seq_length\t" + "seq_description\n") 
num = 0 
for seq_record in SeqIO.parse(AKAP_file,'fasta'): 
    num = num + 1 
    seq_len = str(len(seq_record.seq)) 
    seq_des = str(seq_record.description) 
    Handle.write(str(num) + ':\t' + seq_len + 'aa\t' + seq_des + '\n') 
Handle.close() 
Remove_duplicate_seq-code.py: 
from Bio import SeqIO 
from Bio.Seq import Seq 
from Bio.SeqRecord import SeqRecord 
 
seq_map_des = {}   
AKAP_file = 'All AKAP1 protein from NCBI-143 seq.fasta' 
Handle_out = open("seq_without_duplicate.txt", "w")  
Handle_id = open("id_order.txt", "w")  
 
for seq_record in SeqIO.parse(AKAP_file, "fasta"): 
     
    seq_str = str(seq_record.seq)  
    seq_des = str(seq_record.description)  
    if seq_str not in seq_map_des: 
         
        seq_map_des[seq_str] =  [seq_des]  
    else: 
         
        if len(seq_des) > len(seq_map_des[seq_str][0]): 
            seq_map_des[seq_str].insert(0,seq_des)  
        else: 
             
            seq_map_des[seq_str].append(seq_des)  
 
 
num = 0 
for map_seq in seq_map_des: 
    Handle_out.write(">" + seq_map_des[map_seq][0] + "\n" + map_seq + "\n") 
    num = num + 1 
    Handle_id.write(str(num) + ":\t" + str(len(map_seq)) + "aa\t" + ' '.join(seq_map_des[map_seq]) + '\n')  
Handle_out.close() 
Handle_id.close() 
AKAP_domain_selection-code.py: 
from Bio import SeqIO 
import re 
AKAP_file = 'seq_without_duplicate.txt' 
True_file = 'AKAP_true_protein.txt' 
False_file = 'AKAP_false_protein.txt' 
True_file_info = 'AKAP_true_protein_info.txt' 
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Handle_info = open(True_file_info, 'w') 
Handle_info.write('Seq_num' + '\t' + 'Seq_ID' + '\t' + 'Length_aa' + '\t' + 'AKAP_domain' + '\t' + 
'AKAP_Start' + '\t' + 'AKAP_End' + '\n') 
 
Handle_False = open(False_file,'w') 
Handle_True = open(True_file,'w') 
 
num = 0 
for seq_record in SeqIO.parse(AKAP_file,'fasta'): 
    seq_id = seq_record.id  
    seq_des = seq_record.description  
    seq_len = str(len(seq_record))   
    seq_str = str(seq_record.seq) 
     
    pattern = '[AVLISE]..[AVLIF][AVLI]..[AVLI][AVLIF]..[AVLISE]' 
    find_pattern = re.search(pattern,str(seq_record.seq)) 
    if find_pattern: 
        num = num + 1 
        start_site = str(find_pattern.start() + 1) 
        end_site = str(find_pattern.end()) 
        Handle_info.write(str(num) + '\t' + seq_id + '\t' + seq_len + '\t' + find_pattern.group() + '\t' + 
start_site + '\t' + end_site + '\n') 
        Handle_True.write('>' + seq_des + '\n' + seq_str + '\n') 
    else: 
        Handle_False.write('>' + seq_des + '\n' + seq_str + '\n') 
 
Handle_info.close() 
Handle_True.close() 
Handle_False.close() 
PTS1_predictor_filter-code.py: 
import urllib 
from Bio import SeqIO 
import re 
 
handle_file = open("PTS1_pred_score.txt", "w")  
handle_file.write("Seq_num" + "\t" + "Seq_name" + "\t" + "C-terminus_12seq" + "\t" + "Pred_Score" 
+"\t" + "Classification" + "\n")  
 
 
url = 'http://mendel.imp.ac.at/jspcgi/cgi-bin/pts1/pts1.cgi' 
num = 0 
for seq_record in SeqIO.parse('AKAP_true_protein.txt','fasta'): 
    num = num + 1 
    speices_pattern = re.compile("\[(.+)\]") 
    name_data = "AKAP1_" + speices_pattern.findall(seq_record.description)[0] 
    pred_in = re.search("PREDICTED", seq_record.description) 
    if pred_in: 
        name_data = name_data + "_pred_seq" 
    else: 
        name_data = name_data + "_real_seq" 
    seq_data = str(seq_record.seq)[-20:] + '\n'  
    query_data = {"function": "3", "name" : name_data, "sequence" : seq_data} 
    result_info = urllib.urlopen(url, urllib.urlencode(query_data)) 
    result = result_info.read() 
     
    C_ter_pattern = re.compile('<tr><td>C-terminus</td><td>(.+)</td></tr>') 
    score_pattern = re.compile("<tr><td><b>Score</b><td><b>(.+)</b></td></tr>") 
    pred_clas_pattern = re.compile("<tr><td><i>Prediction classification</i></td><td>(.+)</td></tr>") 
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    C_terminus = C_ter_pattern.findall(result)[0]  
    score = score_pattern.findall(result)[0] 
    pred_clas = pred_clas_pattern.findall(result)[0] 
     
    handle_file.write(str(num) + "\t" + seq_record.id + "_" + name_data + "\t" + C_terminus + "\t" + score 
+ "\t" + pred_clas + "\n") 
 
handle_file.close() 
Barplot_AKAP1.R: 
Rdata <- read.table("AKAP_PTS1_for_R.txt", sep = "\t", header = TRUE)  
domain_start <- Rdata$AKAP_Start  
domain_end <- Rdata$AKAP_End     
seq_length <- Rdata$Length_aa         
seq_name <- as.matrix(Rdata$Seq_name) 
PTS1_Pred <- as.matrix(Rdata$Classification) 
c_terminus <- as.matrix(Rdata$C.terminus_12seq)  
 
barplot_data = NULL 
for(i in 1:length(domain_start)) 
{ 
     if(PTS1_Pred[i] == "Targeted") 
       { 
      barplot_data <- cbind(barplot_data, c(domain_start[i] - 0, domain_end[i] - domain_start[i], 
seq_length[i] - domain_end[i], 12)) 
  } 
  else 
  { 
      barplot_data <- cbind(barplot_data, c(domain_start[i] - 0, domain_end[i] - domain_start[i], 
seq_length[i] - domain_end[i], 0)) 
  } 
} 
colnames(barplot_data) = seq_name  
 
png(filename = "AKAP1_domain_feature.png", width = 1200, height = 600, pointsize = 12) 
 
 
par(mar=c(2, 18, 1, 1),bg = grey(1), ps= 6.5,cex =1)  
                                    
b <- barplot(barplot_data, horiz = TRUE, col = c("light blue", "green", "light blue", "red"),space = 0.95, 
las=1, xlim = c(0, max(seq_length) + 500))  
      
text(x = seq_length + 90, y = b, labels = c_terminus)    
 
dev.off() 
 
pdf(file = "AKAP1_domain_feature.pdf", paper = "a4", width = 12, height = 12) 
 
par(mar=c(2, 18, 1, 1),bg = grey(1), ps= 6.5,cex =1)                                    
b <- barplot(barplot_data, horiz = TRUE, col = c("light blue", "green", "light blue", "red"),space = 0.95, 
las=1, xlim = c(0, max(seq_length) + 500))  
 
text(x = seq_length + 180, y = b, labels = c_terminus)    
 
dev.off() 
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           S 2 RNA Chip result to show the quality of total RNA isolated from rat tissues (see subsection 4.5.3) 
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S 3 The 531 types of C-terminal tripeptides of all known AKAPs retrieved from “UniProt” database (the 
organge marked are hits by the Combination Matrix from Table 15)  
No.            
1 AAA DEA ENS GQE KEK LGQ NIR PSS RRR TES VLC 
2 AAE DED ENT GRD KER LIE NKK PST RSR TEY VNL 
3 ACQ DEG EPE GSR KGS LIK NLF PTE RTP TFD VQI 
4 AEH DEN EPL GTK KIH LIL NLI PTG RVK TFS VRG 
5 AES DEV EPT GVA KIT LKF NLT PVH RVL TGS VRR 
6 AFI DFS EPV HDT KIV LKK NLY PWN RVV THA VSK 
7 AFL DGF EQE HFD KKA LKR NNE QAC SAS THH VSP 
8 AFW DGK EQN HFY KKI LKV NNS QAD SCH TKG VTE 
9 AGP DGS ERG HGK KKK LKW NPG QAL SCL TKI VTV 
10 AGS DGT ERH HLG KKR LLH NPR QAQ SDS TKL VVE 
11 AHQ DHS ETL HLL KLA LLK NPS QAV SEA TKR VVM 
12 AIE DKK EVI HLS KLC LLQ NPY QDN SEE TKV VYE 
13 AIQ DLI EVV HTA KLL LLS NRK QDY SEI TLN VYS 
14 AKG DMY FEC HTE KLS LMY NRR QEV SEN TLT WEA 
15 AKL DNE FEM HTG KLV LNA NRV QLE SET TLV WLE 
16 AKP DNV FGT ICL KMC LNF NSE QLK SFL TMR WNR 
17 AKS DNY FHF IDF KMF LQA NTI QMF SFS TMT WSG 
18 AKV DQL FIK IDL KMR LQR NVE QNL SGA TNL WSR 
19 ALA DRI FKK IEK KNI LRR NVN QRA SGC TPE WSS 
20 ALK DSF FLF IFA KPE LRS NVT QRR SGR TQR WTA 
21 ALP DSL FLI IFC KPP LSC NYK QRT SIC TRR YAG 
22 ALW DSY FNL IFD KQA LSE NYR QRY SIS TSL YAL 
23 ANL DTQ FNN IGA KQD LSI PAC QSC SKK TTC YAP 
24 ARK DVE FPE IGE KQI LSK PAE QSF SLE TTI YDP 
25 ASE EAE FSL IGK KQN LSM PAV QSG SLG TTL YDT 
26 ASG EAP FTL IGR KQP LSR PDP QSP SLS TTV YGS 
27 ASL EDA FVK IIC KQS LSV PDT QSQ SNI TTY YIW 
28 ASP EDC FYD IIL KRE LSY PEE QTD SPM TVM YKQ 
29 ATE EDN GAP IKE KRL LTK PER QTE SPR TVS YMG 
30 ATP EDS GCG ILK KRN LTS PES QTG SPS TVV YRN 
31 ATV EEE GDE IME KSK LVL PFE QVD SRA TYD YSC 
32 AVL EEG GEG INF KSN LVQ PGC QVL SRG TYI 
 
33 AVQ EEL GEP INR KSP LVS PGE RAA SRS TYK 
 
34 AWC EEN GET INT KTE MAQ PGG RAE SRV VAA 
 
35 AYG EEV GGA IPF KVI MEE PGH RAT SSG VAH 
 
36 CCP EGF GGG IPS KVL MEQ PGQ RGF SSL VAP 
 
37 CDI EGK GGP IQE KVR MFI PGS RGL SSS VDS 
 
38 CGK EGT GGS IRR KVV MHR PGW RGR SST VEK 
 
39 CLF EHA GIS ISK KYL MHS PHK RHL STE VER 
 
40 CLI EIA GKS ISN LDM MIK PIL RKF STI VES 
 
41 CMK EKD GLG ITF LDQ MKL PKE RKI STK VEV 
 
42 CPF EKI GLH ITL LEC MKQ PKN RKY STL VFV 
 
43 CRL EKK GLP IYE LEE MLE PLN RLA STV VGH 
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44 CSK EKT GLS KAL LEF MLV PLP RLC SVL VHA 
 
45 CSQ ELE GME KCY LEK MRR PLQ RLE SVS VHR 
 
46 CTE ELG GNA KDQ LET MVV PLS RLQ TAS VHV 
 
47 DAS ELT GNE KDS LFF NCK PNV RMA TCE VIV 
 
48 DDD ENA GNG KEA LFL NDN PPE RPV TEE VKL 
 
49 DDE ENI GNL KEE LFQ NEN PPS RQM TEL VKT 
 
50 DDQ ENP GPA KEF LGK NFS PRE RRD TEM VLA 
 
 
 
 
S 4 All known PTS1 binding sites downloaded from PTS1 BLOCK (http://216.92.14.62/diy_PTS1.html) 
at the “PeroxisomalDB Home” website 
No. Peroxisomal proteins Their last 12-aa residues Their last 3-aa residues 
1 GOX1 TEWDTPRPSARL ARL 
2 GGT1 TQYDNNFGYSKM SKM 
3 EHHADH WQSLAGSPSSKL SKL 
4 mmSerhl LQGLQRMTSARL ARL 
5 mmCrot HDMIQLMNTAHL AHL 
6 AAT2 EVVRFYTIEAKL AKL 
7 AT5G18100.1 IIGLQSSADAKL AKL 
8 mmEphx2 TEVQNPSVTSKI SKI 
9 OPR3 TDYPFLAPFSRL SRL 
10 mmEhhadh WQSLAGPHSSKL SKL 
11 CIT2 YKELVKNIESKL SKL 
12 DHRS4 TVVVGGGTPSRL SRL 
13 LYS4 KGGLEGWVKSQL SQL 
14 AOAT2 SQYADNFGYSRM SRM 
15 mmCrat RTLLQNHPRAKL AKL 
16 mmMlycd SLVAQFQNNSKL SKL 
17 HMGCL TSSKVAQATCKL CKL 
18 NUDT19 NYIVNKRYTAHL AHL 
19 MLS IVAHYPINVSRL SRL 
20 mmAgxt REALQHCPKNKL NKL 
21 PTE2b LGGTQKTAVPKL PKL 
22 PTE2 LGGHEGTIPSKV SKV 
23 BAAT RKHLIPDVTSQL SQL 
24 GNPAT KTPIGKPATAKL AKL 
25 DAMOX EKKLSRMPPSHL SHL 
26 mmPte2a LDGKKKTIPAKL AKL 
27 mmGnpat KKPIGKPATAKL AKL 
28 SPS19 PEALIKSMTSKL SKL 
29 PAOX WAPQVQQPRPRL PRL 
30 EPHX2 SDARNPPVVSKM SKM 
31 CRAT RALLQSHPRAKL AKL 
32 GSTK1 MGPIPPAVNARL ARL 
33 PRDX5 TCSLAPNIISQL SQL 
34 ACH2 ARPPKPSGTSKL SKL 
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35 IDE VKPHINFMAAKL AKL 
36 PECI AVVNFLSRKSKL SKL 
37 PTE1 IRVKPQVSESKL SKL 
38 ACOX2 IRPLLQSWRSKL SKL 
39 mmPaox WDSQVEQSRPRL PRL 
40 MLYCD SLVAQFQKNSKL SKL 
41 GOX2 TEWDTPRHLPRL PRL 
42 IDP3 SSNEDKKGMCKL CKL 
43 HAO2 EINRNLVQFSRL SRL 
44 AGT LQHHIPLIPSRI SRI 
45 AT3G06860.1 LSAPVKQASSRL SRL 
46 mmDao1 EKKLSRLPPSHL SHL 
47 PDCR GLPDFASFSAKL AKL 
48 AT5G63380.1 TKIAVDGNASKL SKL 
49 CHY1 RNNLPALGIAKL AKL 
50 MLS1 STKATPTDLSKL SKL 
51 mmHao3 EISPDLIQFSRL SRL 
52 IDH1 ENLKIKLAQAKL AKL 
53 PECR KMKETFKEKAKL AKL 
54 CAT2 ALENENKRKAKL AKL 
55 DCI1 KQLQEGNRRHKL HKL 
56 mmAcox2 IRPLMQSWKPKL PKL 
57 ECH1 NKELKTVTFSKL SKL 
58 mmPecr RIKESFKKKAKL AKL 
59 CROT HDMIQLMNSTHL THL 
60 mmBC016076 LSGDKRPSPAKL AKL 
61 mmPte1 IRLKPQVSESKL SKL 
62 mmAcox1 YYKHLKPLQSKL SKL 
63 FOX2 AAVKLSQAKSKL SKL 
64 AT1G68010.1 NSKALGLPVSKL SKL 
65 AT3G51840.1 IASFKPATRSRL SRL 
66 mmUox TGTVKRKLPSRL SRL 
67 PCS60 TFAKSSRNKSKL SKL 
68 DASOX HALRTPIPKSNL SNL 
69 mmAmacr RIVESDKLKANL ANL 
70 NPY1 YKNLRKTSSSHL SHL 
71 mmHsd17b4 KLQMILKDYAKL AKL 
72 HSD17B4 KLQMILKDYAKL AKL 
73 MDH3 KGKSFILDSSKL SKL 
74 AGXT RAALQHCPKKKL KKL 
75 mmDecr2 QLLEFESFSAKL AKL 
76 AT2G35690.1 PLIKQRFRSAKL AKL 
77 mmPte2b LGSTHSRASCRL CRL 
78 mmAcox3 NKSVADRLKSQL SQL 
79 ACOX3 NKSVADRLKSQL SQL 
80 TES1 VYGSERDIRAKF AKF 
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81 mmHao1 LVRKNPLAVSKI SKI 
82 ECI1 RQLGSKQRKHRL HRL 
83 HAO1 LVRKNPLAVSKI SKI 
84 ACOX1 SYKHLKSLQSKL SKL 
85 LONP VKTRPGLLNSKL SKL 
86 mmEch1 KRDTKSITFSKL SKL 
87 mm5330420D20Rik HTLRTPASLSKL SKL 
88 PIPOX ISRFPSLGKAHL AHL 
89 mmNudt7 RTFLWRYSLSKL SKL 
90 GPK1 NKDNDITTDAKI AKI 
91 mmPeci AIMSFVSRKPKL PKL 
92 GTO1 VPLGPKPDISRL SRL 
93 ACOX FNWVEANAWSSL SSL 
94 AMACR KIIESNKVKASL ASL 
95 LYS1 RHCARVKRSSRL SRL 
96 CAT GSHLAAREKANL ANL 
97 mmIdi1 SPFVDHEKIHRL HRL 
98 mmCat TGEPVELKTQAL QAL 
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S 5 PTS1 prediction of AKAP1, -4, -10 family members 
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